Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3026179	s-normet	nmol/l (nmol/l)	6112	8078	0.06%
3026179	s-normet	— (—)	302	325	100.00%	Distribution not available
3026179	s-normet	nmol/l____ (nmol/l)	115	123	0.00%
3026179	s-normet	nmol/L (nmol/l)	23	26	0.00%
3026179	s-normet	umol/l (nmol/l)	7	10	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of other endocrine glands

1033

2781

3.77

321.14

1.7

1.2

0.80

2.25

nmol/l

1.01

1001

2676

Hypertension

1639

1955

4.85

307.65

1.3

1.65

1.48

nmol/l

0.05

1587

1904

Cardiovascular diseases

1003

1114

4.87

307.65

1.3

1.4

0.52

2.13

nmol/l

0.51

974

1077

Benign neoplasm of other and unspecified endocrine glands

1439

641

29.39

307.65

1.5

1.3

0.66

3.38

nmol/l

0.49

1412

613

Hypertensive diseases

1638

1958

4.84

307.65

1.3

1.65

1.48

nmol/l

0.05

1586

1907

Benign neoplasm: Adrenal gland

1300

366

59.24

307.65

1.4

1.3

0.64

5.50

nmol/l

0.50

1274

350

Antihypertensive medication - note that there are other indications

1001

975

5.47

307.65

1.3

1.4

2.28

0.50

nmol/l

0.51

968

945

Hypertensive diseases (excluding secondary)

1249

1118

6.72

307.65

1.3

1.64

2.14

nmol/l

0.11

1208

1086

Secondary hypertension

373

207

19.58

307.65

1.4

1.3

3.44

9.09

nmol/l

0.28

354

200

Hypertension, essential

1670

1919

5.06

307.65

1.3

1.63

1.50

nmol/l

0.04

1615

1869

Cardiovascular diseases (excluding rheumatic etc)

1142

1386

4.82

307.65

1.3

1.53

1.82

nmol/l

0.06

1108

1340

Hyperaldosteronism

221

114

24.07

293.10

1.3

1.2

0.56

16.48

nmol/l

0.50

210

107

Malaise and fatigue

997

2239

3.58

272.23

1.3

1.43

2.23

nmol/l

0.28

951

2158

Abnormalities of heart beat

748

1824

4.08

260.61

1.3

2.23

1.70

nmol/l

0.13

720

1758

Headache

1167

2919

3.15

259.49

1.4

1.3

2.25

1.84

nmol/l

0.11

1135

2815

Other heart diseases

746

1098

4.50

258.00

1.4

1.3

0.59

2.16

nmol/l

0.49

721

1066

Benign neoplasms

1457

2921

2.75

232.01

1.4

1.2

2.08

1.46

nmol/l

0.21

1419

2809

Pain in throat and chest

1338

2827

2.84

231.97

1.3

1.66

1.31

nmol/l

0.13

1295

2731

General symptoms and signs

1613

3118

2.63

229.20

1.3

1.27

1.76

nmol/l

0.21

1568

3012

Exclusions for E4_PCOS_BROAD

474

974

5.09

216.74

2.3

1.2

1.04

2.39

nmol/l

0.34

462

942

Metabolic disorders

1515

3604

2.56

216.30

1.4

1.3

1.29

1.58

nmol/l

0.13

1465

3493

Other disorders of fluid, electrolyte and acid-base balance

656

1635

3.89

211.45

1.3

0.89

2.69

nmol/l

0.75

625

1571

Cardiac arrhythmias

973

1982

3.20

210.77

1.3

1.00

1.13

nmol/l

0.07

938

1926

Abnormalities of breathing

1290

2866

2.61

189.01

1.3

0.58

1.30

nmol/l

0.62

1240

2767

Anaemias

315

263

7.83

182.40

1.5

1.3

0.60

0.50

nmol/l

4.07

300

250

Endocrine, nutritional and metabolic diseases

1063

1907

2.85

175.98

1.3

2.41

1.17

nmol/l

0.32

1027

1846

Symptoms and signs involving the circulatory and respiratory systems

1384

2873

2.44

170.86

1.3

2.43

1.30

nmol/l

0.41

1338

2774

Other heart diseases, wide

1403

3650

2.36

169.44

1.3

1.63

1.48

nmol/l

0.05

1351

3549

Other disorders of adrenal gland

191

200

10.51

165.97

3.5

1.2

1.68

9.46

nmol/l

0.42

186

192

Hypokalaemia

327

625

5.48

162.85

1.2

1.3

1.12

5.26

nmol/l

0.65

317

604

Other arrhythmias

1053

3106

2.57

161.22

1.3

1.97

1.64

nmol/l

0.10

1010

3019

Cerebrovascular diseases (FINNGEN)

442

753

4.19

144.68

1.5

1.2

0.62

2.90

nmol/l

0.49

426

729

Hypertensive heart and/or renal disease

394

646

4.55

144.53

1.4

1.3

5.46

3.35

nmol/l

0.20

377

624

Diseases of arteries, arterioles and capillaries (FINNGEN)

370

539

4.84

142.47

1.3

3.54

3.83

nmol/l

0.02

347

524

Any gastric operation

994

1932

2.61

140.32

1.4

1.2

0.57

3.04

nmol/l

1.33

962

1857

GASTRO-related operations

994

1932

2.61

140.32

1.4

1.2

0.57

3.04

nmol/l

1.33

962

1857

Dyspnoea

1351

4560

2.16

139.92

1.3

0.73

1.61

nmol/l

0.99

1303

4409

Medical observation and evaluation for suspected diseases and conditions

926

1790

2.68

137.95

1.4

1.3

0.58

3.19

nmol/l

1.29

911

1719

Episodal and paroxysmal disorders

1458

3474

2.15

136.07

1.3

1.4

1.64

1.49

nmol/l

0.05

1413

3340

Neoplasms

958

1957

2.60

136.00

1.5

1.2

0.58

1.77

nmol/l

0.69

933

1876

Hypothyroidism (congenital or acquired)

298

268

6.32

135.86

1.4

0.50

nmol/l

0.12

288

255

Sleep apnoea

1407

4235

2.12

133.91

1.3

1.60

nmol/l

0.00

1359

4095

Hypothyroidism and >3 levothyroxin purchases

295

268

6.26

133.54

1.4

0.51

0.50

nmol/l

0.19

285

255

Hypothyroidism, levothyroxine purchases

295

268

6.26

133.54

1.4

0.51

0.50

nmol/l

0.19

285

255

Sleep apnoea, including avohilmo

1462

4278

2.09

132.97

1.3

1.56

1.59

nmol/l

0.01

1412

4131

Paroxysmal tachycardia

338

625

4.59

131.25

1.3

3.71

3.38

nmol/l

0.03

319

606

Disorders of lipoprotein metabolism and other lipidaemias

1170

3175

2.27

130.10

1.3

1.50

1.73

nmol/l

0.08

1134

3078

Dizziness and giddiness

1146

4063

2.22

128.73

1.3

3.03

1.19

nmol/l

0.53

1099

3934

Other headache syndromes

684

2515

2.76

128.68

1.3

1.77

1.82

nmol/l

0.01

665

2412

Heart failure and antihypertensive medication

328

436

4.98

127.44

1.3

3.90

0.57

nmol/l

0.52

313

419

Abnormal blood-pressure reading, without diagnosis

163

195

8.98

127.38

1.2

1.4

7.62

9.63

nmol/l

0.07

155

189

Tramadol

1145

3072

2.27

127.02

1.3

0.60

1.76

nmol/l

1.02

1101

2972

Malignant neoplasm of endocrine gland, including Hilmo

253

484

5.54

126.47

3.6

1.3

1.36

6.64

nmol/l

0.64

248

466

Symptoms and signs involving cognition, perception, emotional state and behaviour

1390

4585

2.05

122.83

1.3

2.31

1.13

nmol/l

0.42

1334

4442

Diseases of oesophagus, stomach and duodenum

1488

4438

2.00

119.79

1.3

1.29

1.45

nmol/l

0.07

1428

4296

Other diseases of intestines

1429

3953

2.03

118.74

1.3

0.60

1.79

nmol/l

1.31

1380

3827

Hypertensive Heart Disease

334

601

4.30

116.18

1.3

3.13

3.55

nmol/l

0.04

320

581

Atrial fibrillation and flutter

400

685

3.83

113.37

1.3

0.65

3.14

nmol/l

0.48

388

663

Abdominal and pelvic pain

1270

3060

2.10

112.19

1.3

0.93

1.97

nmol/l

0.67

1219

2972

Hard cardiovascular diseases

1194

3368

2.12

112.05

1.4

1.3

1.48

1.70

nmol/l

0.07

1156

3265

All chronic kidney diseases

832

2817

2.39

111.15

1.4

1.3

2.94

1.93

nmol/l

0.24

796

2713

Examination and observation for other reasons

794

1786

2.54

110.41

1.3

0.58

3.20

nmol/l

1.29

772

1715

Syncope and collapse

643

2034

2.68

110.17

1.3

0.59

2.40

nmol/l

1.10

622

1960

Nausea and vomiting

452

1421

3.16

108.27

1.3

1.87

3.40

nmol/l

0.37

431

1379

Pain in joint

778

1930

2.51

108.09

1.3

1.4

0.57

2.18

nmol/l

0.89

743

1872

Other soft tissue disorders, not elsewhere classified

1267

3561

2.04

107.39

1.3

1.4

1.04

1.49

nmol/l

0.30

1228

3437

Type 2 diabetes, wide definition

1111

3353

2.11

105.32

1.4

1.3

2.11

1.20

nmol/l

0.39

1078

3236

All kidney diseases

1362

4728

1.95

105.18

1.4

1.3

0.62

1.60

nmol/l

1.27

1311

4572

Symptoms and signs involving the digestive system and abdomen

1242

3060

2.05

103.02

1.3

0.92

1.97

nmol/l

0.68

1194

2972

Symptoms and signs involving the nervous and musculoskeletal systems

874

3993

2.22

102.96

1.3

0.59

1.81

nmol/l

1.37

843

3848

Depression medications

283

284

5.07

100.11

1.2

1.4

0.55

0.49

nmol/l

1.19

275

271

Pain in limb

1119

3485

2.06

99.76

1.3

1.4

0.74

1.52

nmol/l

0.67

1084

3362

Implicit Sepsis, including avohilmo

1166

4191

2.01

99.47

1.4

1.3

1.69

1.63

nmol/l

0.02

1119

4058

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1247

4337

1.96

98.12

1.4

1.3

0.94

1.59

nmol/l

0.51

1201

4202

Migraine

731

2408

2.39

97.79

1.3

3.20

1.42

nmol/l

0.42

713

2315

Implicit Sepsis

1084

3950

2.04

97.64

1.4

1.3

1.79

1.70

nmol/l

0.03

1044

3818

Ischemic heart diseases

1147

3396

2.03

96.93

1.3

1.52

1.70

nmol/l

0.06

1112

3285

Percutaneous Coronary Intervention

1094

3266

2.06

96.29

1.3

1.57

1.74

nmol/l

0.05

1054

3159

Low back pain

1049

3455

2.07

96.05

1.3

1.38

1.98

nmol/l

0.25

1008

3347

Pure hypercholesterolaemia

993

2998

2.13

95.89

1.3

0.62

1.79

nmol/l

1.00

964

2906

Sleep disorders (combined)

1427

3973

1.89

95.48

1.3

0.91

1.66

nmol/l

0.60

1378

3834

Pain, not elsewhere classified

435

1486

2.98

94.79

1.4

1.3

2.48

2.93

nmol/l

0.07

418

1426

Condition for Implicit Sepsis (Organ dysfunction codes)

1190

4243

1.96

94.55

1.4

1.3

0.96

1.62

nmol/l

0.50

1143

4109

Codeine

1200

3278

2.00

94.43

1.3

1.47

1.68

nmol/l

0.07

1150

3166

Other CVD (FINNGEN)

188

246

5.99

94.07

1.5

1.3

0.62

7.80

nmol/l

0.50

177

237

Coronary revascularization (ANGIO or CABG)

1087

3267

2.04

93.65

1.3

1.58

1.74

nmol/l

0.05

1049

3160

Diabetes mellitus

1351

4153

1.90

93.14

1.4

1.3

3.16

1.06

nmol/l

0.73

1309

4008

Major coronary heart disease event

1146

3469

2.00

92.48

1.3

1.53

1.68

nmol/l

0.05

1109

3356

Diabetes, varying definitions

1343

4154

1.89

92.07

1.4

1.3

3.18

1.06

nmol/l

0.74

1300

4010

Emergency coronary revascularization (for ACS)

1155

3563

1.98

90.89

1.3

1.53

1.66

nmol/l

0.04

1111

3448

Type 2 diabetes

1304

4006

1.90

90.82

1.4

1.3

3.26

1.08

nmol/l

0.73

1261

3869

Other functional intestinal disorders

655

2533

2.38

89.63

1.4

1.3

1.90

2.48

nmol/l

0.15

627

2450

Dorsalgia

1265

3516

1.92

89.13

1.3

0.58

1.96

nmol/l

1.38

1216

3406

Fever of other and unknown origin

700

2660

2.30

88.31

1.4

1.3

0.61

1.97

nmol/l

1.07

680

2567

Atrial fibrillation and flutter with reimbursement

314

527

3.82

87.98

1.3

3.95

3.94

nmol/l

0.00

304

509

Benzodiazepine use

1344

4985

1.84

86.97

1.4

1.3

1.54

1.47

nmol/l

0.03

1297

4813

Opioids

1225

3303

1.93

86.91

1.3

1.44

1.67

nmol/l

0.08

1179

3191

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1306

4809

1.85

86.11

1.4

1.3

0.64

1.76

nmol/l

1.48

1259

4648

Type 2 diabetes, definitions combined

1244

3865

1.89

85.21

1.3

2.56

1.11

nmol/l

0.48

1205

3736

Chronic kidney disease

468

1690

2.71

84.77

1.4

1.3

0.73

3.09

nmol/l

1.05

444

1627

Type 2 diabetes, strict (exclude DM1)

1248

3894

1.88

84.40

1.3

2.56

1.10

nmol/l

0.48

1209

3760

Type 2 diabetes, definitions combined, including avohilmo

1244

3866

1.88

83.40

1.3

2.57

1.10

nmol/l

0.48

1205

3736

Disorders of thyroid, IBD co-morbidities

243

388

4.36

83.20

1.2

1.3

0.56

0.59

nmol/l

0.66

235

375

Gastro-oesophageal reflux disease

938

3980

2.01

83.00

1.3

0.58

1.55

nmol/l

1.13

911

3855

Lower back pain or/and sciatica

1416

4961

1.79

82.84

1.3

1.18

1.56

nmol/l

0.21

1360

4800

Codeine or tramadol medication

1437

4388

1.79

82.19

1.3

1.45

1.60

nmol/l

0.06

1382

4238

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

390

602

3.28

81.55

1.3

1.4

5.07

0.58

nmol/l

0.50

378

586

Other nutritional deficiencies

953

4467

1.97

80.86

1.3

1.00

1.57

nmol/l

0.39

922

4313

Neurological diseases

1011

2535

2.02

80.68

1.3

1.4

2.10

1.40

nmol/l

0.21

981

2430

Diverticular disease of intestine

934

2887

2.04

80.27

1.3

0.63

2.26

nmol/l

1.32

904

2797

Heart failure, not strict

1011

3499

1.96

79.96

1.3

1.68

1.86

nmol/l

0.05

974

3391

Spondylopathies

1010

3065

1.97

78.14

1.3

0.60

2.17

nmol/l

1.36

965

2973

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

553

2351

2.40

77.83

1.5

1.3

0.59

2.03

nmol/l

0.95

537

2264

Anxiety disorders, excluding more controls

1107

3776

1.89

77.64

1.3

1.70

1.75

nmol/l

0.01

1066

3656

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1206

3905

1.85

77.60

1.3

3.47

1.10

nmol/l

0.75

1170

3775

Persons encountering health services in other circumstances, wide

1428

4195

1.76

76.30

1.3

0.88

1.64

nmol/l

0.65

1376

4056

Irritable bowel syndrome

439

1698

2.63

75.66

1.2

1.3

2.44

3.16

nmol/l

0.12

426

1646

STROKE

736

2315

2.17

75.62

1.4

1.3

0.62

2.19

nmol/l

1.04

712

2245

Renal tubulo-interstitial diseases

1143

4609

1.83

75.02

1.4

1.3

1.38

1.62

nmol/l

0.10

1095

4460

Other symptoms and signs involving the nervous and musculoskeletal systems

622

2821

2.24

74.96

1.3

0.60

2.24

nmol/l

1.27

602

2718

Asthma, unspecified (mode), excluding more controls

702

2327

2.18

74.67

1.3

2.02

1.63

nmol/l

0.11

677

2260

Spondylosis

740

2759

2.12

74.57

1.3

1.74

2.34

nmol/l

0.17

705

2677

Neurological diseases, wide definition

333

501

3.38

72.57

1.3

1.4

0.55

0.57

nmol/l

0.25

324

481

Oedema, not elsewhere classified

437

1675

2.59

72.56

1.3

0.63

2.67

nmol/l

0.99

422

1613

Parasetamol

830

2032

2.08

72.01

1.3

1.4

0.56

2.31

nmol/l

1.02

797

1979

Obesity

882

4354

1.93

70.70

1.3

1.04

1.59

nmol/l

0.36

853

4200

Obesity and other hyperalimentation

885

4367

1.93

70.69

1.3

1.04

1.59

nmol/l

0.36

856

4213

Obesity due to excess calories

690

3335

2.10

70.65

1.3

1.16

1.84

nmol/l

0.34

672

3220

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1361

4191

1.74

69.92

1.3

0.89

1.64

nmol/l

0.63

1320

4054

First line medication for Crohn's disease

1361

4253

1.73

69.57

1.3

0.62

1.71

nmol/l

1.28

1305

4120

Asthma, unspecified (mode)

719

2498

2.10

69.53

1.3

1.99

1.57

nmol/l

0.12

693

2423

Hyperlipidaemia, other/unspecified

516

1990

2.36

69.43

1.3

4.25

2.42

nmol/l

0.29

499

1920

Anxiety disorders

1191

4647

1.77

69.22

1.3

1.62

1.50

nmol/l

0.05

1149

4492

Neurotic, stress-related and somatoform disorders

1181

4622

1.78

68.96

1.3

1.62

1.51

nmol/l

0.05

1140

4467

Asthma, excluding more controls

925

2442

1.96

68.66

1.3

0.76

1.57

nmol/l

0.54

889

2368

Diabetes medication

1306

4421

1.74

68.64

1.3

3.25

1.04

nmol/l

0.75

1263

4270

Diabetes, insulin treatment (Kela reimbursement)

1274

4369

1.75

68.62

1.3

3.32

1.05

nmol/l

0.76

1235

4221

Other (not insulin) diabetes medications

1241

4166

1.76

68.39

1.3

2.56

1.08

nmol/l

0.49

1200

4028

Sciatica+with lumbago

700

3021

2.07

68.38

1.2

1.3

0.59

2.18

nmol/l

1.36

674

2927

Asthma (only as main-diagnosis), excluding more controls

870

2442

1.99

68.30

1.3

0.77

1.57

nmol/l

0.53

836

2368

Symptoms and signs concerning food and fluid intake

191

477

4.11

68.12

1.3

0.59

4.35

nmol/l

0.51

181

461

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

895

4139

1.90

67.92

1.3

2.70

1.52

nmol/l

0.35

863

3994

Mood disorders, excluding more controls

1182

3928

1.78

67.74

1.3

1.67

1.70

nmol/l

0.01

1137

3804

Other dorsopathies, not elsewhere classified

1199

3525

1.78

66.45

1.4

1.3

0.58

1.95

nmol/l

1.37

1157

3415

Other specific joint derangements/joint disorders

935

3104

1.89

65.75

1.3

1.4

1.02

1.04

nmol/l

0.01

893

2997

Renal failure

626

2524

2.14

65.67

1.4

1.3

0.72

2.44

nmol/l

1.16

595

2428

Disorders of parathyroid gland

344

1252

2.78

65.43

1.3

1.2

1.11

3.33

nmol/l

0.67

330

1195

Complications of surgical and medical care, not elsewhere classified

1262

4946

1.72

65.08

1.3

1.59

1.49

nmol/l

0.04

1217

4775

Functional dyspepsia

421

1722

2.49

64.65

1.3

2.56

2.54

nmol/l

0.00

402

1668

Other intervertebral disc disorders

1009

3296

1.84

64.37

1.3

0.59

2.06

nmol/l

1.37

972

3194

Other antidepressants

1231

3615

1.75

64.33

1.3

0.96

1.80

nmol/l

0.60

1187

3498

Disorders of gallbladder, biliary tract and pancreas

1236

4502

1.72

63.69

1.3

0.61

1.66

nmol/l

1.33

1197

4351

Persons encountering health services in other circumstances

568

2625

2.17

63.47

1.3

0.58

2.26

nmol/l

1.21

543

2526

ILD medications: prednisolone, methylprednisolone, prednisone

1336

4428

1.69

62.71

1.3

0.60

1.68

nmol/l

1.33

1282

4278

Hernia of abdominal wall, postoperative

243

749

3.28

62.48

1.4

1.2

0.65

6.94

nmol/l

1.31

236

722

Asthma (only as main-diagnosis)

888

2624

1.91

62.31

1.3

0.76

1.52

nmol/l

0.53

853

2542

Asthma

948

2624

1.88

62.24

1.3

0.76

1.52

nmol/l

0.54

912

2542

General examination and investigation of persons without complaint and reported diagnosis

711

1789

2.08

62.20

1.3

0.59

3.19

nmol/l

1.28

690

1718

Hyperparathyroidism

304

1067

2.88

62.08

1.4

1.2

1.18

3.78

nmol/l

0.67

291

1021

Exclusions for E4_PCOS_CONSORTIUM

955

3270

1.84

61.47

1.6

1.3

0.77

1.86

nmol/l

0.89

921

3160

Ischaemic heart disease, wide definition

982

3342

1.83

61.45

1.4

1.3

1.69

1.73

nmol/l

0.01

947

3231

Intracranial trauma

654

2140

2.08

61.27

1.3

1.4

0.58

1.54

nmol/l

0.61

636

2060

Pain (limb, back, neck, head abdominally)

777

1957

2.00

61.06

1.3

1.4

2.06

2.15

nmol/l

0.02

747

1901

Used for control exclusion in common control thyroid runs

1225

3607

1.72

60.60

1.3

2.68

1.15

nmol/l

0.57

1185

3484

Migraine without aura

293

1034

2.88

60.41

1.3

4.37

2.24

nmol/l

0.21

285

1004

Asthma (mode)

936

2661

1.86

60.21

1.3

0.76

1.50

nmol/l

0.53

902

2579

Hypo-osmolality and hyponatraemia

269

901

3.02

60.12

1.3

0.65

4.34

nmol/l

0.92

254

866

Oral corticosteroids

1306

4606

1.67

60.06

1.3

0.60

1.63

nmol/l

1.32

1251

4454

Dysphagia

350

1361

2.61

59.76

1.4

1.3

3.02

3.56

nmol/l

0.07

333

1317

Persons encountering health services for specific procedures and health care

1316

4692

1.67

59.63

1.4

1.3

0.61

1.57

nmol/l

1.24

1269

4531

Concussion

578

2120

2.13

59.43

1.3

1.4

0.57

1.54

nmol/l

0.61

564

2040

Biguanides

1182

4200

1.71

59.37

1.3

2.66

1.32

nmol/l

0.40

1145

4059

Primary hyperparathyroidism

230

720

3.31

59.04

1.4

1.3

0.62

4.66

nmol/l

0.78

218

696

Dorsopathies

1194

3536

1.72

58.85

1.3

0.57

1.95

nmol/l

1.38

1154

3425

Depression

1210

4851

1.68

57.96

1.3

1.62

1.49

nmol/l

0.05

1165

4693

Mood disorders

1276

4954

1.66

57.72

1.3

1.58

1.48

nmol/l

0.04

1231

4793

Mood [affective] disorders

1273

4955

1.66

57.43

1.3

1.58

1.48

nmol/l

0.04

1228

4794

Symptoms and signs involving the skin and subcutaneous tissue

931

5007

1.77

57.21

1.4

1.3

1.49

1.56

nmol/l

0.03

904

4827

Hypopituitarism

135

297

4.70

57.11

1.4

1.3

0.58

6.51

nmol/l

0.50

130

287

Implicit viral Sepsis, including avohilmo

431

1883

2.32

56.71

1.4

1.3

2.55

2.82

nmol/l

0.04

412

1811

Depression or dysthymia

799

2301

1.91

56.23

1.3

1.4

0.62

1.73

nmol/l

0.99

771

2228

Other special examinations and investigations of persons without complaint or reported diagnosis

705

1790

2.01

56.08

1.2

1.3

0.57

3.19

nmol/l

1.30

676

1719

Gastrointestinal diseases

642

1557

2.08

55.88

1.3

0.56

2.69

nmol/l

0.94

624

1505

Anxiety (asthma-related co-morbidities)

788

3230

1.87

55.85

1.3

1.08

1.86

nmol/l

0.42

762

3128

Migraine with aura

345

1379

2.54

55.57

1.3

0.55

1.85

nmol/l

0.51

336

1334

Non-invasive ventilation

281

859

2.86

55.51

1.5

1.3

2.07

1.91

nmol/l

0.03

274

831

Obesity related asthma

508

2403

2.15

55.32

1.3

2.53

2.52

nmol/l

0.00

491

2320

ILD medications

1348

4481

1.63

55.26

1.3

0.61

1.66

nmol/l

1.32

1300

4330

Disorders of mineral metabolism

159

421

3.90

52.67

1.2

1.3

0.66

4.82

nmol/l

0.49

153

406

Any reimbursement code in KELA

646

1608

2.03

52.59

1.3

3.29

0.53

nmol/l

0.50

623

1564

Major coronary heart disease event excluding revascularizations

730

2561

1.90

52.58

1.4

1.3

2.07

2.08

nmol/l

0.00

703

2467

Continuous positive airway pressure

223

593

3.18

52.42

1.2

1.3

0.57

2.52

nmol/l

0.51

208

576

Inflammatory bowel disease treatment related agents

1349

4694

1.60

52.02

1.3

0.62

1.61

nmol/l

1.27

1292

4539

Complications of procedures, not elsewhere classified

1004

4803

1.70

51.74

1.3

1.83

1.51

nmol/l

0.12

969

4642

Somatoform disorder

270

994

2.78

51.68

1.3

0.55

3.49

nmol/l

0.80

256

968

Disturbances of skin sensation

411

1842

2.27

51.32

1.3

2.56

2.50

nmol/l

0.01

402

1785

Statin medication

777

2364

1.86

51.22

1.3

3.09

1.42

nmol/l

0.32

756

2294

All anxiety disorders

794

3431

1.81

51.01

1.3

1.08

1.80

nmol/l

0.39

766

3327

Disorders of the thyroid gland

1110

4361

1.66

50.92

1.3

2.04

1.52

nmol/l

0.19

1073

4208

Constipation

1092

4479

1.66

50.68

1.4

1.3

0.66

1.66

nmol/l

1.22

1050

4335

Lumbar disc prolapse

776

3181

1.82

50.41

1.3

0.59

2.11

nmol/l

1.38

752

3084

Asthma (diagnoses ohter than nonallergic)

1065

5226

1.66

50.32

1.3

1.52

1.48

nmol/l

0.01

1022

5052

Spinal stenosis

618

2347

1.96

50.04

1.3

1.99

2.66

nmol/l

0.16

588

2272

Infections, IBD-co-morbidities

176

337

3.72

49.92

1.4

1.3

0.62

0.61

nmol/l

0.04

170

325

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

387

1030

2.39

49.59

1.3

0.59

2.27

nmol/l

0.49

370

998

Other/unspecified dorsalgia

476

2265

2.10

49.18

1.4

1.3

2.34

2.71

nmol/l

0.07

454

2187

Recurrent or chronic depression

505

1686

2.10

48.72

1.3

1.4

0.57

2.01

nmol/l

0.93

482

1633

Symptoms and signs involving the urinary system

933

4182

1.70

47.48

1.3

1.53

1.74

nmol/l

0.08

894

4045

Follow-up examination after treatment for conditions other than malignant neoplasms

492

1574

2.10

47.19

1.4

1.3

0.59

3.54

nmol/l

1.27

480

1507

Any mental disorder

1256

3952

1.60

47.13

1.3

0.95

1.70

nmol/l

0.56

1200

3828

Chronic lower respiratory diseases

1402

4774

1.56

47.04

1.3

0.72

1.56

nmol/l

0.99

1347

4618

Abnormal findings on diagnostic imaging of other body structures

244

904

2.76

46.27

1.4

1.3

4.00

3.84

nmol/l

0.01

235

873

Other general symptoms and signs

200

5.06

45.80

1.3

1.4

8.58

9.38

nmol/l

0.02

194

Vocal cord dysfunction

175

466

3.36

45.60

1.5

1.3

0.61

0.59

nmol/l

0.45

167

455

Diaphragmatic hernia

482

2429

2.01

44.31

1.3

0.63

2.60

nmol/l

1.35

460

2338

574

3044

1.89

44.08

1.3

2.01

2.10

nmol/l

0.02

553

2939

Cholelithiasis

990

4141

1.64

43.98

1.3

0.61

1.76

nmol/l

1.34

963

4000

Cholelithiasis, broad definition with cholecystitis

1024

4207

1.63

43.98

1.3

0.61

1.74

nmol/l

1.34

997

4063

Pain in thoracic spine

232

862

2.74

43.66

1.2

1.3

0.55

4.44

nmol/l

0.94

221

836

Myocardial infarction

577

2121

1.92

43.61

1.4

1.3

2.45

2.39

nmol/l

0.01

558

2036

Cervicalgia

294

1225

2.44

43.56

1.3

0.56

4.37

nmol/l

1.29

281

1180

Other anxiety disorders

585

2668

1.88

43.35

1.3

1.26

1.74

nmol/l

0.19

567

2587

Asthma-related infections

725

4072

1.75

43.22

1.3

1.74

nmol/l

0.00

695

3926

Asthma, hospital admission 2, infections

725

4072

1.75

43.22

1.3

1.74

nmol/l

0.00

695

3926

Valvular heart disease excluding rheumatic fever

542

2004

1.95

43.09

1.4

1.3

4.12

2.26

nmol/l

0.31

522

1945

Non-rheumatic valve diseases

538

1989

1.95

42.70

1.4

1.3

4.15

2.27

nmol/l

0.31

518

1930

Nerve, nerve root and plexus disorders

1243

4837

1.55

42.60

1.3

1.42

1.55

nmol/l

0.05

1211

4659

Disorders of calcium metabolism

122

312

4.04

42.57

1.2

1.3

0.66

6.31

nmol/l

0.49

117

299

Soft tissue disorders

1115

3585

1.60

42.24

1.2

1.4

1.88

1.49

nmol/l

0.13

1072

3459

Cough

447

2071

2.03

42.17

1.3

0.61

1.57

nmol/l

0.59

431

1998

Disorder of lipoprotein metabolism, unspecified

182

607

3.06

41.84

1.4

1.3

1.60

4.23

nmol/l

0.40

170

586

Shoulder lesions

868

3101

1.69

41.78

1.3

1.4

0.60

1.65

nmol/l

0.91

830

2996

Psychiatric diseases

1099

3458

1.60

41.37

1.3

2.60

1.35

nmol/l

0.33

1056

3342

Malignant neoplasm of urinary organs

157

485

3.32

41.18

1.6

1.3

0.67

4.29

nmol/l

0.49

152

468

Hypothyroidism, other/unspecified

1003

4121

1.61

40.89

1.4

1.3

2.20

1.57

nmol/l

0.21

969

3975

Haemorrhage from respiratory passages

373

1545

2.16

40.82

1.3

0.65

1.92

nmol/l

0.57

354

1491

Intestinal infectious diseases, including avohilmo, including avohilmo

1320

4869

1.52

40.30

1.3

1.22

1.58

nmol/l

0.19

1276

4700

Malignant neoplasm of urinary organs, including Hilmo

173

575

3.08

40.10

1.6

1.3

0.69

3.71

nmol/l

0.49

168

556

Complications of medical and surgical care

885

4917

1.63

39.88

1.4

1.3

1.53

1.58

nmol/l

0.02

854

4750

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

158

500

3.24

39.85

1.6

1.3

0.69

4.16

nmol/l

0.49

153

485

Malignant neoplasm of kidney, except renal pelvis

145

436

3.41

39.75

1.7

1.3

0.68

4.68

nmol/l

0.49

140

422

Persons encountering health services for examination and investigation

650

1790

1.83

39.73

1.3

0.61

3.19

nmol/l

1.27

628

1719

Dipeptidyl peptidase 4 (DPP-4) inhibitors

644

2856

1.78

39.58

1.3

0.64

1.70

nmol/l

1.07

622

2750

Diarrhoea and gastroenteritis of presumed infectious origin

829

4509

1.65

39.57

1.4

1.3

1.57

1.66

nmol/l

0.03

804

4345

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1175

4917

1.54

39.57

1.3

1.30

1.57

nmol/l

0.13

1136

4747

Bleeding

968

4256

1.61

39.47

1.3

0.63

1.93

nmol/l

1.55

931

4117

Other neurological diseases

852

4043

1.65

39.10

1.4

1.3

1.58

1.80

nmol/l

0.08

827

3895

Abnormal weight loss

167

554

3.10

38.97

1.3

0.59

3.85

nmol/l

0.51

158

531

Autoimmune diseases excluding thyroid diseases

1164

4091

1.55

38.95

1.3

1.60

1.08

nmol/l

0.20

1125

3952

Coronary atherosclerosis

729

2683

1.73

38.48

1.3

2.07

2.01

nmol/l

0.01

698

2590

Abnormal findings on examination of blood, without diagnosis

549

2725

1.84

38.34

1.4

1.3

0.64

2.36

nmol/l

1.30

527

2629

Angina pectoris

644

2418

1.78

38.24

1.3

3.56

2.17

nmol/l

0.27

619

2329

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

408

2047

2.02

38.10

1.3

0.96

1.67

nmol/l

0.39

395

1983

Glucagon-like peptide-1 (GLP-1) analogues

408

2047

2.02

38.10

1.3

0.96

1.67

nmol/l

0.39

395

1983

Nonorganic sleeping disorders, excluding more controls

268

1138

2.39

38.09

1.3

0.58

3.09

nmol/l

0.77

260

1109

Cervical disc disorders

434

2224

1.97

38.06

1.3

2.51

2.76

nmol/l

0.04

424

2152

Autoimmune diseases excluding thyroid diseases, strict definition

1101

3864

1.56

37.72

1.3

1.66

1.11

nmol/l

0.20

1064

3730

Viral Sepsis

277

1199

2.34

37.72

1.4

1.3

3.60

3.91

nmol/l

0.03

267

1160

Adverse effects, not elsewhere classified

280

1219

2.33

37.67

1.2

1.3

0.51

3.29

nmol/l

0.96

269

1182

Implicit viral Sepsis

276

1195

2.34

37.56

1.4

1.3

3.61

3.92

nmol/l

0.03

266

1156

Weight loss

174

603

2.96

37.56

1.3

0.59

3.59

nmol/l

0.51

165

576

Other CVD

261

1104

2.40

37.46

1.4

1.3

0.60

2.28

nmol/l

0.53

247

1060

Excluding asthma or asthma-COPD overlap

871

2654

1.65

37.38

1.3

1.90

1.50

nmol/l

0.10

843

2572

Other pulmonary diagnosis

870

2654

1.65

37.18

1.3

1.90

1.50

nmol/l

0.10

842

2572

Hypotension

231

929

2.53

37.05

1.5

1.3

0.61

2.60

nmol/l

0.52

217

887

Hypothyreosis and Thyroxine purchase for inclusion criteria

1043

4416

1.56

36.86

1.4

1.3

2.14

1.51

nmol/l

0.22

1007

4255

Insulin medication

670

3257

1.72

36.72

1.4

1.3

2.42

0.96

nmol/l

0.44

648

3141

1294

4396

1.50

36.68

1.3

2.13

1.43

nmol/l

0.25

1250

4249

Asthma, hospital admissions , main diagnosis only

948

5284

1.57

36.56

1.3

1.63

1.47

nmol/l

0.06

912

5104

Finngen Rheumatological endpoints

1063

3899

1.56

36.54

1.3

2.64

1.21

nmol/l

0.38

1024

3768

Other and unspecified effects of external causes

358

1748

2.07

36.05

1.2

1.3

0.52

2.47

nmol/l

0.96

344

1695

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1117

4654

1.52

35.81

1.5

1.3

1.51

1.40

nmol/l

0.04

1086

4484

Cholecystectomy

833

4422

1.61

35.67

1.3

1.58

1.70

nmol/l

0.04

812

4261

Other disorders of kidney and ureter

197

749

2.69

35.63

1.5

1.4

0.73

2.99

nmol/l

0.47

186

722

Exposure to unspecified factor

1166

5299

1.50

35.59

1.3

2.82

1.17

nmol/l

0.48

1127

5118

COPD differential diagnosis

863

2661

1.63

35.42

1.3

1.91

1.50

nmol/l

0.11

835

2579

ILD differential diagnosis

863

2661

1.63

35.41

1.3

1.91

1.50

nmol/l

0.11

835

2579

Other disorders of urethra and urinary system

800

3422

1.64

35.38

1.3

0.60

1.84

nmol/l

1.24

759

3317

Visual disturbances and blindness

634

3733

1.71

35.15

1.3

3.66

1.59

nmol/l

0.44

619

3587

Intestinal infectious diseases

1079

5306

1.52

35.13

1.4

1.3

1.35

1.50

nmol/l

0.06

1047

5122

Benign neoplasm of colon, rectum, anus and anal canal

748

3867

1.65

35.04

1.4

1.3

1.76

1.86

nmol/l

0.03

713

3738

Autoimmune diseases

1216

4127

1.50

34.89

1.3

2.85

1.08

nmol/l

0.70

1176

3988

Myalgia

319

1512

2.14

34.80

1.3

0.56

2.54

nmol/l

0.81

304

1456

Endocrine disorders, other/unspecified

7.53

34.72

2.4

1.2

0.63

0.56

nmol/l

0.65

Implicit bacterial Sepsis, including avohilmo

533

2479

1.80

34.50

1.4

1.3

3.03

2.39

nmol/l

0.13

510

2383

Malignant neoplasm, wide definition

983

3692

1.56

34.29

1.7

1.2

1.69

1.54

nmol/l

0.05

957

3569

Disorders of vestibular function (Vertigo)

583

3291

1.74

34.27

1.3

2.04

2.08

nmol/l

0.01

562

3174

Visual disturbances

598

3503

1.72

33.99

1.3

3.84

1.65

nmol/l

0.44

584

3364

Asthma, including avohilmo

1315

4966

1.46

33.88

1.3

0.71

1.53

nmol/l

1.00

1270

4794

Certain infectious and parasitic diseases

1078

3543

1.53

33.74

1.3

1.66

1.61

nmol/l

0.01

1040

3428

Other joint disorders

945

3145

1.58

33.73

1.3

1.4

2.86

1.03

nmol/l

0.46

917

3036

Diseases of inner ear

654

3753

1.68

33.73

1.3

1.89

nmol/l

0.00

630

3619

Osteopathies and chondropathies

685

3794

1.66

33.71

1.4

1.3

1.85

1.82

nmol/l

0.01

662

3657

Malignant neoplasm, including Hilmo

978

3688

1.55

33.62

1.7

1.2

1.70

1.54

nmol/l

0.05

952

3565

Diseases of arteries, arterioles and capillaries

754

3406

1.64

33.50

1.3

3.16

1.72

nmol/l

0.35

719

3284

Aplastic and other anaemias

529

2739

1.78

33.45

1.4

1.3

0.71

2.30

nmol/l

1.17

504

2631

Other reaction to severe stress, and adjustment disorders

440

2367

1.88

33.27

1.4

1.3

2.40

1.89

nmol/l

0.09

432

2299

Acute upper respiratory infections

1175

4757

1.49

33.26

1.3

2.26

1.37

nmol/l

0.32

1139

4590

Other bacterial diseases, including avohilmo

1143

4805

1.49

33.11

1.4

1.3

0.98

1.67

nmol/l

0.56

1100

4656

Selective serotonin reuptake inhibitors

1060

3625

1.53

33.07

1.3

0.99

1.80

nmol/l

0.54

1016

3508

Insulin, intermediate and long-acting

621

3565

1.69

33.05

1.3

2.55

1.61

nmol/l

0.22

603

3437

Polyarthropathies

727

2847

1.65

32.75

1.2

1.4

2.06

1.09

nmol/l

0.29

694

2747

Disorders of eyelid, lacrimal system and orbit

994

4809

1.52

32.64

1.3

0.59

1.60

nmol/l

1.38

953

4653

Use of hypnotics and sedatives

1188

4609

1.48

32.55

1.3

1.00

1.53

nmol/l

0.41

1145

4459

Genitourinary diseases

573

1617

1.79

32.53

1.3

0.58

2.80

nmol/l

1.07

553

1574

Other symptoms and signs involving the digestive system and abdomen

218

912

2.43

32.17

1.4

1.3

0.61

3.82

nmol/l

0.79

211

884

Migraine without aura and triptan purchases

226

962

2.39

32.10

1.2

1.3

5.52

2.38

nmol/l

0.25

219

929

Cystitis

929

3583

1.55

31.88

1.3

1.83

1.78

nmol/l

0.01

888

3471

Implicit bacterial Sepsis

477

2271

1.82

31.82

1.4

1.3

2.44

2.55

nmol/l

0.02

456

2182

Oxycodone

447

2081

1.85

31.77

1.4

1.3

2.52

2.33

nmol/l

0.03

426

2008

Other bacterial diseases

1062

4719

1.50

31.73

1.4

1.3

0.62

1.78

nmol/l

1.53

1018

4572

Abnormal involuntary movements

193

770

2.55

31.65

1.3

0.53

4.39

nmol/l

0.81

185

742

Myocardial infarction, without ST-elevation

436

2135

1.86

31.63

1.4

1.3

3.08

2.41

nmol/l

0.10

420

2042

Nutritional anaemias

576

3241

1.71

31.58

1.4

1.3

0.67

2.03

nmol/l

1.19

548

3119

Benign neoplasm of other and ill-defined parts of digestive system

254

1149

2.25

31.36

1.5

1.3

0.60

3.51

nmol/l

0.93

239

1112

Rotator cuff syndrome

684

2874

1.65

31.21

1.2

1.3

0.60

1.72

nmol/l

0.90

655

2775

COPD/asthma/ILD related infections

1131

3827

1.49

30.91

1.3

1.61

1.54

nmol/l

0.02

1087

3707

COPD/asthma related infections

1131

3827

1.49

30.91

1.3

1.61

1.54

nmol/l

0.02

1087

3707

Diseases of the digestive system

515

2950

1.75

30.85

1.3

0.62

2.24

nmol/l

1.34

488

2843

Solid cancers, including Hilmo

948

3638

1.53

30.25

1.7

1.2

1.73

1.56

nmol/l

0.05

922

3517

Other and unspecified iron deficiency

411

2236

1.85

29.97

1.4

1.3

0.66

2.57

nmol/l

1.14

396

2157

Personality disorders, excluding more controls

292

1414

2.08

29.93

1.2

1.3

2.00

3.46

nmol/l

0.30

280

1380

Hernia

1051

4734

1.48

29.92

1.3

0.62

1.78

nmol/l

1.53

1011

4579

Other and unspecified anaemias

477

2546

1.77

29.87

1.4

1.3

0.71

2.43

nmol/l

1.17

455

2448

Convulsions, not elsewhere classified

244

1092

2.23

29.75

1.3

0.59

3.74

nmol/l

0.99

234

1053

Diseases of the musculoskeletal system and connective tissue

532

1509

1.78

29.74

1.3

1.4

3.84

1.50

nmol/l

0.31

516

1456

Chronic gastritis

315

1577

2.02

29.71

1.3

4.01

2.89

nmol/l

0.12

295

1516

Iron deficiency anaemia

499

2834

1.74

29.54

1.4

1.3

0.68

2.23

nmol/l

1.19

476

2728

Dermatitis and eczema

1243

5143

1.44

29.52

1.3

0.61

1.68

nmol/l

1.54

1195

4975

Care involving use of rehabilitation procedures

725

4139

1.59

29.46

1.3

1.73

1.71

nmol/l

0.01

705

3995

Other anaemias

480

2570

1.76

29.42

1.5

1.3

0.71

2.41

nmol/l

1.17

458

2470

Cerebrovascular diseases

827

3719

1.55

29.34

1.4

1.3

1.65

1.91

nmol/l

0.08

792

3593

Autoimmune diseases related-to ILD

952

5346

1.49

29.30

1.3

1.50

1.49

nmol/l

0.00

918

5165

Insulin, combination of fast acting with intermediate-acting or long-acting

670

3799

1.61

29.10

1.4

1.3

2.42

1.56

nmol/l

0.22

648

3661

Paralytic ileus and intestinal obstruction

289

1413

2.07

29.02

1.4

1.3

3.48

3.86

nmol/l

0.04

282

1364

Obesity, other/unspecified

412

2273

1.83

28.94

1.3

0.57

2.40

nmol/l

1.13

395

2201

Subjective visual disturbances

336

1740

1.96

28.82

1.3

3.02

1.87

nmol/l

0.18

327

1676

Diseases of the ear and mastoid process

1248

4368

1.44

28.78

1.3

0.58

1.69

nmol/l

1.37

1203

4218

Hypothyroidism, strict autoimmune

765

3214

1.57

28.41

1.3

2.72

1.23

nmol/l

0.46

734

3098

Bacterial Sepsis

524

2553

1.71

28.30

1.4

1.3

2.28

2.33

nmol/l

0.01

501

2454

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

695

4339

1.58

28.29

1.4

1.3

1.79

1.72

nmol/l

0.02

672

4186

Urticaria and erythema

447

2547

1.77

28.16

1.3

0.56

2.38

nmol/l

1.30

438

2463

Other systemic involvement of connective tissue (FG)

324

1641

1.96

27.98

1.3

0.61

1.96

nmol/l

0.82

312

1576

Acute upper respiratory infections of multiple and unspecified sites

857

4137

1.52

27.93

1.3

2.86

1.48

nmol/l

0.38

829

3992

Heart failure and coronary heart disease

445

1746

1.80

27.85

1.4

1.3

3.11

2.67

nmol/l

0.06

423

1673

Other diseases of urinary system

1048

4019

1.47

27.81

1.3

1.70

nmol/l

0.00

1004

3894

Myocardial infarction, strict

486

1983

1.75

27.66

1.4

1.3

2.80

2.52

nmol/l

0.04

469

1899

Malignant neoplasm

923

3631

1.50

26.94

1.7

1.2

0.62

1.56

nmol/l

0.95

898

3513

Substance abuse, excluding more controls

573

2931

1.64

26.82

1.3

0.63

2.06

nmol/l

1.13

549

2847

Disorders of conjunctiva

945

5000

1.47

26.68

1.3

0.57

1.72

nmol/l

1.64

909

4830

Abnormal findings on diagnostic imaging of lung

534

3063

1.66

26.67

1.3

2.57

1.87

nmol/l

0.14

515

2943

Covid-19 confirmed case

421

2393

1.77

26.65

1.3

2.56

2.05

nmol/l

0.09

411

2298

Heart failure,strict

576

2452

1.65

26.54

1.3

2.52

2.41

nmol/l

0.02

550

2368

Malignant neoplasm

920

3630

1.49

26.47

1.7

1.2

0.62

1.56

nmol/l

0.95

895

3512

Urticaria

366

2003

1.85

26.46

1.2

1.3

0.55

2.24

nmol/l

0.95

358

1940

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

963

3827

1.48

26.44

1.4

1.3

0.62

1.54

nmol/l

1.05

909

3707

963

3827

1.48

26.44

1.4

1.3

0.62

1.54

nmol/l

1.05

909

3707

Diseases of pulp and periapical tissues, including avohilmo

1111

3998

1.44

26.38

1.3

1.4

0.60

2.00

nmol/l

1.57

1076

3861

Diseases of the skin and subcutaneous tissue

1028

3538

1.46

26.14

1.3

0.59

1.94

nmol/l

1.34

981

3433

Pacemaker

385

1989

1.82

26.10

1.3

3.40

2.44

nmol/l

0.13

370

1897

Adjustment and management of implanted device

212

961

2.24

26.06

1.3

0.64

3.61

nmol/l

0.78

205

925

Codes for special purposes

593

3681

1.61

26.04

1.3

4.23

1.53

nmol/l

0.57

579

3533

Diseases of the eye and adnexa

816

2677

1.53

25.98

1.3

1.4

4.12

0.83

nmol/l

0.70

790

2589

Provisional assignment of new diseases of uncertain etiology

592

3678

1.61

25.92

1.3

4.23

1.53

nmol/l

0.57

578

3530

Asthma/COPD (KELA code 203)

1028

4773

1.45

25.86

1.3

0.76

1.56

nmol/l

0.90

985

4617

Epilepsy

313

1635

1.92

25.86

1.3

4.19

2.48

nmol/l

0.18

306

1573

Cervicobrachial syndrome

266

1320

2.04

25.82

1.3

0.54

4.06

nmol/l

1.30

261

1277

Hyperkalaemia

226

3.71

25.81

1.2

1.3

0.67

8.51

nmol/l

0.49

216

Infections of the skin and subcutaneous tissue

654

4133

1.57

25.70

1.3

0.57

1.75

nmol/l

1.37

629

3988

Bronchitis

1193

5095

1.41

25.70

1.3

2.24

1.32

nmol/l

0.33

1150

4920

Benign neoplasm: Colon

613

3637

1.59

25.67

1.4

1.3

1.99

1.95

nmol/l

0.01

584

3510

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

113

382

3.03

25.64

1.2

1.3

0.54

0.51

nmol/l

0.49

105

376

Chronic pancreatitis

167

690

2.46

25.53

1.5

1.3

0.61

3.19

nmol/l

0.50

156

665

Haemorrhoids and perianal venous thrombosis

365

2004

1.82

25.45

1.3

0.60

3.00

nmol/l

1.36

356

1935

Other diseases of upper respiratory tract

1161

4281

1.42

25.19

1.3

0.61

1.71

nmol/l

1.32

1115

4132

Non-selective monoamine reuptake inhibitors

423

2348

1.74

25.16

1.3

1.64

2.39

nmol/l

0.23

411

2268

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

580

3510

1.60

25.13

1.3

1.4

0.58

1.95

nmol/l

1.36

559

3394

Arthropathies

918

3150

1.48

24.65

1.3

1.4

2.49

1.03

nmol/l

0.34

886

3040

Any event in cancer register

976

3942

1.45

24.60

1.7

1.2

0.62

1.74

nmol/l

1.20

946

3814

Ovarian cyst

393

1244

1.82

24.60

1.3

0.58

2.36

nmol/l

0.65

378

1195

Gonarthrosis [arthrosis of knee](FG)

805

3086

1.51

24.43

1.3

3.51

1.40

nmol/l

0.45

780

2982

Dental caries

289

1415

1.95

24.42

1.4

1.3

0.61

2.93

nmol/l

0.92

282

1367

Unstable angina pectoris

379

1667

1.80

24.40

1.3

0.69

2.89

nmol/l

1.04

361

1598

Behavioural syndromes associated with physiological disturbances and physical factors

1039

4956

1.42

24.25

1.3

0.60

1.73

nmol/l

1.58

1007

4787

Other gastritis (incl. Duodenitis)

255

1276

2.02

24.23

1.3

0.63

3.24

nmol/l

0.92

248

1234

Systemic connective tissue disorders

419

2450

1.73

24.22

1.3

0.62

2.42

nmol/l

1.19

403

2352

Dialysis, with operation codes

160

665

2.45

24.17

1.4

1.3

0.77

4.84

nmol/l

0.73

151

640

Gonarthrosis

677

2458

1.57

24.14

1.3

3.82

1.18

nmol/l

0.48

655

2373

Dermatitis

701

4535

1.52

24.10

1.3

0.63

1.84

nmol/l

1.52

678

4388

Nonorganic sleeping disorders

268

1370

1.98

23.98

1.3

0.58

2.68

nmol/l

0.77

260

1326

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

637

4127

1.55

23.94

1.4

1.3

0.60

1.78

nmol/l

1.37

616

3977

Sleep disorders

1005

4869

1.43

23.83

1.3

0.60

1.75

nmol/l

1.58

974

4703

Urinary track infection

678

2177

1.57

23.83

1.3

2.28

1.59

nmol/l

0.15

651

2111

Caries of dentine

262

1281

1.99

23.79

1.3

1.4

0.61

3.17

nmol/l

0.92

256

1236

Polyuria

254

1279

2.01

23.73

1.4

1.3

0.62

3.85

nmol/l

1.11

238

1236

182

807

2.29

23.68

1.5

1.3

2.88

4.17

nmol/l

0.15

173

780

Disorders of synovium and tendon

575

3086

1.59

23.64

1.2

1.4

2.37

1.63

nmol/l

0.16

561

2977

Diseases of salivary glands

397

2303

1.74

23.64

1.3

0.60

2.59

nmol/l

1.26

386

2220

Other disorders of lacrimal gland

445

2666

1.68

23.51

1.3

0.56

2.27

nmol/l

1.26

430

2574

Solid cancers

885

3556

1.47

23.45

1.7

1.2

0.62

1.58

nmol/l

0.96

860

3440

Other noninfective gastroenteritis and colitis

291

1540

1.91

23.42

1.4

1.3

0.62

2.76

nmol/l

0.91

280

1488

Panic disorder

181

810

2.26

23.03

1.4

1.3

2.85

2.71

nmol/l

0.02

172

789

Acute tubulo-interstitial nephritis

667

3707

1.53

22.95

1.4

1.3

1.89

1.83

nmol/l

0.01

634

3578

Enthesopathies of lower limb, excluding foot

268

1391

1.95

22.94

1.2

1.3

3.66

3.89

nmol/l

0.02

258

1345

Generalized anxiety disorder

196

907

2.18

22.86

1.3

2.61

3.72

nmol/l

0.14

190

882

Other enthesopathies

341

1912

1.80

22.82

1.2

1.3

0.57

2.25

nmol/l

0.90

335

1843

Disorders of lacrimal system

518

3192

1.61

22.81

1.3

0.56

1.99

nmol/l

1.26

496

3084

GI-bleeding

335

1871

1.81

22.70

1.4

1.3

0.66

3.07

nmol/l

1.23

318

1801

Chronic apical periodontitis

1190

4846

1.38

22.62

1.3

0.62

1.75

nmol/l

1.51

1148

4677

Noninfective enteritis and colitis

514

3220

1.61

22.55

1.4

1.3

0.66

2.01

nmol/l

1.17

497

3110

Other and unspecified urticaria

247

1255

1.99

22.55

1.2

1.3

0.54

3.21

nmol/l

0.94

241

1217

Glomerular diseases

214

1033

2.10

22.52

1.2

1.3

0.67

3.33

nmol/l

0.75

202

997

Coxibs

261

674

2.05

22.46

1.3

7.43

1.61

nmol/l

0.40

248

647

Endometriosis

376

1230

1.79

22.44

1.3

0.56

2.38

nmol/l

0.66

363

1182

Other diseases of the digestive system

337

1894

1.79

22.39

1.4

1.3

0.65

3.04

nmol/l

1.24

319

1823

Nephropathy related operations

156

665

2.39

22.33

1.4

1.3

0.76

3.29

nmol/l

0.47

148

640

Glomerular disorders in diseases classified elsewhere

150

629

2.43

22.27

1.2

1.3

0.69

3.44

nmol/l

0.48

141

604

Acute renal failure

244

1241

1.99

22.19

1.3

0.67

3.82

nmol/l

1.02

233

1197

Conduction disorders

300

1292

1.88

22.16

1.3

0.65

3.03

nmol/l

0.84

294

1244

Benign thyroid growths and nodules

387

2103

1.73

22.15

1.4

1.3

0.63

2.41

nmol/l

1.02

373

2033

Benign paroxysmal vertigo

358

2058

1.76

22.08

1.3

2.92

2.77

nmol/l

0.02

347

1980

Other systemic involvement of connective tissue

330

1853

1.80

22.06

1.3

0.60

2.43

nmol/l

0.94

318

1777

Thyrotoxicosis, other and/or unspecified

253

1310

1.96

21.88

1.3

0.62

2.83

nmol/l

0.78

242

1267

Care involving dialysis

111

407

2.79

21.77

1.4

0.67

4.96

nmol/l

0.49

105

394

Conjunctivitis

844

4732

1.44

21.76

1.3

0.56

1.74

nmol/l

1.57

812

4570

Diseases of the respiratory system

664

2172

1.54

21.58

1.3

2.30

2.17

nmol/l

0.02

641

2105

Cervicocranial syndrome

139

574

2.46

21.35

1.2

1.3

0.55

6.37

nmol/l

0.93

134

557

Other diseases of pancreas

125

494

2.59

21.16

1.4

1.3

0.62

4.23

nmol/l

0.50

119

472

Insomnia

978

4871

1.40

21.12

1.3

0.59

1.75

nmol/l

1.58

948

4702

Other and unspecified dermatitis

590

3879

1.53

21.07

1.3

0.59

1.84

nmol/l

1.37

569

3747

Other extrapyramidal and movement disorders in other diseases

298

1649

1.83

20.97

1.3

0.59

3.27

nmol/l

1.21

289

1593

Certain infectious and parasitic diseases, including avohilmo

734

2471

1.50

20.85

1.3

2.73

1.89

nmol/l

0.19

705

2397

Extracorporeal dialysis

292

3.09

20.75

1.5

1.3

0.68

6.69

nmol/l

0.49

280

Fall on same level

1207

4747

1.36

20.65

1.3

0.76

1.55

nmol/l

0.87

1160

4593

Benign neoplasm: Pancreas

144

4.13

20.52

1.6

1.3

0.57

13.16

nmol/l

0.50

136

Other diseases of intestine

181

850

2.16

20.51

1.4

1.3

0.66

5.74

nmol/l

1.17

174

823

Soft tissue disorders related to use, overuse and pressure

313

1770

1.79

20.45

1.3

3.26

2.42

nmol/l

0.11

302

1697

Inflammatory diseases of female pelvic organs

721

3363

1.48

20.38

1.3

0.56

1.84

nmol/l

1.21

693

3247

Other diseases of anus and rectum

311

1750

1.78

20.35

1.3

3.28

3.22

nmol/l

0.01

301

1690

Pneumonia, organism unspecified

985

4871

1.39

20.33

1.4

1.3

0.63

1.57

nmol/l

1.26

928

4727

Heart failure, strict

614

2820

1.52

20.24

1.3

2.42

2.25

nmol/l

0.03

584

2712

Intestinal stricture

339

1969

1.74

20.17

1.4

1.3

3.08

2.96

nmol/l

0.02

330

1892

Heartburn

134

561

2.42

19.98

1.2

1.4

0.59

5.77

nmol/l

0.78

129

544

Adenomyosis (Endometriosis of uterus)

174

813

2.17

19.93

1.4

1.3

0.57

3.33

nmol/l

0.66

169

782

Insulin, fast-acting

377

2262

1.68

19.83

1.4

1.3

3.35

2.18

nmol/l

0.16

366

2185

Congenital malformations, deformations and chromosomal abnormalities

624

3979

1.49

19.80

1.6

1.3

2.21

1.48

nmol/l

0.17

606

3841

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

684

4264

1.47

19.79

1.6

1.3

2.07

1.42

nmol/l

0.17

663

4115

Transient ischemic attack

547

2841

1.54

19.65

1.3

0.63

2.33

nmol/l

1.36

530

2729

Falls/tendency to fall

1115

4096

1.37

19.61

1.3

2.17

1.33

nmol/l

0.31

1073

3970

Influenza and pneumonia

1117

5087

1.36

19.61

1.4

1.3

0.61

1.52

nmol/l

1.29

1062

4932

Other diseases of liver

225

1164

1.96

19.59

1.4

1.3

0.63

3.46

nmol/l

0.91

220

1126

Erysipelas, including avohilmo

775

4010

1.44

19.52

1.2

1.3

1.13

1.90

nmol/l

0.46

746

3884

Tinnitus

279

1549

1.82

19.46

1.4

1.3

0.58

3.44

nmol/l

1.21

272

1500

Pneumonias (Asthma/COPD co-morbidities)

1074

5160

1.36

19.46

1.4

1.3

0.63

1.51

nmol/l

1.26

1015

5007

Chronic rhinitis, nasopharyngitis and pharyngitis

367

2201

1.68

19.39

1.3

0.58

2.68

nmol/l

1.28

348

2123

All pneumoniae

1078

5158

1.36

19.38

1.4

1.3

0.63

1.51

nmol/l

1.26

1019

5004

Other or unspecified ileus, impaction or obstruction

193

949

2.05

19.33

1.4

1.3

4.96

5.23

nmol/l

0.02

186

916

COPD (mode)

322

1438

1.76

19.32

1.3

0.71

2.31

nmol/l

0.68

308

1385

Algoneurodystrophy

169

3.73

19.25

1.2

1.4

0.57

0.59

nmol/l

0.20

163

Factors influencing health status and contact with health services

250

643

1.96

19.14

1.4

1.2

0.62

5.47

nmol/l

0.86

243

622

Injuries to the head

1174

5197

1.34

19.09

1.3

0.77

1.48

nmol/l

0.83

1125

5028

Candidiasis, including avohilmo

358

2145

1.68

19.04

1.3

0.59

2.16

nmol/l

0.94

347

2072

All-cause Heart Failure

598

2773

1.51

18.95

1.3

2.47

2.28

nmol/l

0.04

569

2665

Acute sinusitis

564

3408

1.51

18.90

1.3

2.06

1.60

nmol/l

0.11

540

3291

Arthrosis

714

2680

1.47

18.86

1.3

1.4

3.68

1.13

nmol/l

0.49

686

2588

Disorders of vitreous body and globe

572

3614

1.51

18.85

1.3

0.59

2.13

nmol/l

1.56

552

3490

Triptan medication for migraine, single purchase ok

833

4009

1.41

18.81

1.3

2.87

1.45

nmol/l

0.38

816

3871

Migraine, single triptan purchase ok & required. ICD-code if available is included

833

4009

1.41

18.81

1.3

2.87

1.45

nmol/l

0.38

816

3871

Gingivitis and periodontal diseases

1025

3865

1.37

18.69

1.3

0.61

2.05

nmol/l

1.57

994

3740

Hypermobility syndrome

252

3.13

18.62

1.2

1.3

0.52

0.54

nmol/l

0.25

246

Cardiomyopathy

178

862

2.09

18.60

1.3

0.71

4.22

nmol/l

0.82

172

829

Disorders of vitreous body

559

3557

1.50

18.35

1.2

1.3

0.59

2.15

nmol/l

1.56

539

3435

Thyrotoxicosis

305

1771

1.74

18.27

1.3

0.62

2.50

nmol/l

0.92

294

1708

Substance use, excluding alcohol

229

1221

1.90

18.21

1.3

0.65

2.94

nmol/l

0.74

217

1183

Dental pulpitis, including avohilmo

974

4571

1.37

18.11

1.3

0.57

1.63

nmol/l

1.38

947

4418

Extrapyramidal and movement disorders

421

2663

1.59

18.02

1.3

0.60

2.36

nmol/l

1.30

407

2554

Polycystic ovarian syndrome, consortium definition

796

3228

1.42

18.00

1.3

0.59

1.63

nmol/l

0.93

767

3112

Explicit Sepsis

446

2595

1.57

17.97

1.4

1.3

0.67

2.29

nmol/l

1.13

427

2496

Insulin, fast-acting or short human

379

2341

1.63

17.85

1.4

1.3

3.34

2.13

nmol/l

0.17

368

2262

Other symptoms and signs involving cognitive functions and awareness

470

2698

1.55

17.77

1.4

1.3

1.53

1.52

nmol/l

0.00

447

2602

Cyst of kidney

382

2.65

17.68

1.3

0.74

5.31

nmol/l

0.49

365

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1044

5179

1.35

17.56

1.4

1.3

0.63

1.51

nmol/l

1.25

985

5027

Stroke, excluding SAH

609

2993

1.48

17.54

1.4

1.3

2.02

2.24

nmol/l

0.05

586

2878

Urolithiasis

320

1905

1.69

17.47

1.3

0.64

3.11

nmol/l

1.31

312

1839

Disorders of skin appendages

537

3586

1.50

17.46

1.3

0.55

1.87

nmol/l

1.32

510

3468

Intestinal malabsorption

258

3.02

17.32

1.4

1.2

0.61

0.63

nmol/l

0.16

249

Bacterial infection, other or unspecified, including avohilmo

606

3402

1.47

17.26

1.4

1.3

0.68

2.26

nmol/l

1.48

580

3284

Conjunctivitis (acute, non atopic), including avohilmo

1055

4757

1.34

17.20

1.3

0.58

1.78

nmol/l

1.62

1018

4598

Hyperkinetic disorders, excluding more controls

128

521

2.31

17.17

1.2

1.4

0.45

0.46

nmol/l

0.15

123

508

Explicit Sepsis, including avohilmo

453

2661

1.55

17.15

1.4

1.3

0.67

2.25

nmol/l

1.12

433

2563

Certain disorders involving the immune mechanism

218

1169

1.89

17.10

1.2

1.3

0.56

3.45

nmol/l

0.94

213

1132

Gonarthrosis,primary

915

4038

1.37

17.02

1.3

3.17

1.43

nmol/l

0.41

885

3895

Diseases of liver

376

2350

1.61

16.97

1.3

0.64

2.56

nmol/l

1.23

366

2268

ILD medications: immunosuppressive drugs

663

4209

1.43

16.96

1.3

0.60

1.73

nmol/l

1.33

639

4077

Chronic periodontitis, including avohilmo

1045

4992

1.34

16.92

1.3

0.63

1.72

nmol/l

1.50

1007

4828

Carpal tunnel syndrome

656

3975

1.44

16.92

1.2

1.3

2.16

1.76

nmol/l

0.09

639

3826

Hypothyroidism, strict autoimmune, 3 medication purchases required

847

4131

1.38

16.89

1.3

2.52

1.57

nmol/l

0.29

811

3977

External causes of morbidity and mortality

648

2225

1.47

16.86

1.3

5.10

0.69

nmol/l

0.75

620

2160

Phobic anxiety disorders

148

696

2.14

16.68

1.2

1.3

3.31

0.53

nmol/l

0.49

142

677

Nonalcoholic fatty liver disease

137

628

2.22

16.67

1.3

1.4

0.62

3.41

nmol/l

0.50

132

609

Injuries to the knee and lower leg

1229

5082

1.31

16.61

1.3

2.93

1.14

nmol/l

0.53

1197

4894

Periodontitis

1043

4994

1.34

16.51

1.3

0.64

1.72

nmol/l

1.50

1005

4830

Pain and other conditions associated with female genital organs and menstrual cycle

229

1044

1.85

16.47

1.2

1.3

0.51

2.67

nmol/l

0.67

222

1008

Substance abuse

573

3658

1.46

16.40

1.3

0.63

1.89

nmol/l

1.27

549

3545

Allergic asthma (mode), excluding more controls

229

1230

1.83

16.40

1.2

1.3

0.52

2.53

nmol/l

0.76

220

1191

Gastroduodenal ulcer

247

1389

1.79

16.37

1.3

0.64

3.19

nmol/l

1.00

239

1336

Asthma-related pneumonia

374

2349

1.60

16.28

1.4

1.3

2.91

2.59

nmol/l

0.05

349

2258

Intracranial injury

601

3889

1.45

16.28

1.3

0.59

1.79

nmol/l

1.30

583

3750

Mental and behavioural disorders due to psychoactive substance use

588

3724

1.45

16.25

1.3

0.63

1.86

nmol/l

1.27

564

3609

Restless leg syndrome

177

902

1.99

16.22

1.3

0.58

3.84

nmol/l

0.79

171

870

Personality disorders

292

1733

1.70

16.19

1.2

1.3

2.00

2.34

nmol/l

0.07

280

1680

Asthma-related pneumonia or sepsis

374

2353

1.59

16.17

1.4

1.3

2.91

2.59

nmol/l

0.05

349

2262

Asthma, hospital admissions 3, pneumonia

374

2353

1.59

16.17

1.4

1.3

2.91

2.59

nmol/l

0.05

349

2262

Osteoporosis

311

1720

1.68

16.15

1.5

1.3

3.37

2.60

nmol/l

0.10

298

1645

Calculus of kidney and ureter

299

1788

1.69

16.11

1.3

0.64

3.27

nmol/l

1.31

292

1727

Stroke, including SAH

634

3176

1.44

16.07

1.4

1.3

1.96

2.14

nmol/l

0.04

611

3055

Persons with potential health hazards related to communicable diseases

377

2366

1.59

16.06

1.4

1.3

0.54

1.87

nmol/l

0.87

363

2293

Noninfectious colitis NAS

159

783

2.06

16.03

1.5

1.3

0.59

4.32

nmol/l

0.78

150

755

Cutaneous abscess, furuncle and carbuncle

284

1678

1.71

16.02

1.3

0.57

3.30

nmol/l

1.27

273

1619

Atherosclerosis, excluding cerebral and coronary sclerosis

385

1911

1.59

15.97

1.3

3.49

2.50

nmol/l

0.13

361

1831

COPD

440

2333

1.54

15.90

1.3

2.61

2.62

nmol/l

0.00

417

2241

Other retinal disorders

659

3534

1.42

15.86

1.3

4.90

1.09

nmol/l

0.65

635

3413

Other disorders of ear

949

4575

1.35

15.83

1.3

0.60

1.83

nmol/l

1.58

918

4420

Other arthrosis

527

2382

1.49

15.77

1.3

0.62

1.20

nmol/l

0.64

506

2300

Other and unspecified polyneuropathies, also in other diseases

204

1102

1.87

15.67

1.4

1.3

0.65

3.18

nmol/l

0.76

196

1062

Sequelae of external causes of morbidity and mortality

282

1674

1.70

15.66

1.4

1.3

0.59

3.22

nmol/l

1.20

273

1621

Polyarthrosis

238

1208

1.79

15.62

1.2

1.3

4.11

1.61

nmol/l

0.31

229

1158

Other inflammation of eyelid, including avohilmo

482

3242

1.50

15.62

1.3

0.57

2.00

nmol/l

1.29

461

3142

Unspecified haematuria

406

2133

1.56

15.49

1.4

1.3

2.74

2.84

nmol/l

0.02

388

2065

Acetic acid derivatives and related substances

236

663

1.85

15.45

1.3

0.60

1.63

nmol/l

0.84

224

636

Other septicaemia

382

2308

1.57

15.38

1.5

1.3

0.69

2.60

nmol/l

1.19

365

2221

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

492

2880

1.49

15.36

1.2

1.3

0.56

1.74

nmol/l

0.96

475

2786

Unspecified kidney failure

109

470

2.35

15.33

1.3

1.4

0.71

4.42

nmol/l

0.49

450

Acute bronchitis

416

2672

1.54

15.27

1.2

1.3

0.59

2.33

nmol/l

1.28

400

2578

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

936

5484

1.33

15.16

1.3

1.48

1.47

nmol/l

0.00

903

5298

Allergic asthma (mode)

229

1263

1.78

15.07

1.2

1.3

0.52

2.48

nmol/l

0.77

220

1223

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

221

2.72

14.98

1.5

1.3

0.70

0.65

nmol/l

0.38

212

Other and unspecified disorders of vitreous body

468

3086

1.49

14.98

1.2

1.3

0.61

2.39

nmol/l

1.52

452

2970

Polyneuropathies and other disorders of the peripheral nervous system

227

1285

1.78

14.97

1.4

1.3

0.65

3.71

nmol/l

1.03

219

1238

Sequelae with surgical and medical care as external cause

227

1286

1.78

14.95

1.3

0.62

2.89

nmol/l

0.79

219

1244

Other chronic obstructive pulmonary disease, including avohilmo

531

3002

1.46

14.86

1.3

2.27

2.23

nmol/l

0.01

507

2886

Meniscus derangement

539

2453

1.47

14.85

1.3

1.4

3.85

1.18

nmol/l

0.38

524

2369

Cardiodefibrillation

345

2177

1.59

14.84

1.3

0.71

2.84

nmol/l

1.27

329

2087

Gout

258

1293

1.72

14.84

1.2

1.4

0.62

1.73

nmol/l

0.65

236

1239

Early onset COPD, excluding more controls

197

1070

1.86

14.82

1.2

1.3

0.62

2.85

nmol/l

0.72

186

1034

Missing teeth due to accident, extraction or parodontitis

656

4202

1.40

14.81

1.3

1.29

1.86

nmol/l

0.29

633

4052

Ventral hernia

258

1520

1.71

14.77

1.5

1.3

0.64

3.50

nmol/l

1.17

250

1468

Other septicaemia, including avohilmo

386

2350

1.55

14.74

1.5

1.3

0.69

2.57

nmol/l

1.19

369

2261

Artrosis, including avohilmo

806

3234

1.37

14.69

1.3

1.4

2.80

1.36

nmol/l

0.28

775

3131

Other chronic obstructive pulmonary disease

415

2235

1.53

14.54

1.3

2.73

2.61

nmol/l

0.02

393

2146

Bacterial infection, other or unspecified

540

3168

1.45

14.41

1.5

1.3

0.69

2.38

nmol/l

1.46

515

3058

Erysipelas

567

3432

1.43

14.39

1.3

0.59

2.00

nmol/l

1.38

545

3317

Aortic aneurysm

205

1117

1.81

14.33

1.2

1.3

0.62

2.40

nmol/l

0.58

195

1074

Septicaemia

420

2546

1.51

14.25

1.4

1.3

0.68

2.50

nmol/l

1.27

401

2449

Other diseases of hard tissues of teeth

541

1922

1.46

14.22

1.3

0.64

2.33

nmol/l

0.91

524

1854

Corticotropin deficiency

6.22

14.22

1.2

1.3

0.56

0.53

nmol/l

0.19

Other disorders of bladder

130

625

2.11

14.05

1.3

0.55

3.46

nmol/l

0.52

123

603

Benign neoplasm: Rectum, anus and anal canal

219

1252

1.77

14.02

1.5

1.3

0.67

4.13

nmol/l

1.16

208

1206

Other sleep disorders

116

534

2.20

14.00

1.3

7.74

3.93

nmol/l

0.20

111

514

Other disorders of skin and subcutaneous tissue

744

4643

1.36

13.82

1.3

1.76

1.63

nmol/l

0.04

712

4487

Other diseases of blood and blood-forming organs, wide

237

1392

1.72

13.78

1.4

1.3

0.67

3.74

nmol/l

1.14

229

1346

Disease of hard tissues of teeth, NOS

529

1907

1.46

13.68

1.2

1.3

0.61

2.35

nmol/l

0.93

521

1839

Other specified/unspecified arthritis

275

1682

1.65

13.67

1.3

0.62

1.44

nmol/l

0.63

260

1617

Special screening examination for other diseases and disorders

121

574

2.13

13.50

1.2

1.3

0.55

8.30

nmol/l

1.19

114

546

Inflammatory disease of uterus

161

848

1.92

13.47

1.2

1.3

0.53

3.96

nmol/l

0.79

154

826

Transport accidents

468

2671

1.46

13.45

1.3

1.4

2.35

0.67

nmol/l

0.47

451

2595

Presence of other functional implants

595

2903

1.41

13.45

1.3

2.35

1.92

nmol/l

0.09

579

2794

Artificial joint operation, meniscal resection

917

4464

1.32

13.40

1.3

3.17

1.35

nmol/l

0.44

883

4315

Trochanteric bursitis

174

942

1.87

13.38

1.2

1.3

5.37

3.79

nmol/l

0.12

168

896

Other acute lower respiratory infections

523

3503

1.43

13.38

1.3

0.59

1.97

nmol/l

1.37

501

3381

Disorders of adult personality and behaviour

292

1823

1.61

13.37

1.2

1.3

1.99

2.26

nmol/l

0.05

281

1766

COPD related to multimorbidity

371

2056

1.53

13.34

1.3

2.97

2.87

nmol/l

0.01

350

1970

Diseases of oral cavity, salivary glands and jaws

538

1924

1.45

13.31

1.3

0.62

2.33

nmol/l

0.92

514

1855

Other external causes of accidental injury

785

2910

1.36

13.29

1.3

1.4

4.83

0.67

nmol/l

0.89

754

2827

Deforming dorsopathies

278

1718

1.63

13.25

1.3

0.64

3.29

nmol/l

1.24

267

1651

Pregnancy hypertension

430

2608

1.48

13.22

1.2

1.3

0.54

1.86

nmol/l

0.97

416

2523

Other arthritis (FG)

318

2031

1.58

13.22

1.3

0.63

1.80

nmol/l

0.90

303

1956

Peripheral artery disease

397

2088

1.51

13.14

1.3

3.37

2.34

nmol/l

0.14

375

2004

Specific personality disorders

243

1459

1.68

13.02

1.2

1.3

2.30

2.68

nmol/l

0.06

232

1413

Injuries to the ankle and foot

742

4729

1.34

13.02

1.3

0.57

1.57

nmol/l

1.32

717

4565

Gastric ulcer

169

914

1.87

13.01

1.3

0.63

3.84

nmol/l

0.79

164

880

Adhesive capsulitis of shoulder

180

999

1.82

12.78

1.4

1.3

0.64

3.56

nmol/l

0.78

172

962

Excessive, frequent and irregular menstruation

370

1283

1.55

12.78

1.3

0.56

2.30

nmol/l

0.66

357

1233

Oxicams

195

608

1.83

12.78

1.3

0.64

1.74

nmol/l

0.82

189

584

Neuromuscular dysfunction of bladder

107

497

2.18

12.71

1.3

1.4

0.62

4.15

nmol/l

0.50

482

Accidents

780

2910

1.35

12.70

1.3

1.4

4.86

0.67

nmol/l

0.89

750

2827

Thoracic aortic aneurysm

142

732

1.96

12.69

1.3

0.61

3.29

nmol/l

0.57

137

705

Primary gonarthrosis, bilateral

525

3117

1.42

12.65

1.2

1.3

0.61

1.69

nmol/l

1.26

507

2994

Ischaemic Stroke, excluding all haemorrhages

543

2845

1.41

12.54

1.4

1.3

2.19

2.33

nmol/l

0.03

521

2732

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

579

4018

1.39

12.51

1.2

1.3

0.56

1.74

nmol/l

1.33

557

3880

Later onset COPD, excluding more controls

208

912

1.75

12.49

1.4

1.3

4.83

3.07

nmol/l

0.16

197

872

Injuries to the neck

238

1439

1.67

12.45

1.2

1.3

0.56

2.73

nmol/l

0.86

231

1392

Other noninflammatory disorders of uterus, except cervix

235

928

1.70

12.44

1.4

1.3

0.67

3.01

nmol/l

0.63

223

893

Conjunctivitis (acute, non atopic)

293

1856

1.58

12.42

1.4

1.3

0.56

2.49

nmol/l

1.02

278

1796

Fenamates

139

475

2.01

12.41

1.5

1.3

0.66

2.02

nmol/l

0.78

132

453

Chronic sinusitis

430

2962

1.46

12.39

1.3

2.52

2.16

nmol/l

0.06

416

2856

Localized swelling, mass and lump of skin and subcutaneous tissue

327

2135

1.54

12.37

1.4

1.3

0.63

2.66

nmol/l

1.17

321

2061

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

252

1529

1.64

12.31

1.3

0.58

3.25

nmol/l

1.09

242

1481

Injury, poisoning and certain other consequences of external causes

501

1745

1.44

12.31

1.3

4.09

0.72

nmol/l

0.48

487

1686

Nontoxic multinodular goitre

216

1282

1.70

12.17

1.3

0.62

2.94

nmol/l

0.80

207

1231

Volume depletion

390

2.31

12.15

1.8

1.3

0.71

5.22

nmol/l

0.49

373

Type 1 diabetes

227

1362

1.68

12.15

1.4

1.3

5.07

1.41

nmol/l

0.37

221

1314

Asthma and allergy, excluding more controls

126

624

2.01

12.14

1.2

1.3

0.49

3.33

nmol/l

0.51

119

610

Benign neoplasm: Rectum

194

1119

1.75

12.12

1.5

1.3

0.69

3.61

nmol/l

0.90

185

1080

Benign neoplasm: Kidney

192

2.94

12.06

1.5

1.3

0.63

9.98

nmol/l

0.50

182

Venous thromboembolism

525

3633

1.40

11.97

1.4

1.3

1.42

2.06

nmol/l

0.27

511

3492

Allergic conjunctivitis

605

4280

1.37

11.96

1.2

1.3

0.56

1.67

nmol/l

1.34

582

4135

Hernia of abdominal wall

451

3162

1.43

11.94

1.4

1.3

0.63

2.13

nmol/l

1.31

439

3050

Other symptoms and signs involving the urinary system

108

518

2.11

11.83

1.4

0.60

4.05

nmol/l

0.50

103

496

Temporomandibular joint disorders, including avohilmo

467

3193

1.42

11.83

1.3

0.57

1.68

nmol/l

1.01

445

3089

Irregular menses

502

2679

1.41

11.81

1.3

0.56

1.82

nmol/l

0.95

489

2590

Mouth breathing

390

2665

1.47

11.76

1.3

0.56

2.32

nmol/l

1.31

379

2582

Other and unspecified nerve root and plexus disorders, also in other diseases

221

1332

1.67

11.74

1.3

0.55

3.25

nmol/l

1.03

213

1290

Coxarthrosis

473

2139

1.43

11.71

1.3

0.66

1.28

nmol/l

0.60

457

2061

Dissociative [conversion] disorders

174

2.99

11.62

1.6

1.3

0.47

10.83

nmol/l

0.50

166

Injuries to the abdomen, lower back, lumbar spine and pelvis

403

2740

1.46

11.62

1.3

0.60

2.30

nmol/l

1.29

388

2633

Asthma and allergy

126

634

1.98

11.61

1.2

1.3

0.49

3.31

nmol/l

0.51

119

618

Disorders of choroid and retina

797

4264

1.31

11.58

1.3

5.61

1.00

nmol/l

0.92

762

4121

Nontoxic goitre/thyroid nodule

322

2131

1.52

11.51

1.4

1.3

0.62

2.21

nmol/l

0.94

309

2050

Non-ischemic cardiomyopathy

297

1523

1.56

11.38

1.3

0.71

2.96

nmol/l

0.94

284

1457

Leiomyoma of uterus

663

2762

1.35

11.36

1.3

0.58

2.12

nmol/l

1.20

636

2671

Gout, idiopatic and unspecified

224

1368

1.65

11.31

1.3

0.63

2.85

nmol/l

0.85

204

1315

Thyroiditis, ILD-related definition

131

685

1.94

11.30

1.3

0.57

4.79

nmol/l

0.79

123

668

Malignant neoplasm of small intestine, including Hilmo

156

3.09

11.28

1.6

1.3

0.64

12.08

nmol/l

0.50

149

Fissure and fistula of anal and rectal regions

224

1371

1.65

11.21

1.2

1.3

0.58

3.92

nmol/l

1.27

212

1331

Internal derangement of knee

354

2375

1.48

11.21

1.3

0.61

1.19

nmol/l

0.63

343

2293

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

194

991

1.72

11.19

1.2

1.3

0.48

2.24

nmol/l

0.50

187

963

Gout, strict definition

167

946

1.78

11.14

1.3

0.61

3.62

nmol/l

0.78

148

912

Mycoses, including avohilmo

923

5513

1.28

11.10

1.3

0.59

1.61

nmol/l

1.59

888

5330

Dental operations

571

2132

1.38

11.07

1.3

3.74

1.34

nmol/l

0.35

547

2062

Benign neoplasm: Stomach

117

594

2.00

11.04

1.5

1.3

0.63

3.61

nmol/l

0.50

109

573

Special screening examination for infectious and parasitic diseases

198

848

1.71

10.98

1.3

0.52

5.95

nmol/l

1.28

191

823

Retention of urine

293

1548

1.54

10.75

1.3

0.64

2.56

nmol/l

0.84

281

1497

Triptan medication for migraine, min. 3 purchases

571

3152

1.36

10.66

1.3

2.51

1.33

nmol/l

0.25

556

3053

Gout, FINNGEN

258

1643

1.57

10.66

1.2

1.4

0.62

1.98

nmol/l

0.67

236

1582

Diseases of pulp and periapical tissues and dental caries

607

2299

1.36

10.60

1.3

0.62

2.24

nmol/l

1.08

582

2219

Haemorrhage, not elsewhere classified

141

3.10

10.51

1.4

1.3

1.20

13.34

nmol/l

0.47

134

Chronic periodontitis, complicated

565

4094

1.35

10.50

1.3

0.65

1.78

nmol/l

1.28

553

3950

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

377

2590

1.44

10.43

1.3

0.51

2.32

nmol/l

1.32

366

2507

Gout, unspecified

186

1109

1.69

10.36

1.3

0.61

3.33

nmol/l

0.85

169

1071

Other disorders of eyelid

435

2931

1.41

10.36

1.3

2.52

2.21

nmol/l

0.06

420

2821

Other diseases of lip and oral mucosa

437

3132

1.40

10.30

1.4

1.3

4.86

1.75

nmol/l

0.50

423

3016

Combinations of oral blood glucose lowering drugs

257

1662

1.56

10.26

1.3

0.68

1.95

nmol/l

0.77

246

1603

COPD, early/later onset

415

2467

1.42

10.20

1.3

2.73

2.50

nmol/l

0.04

393

2366

Cerebral aneurysm, nonruptured

104

522

2.02

10.17

1.7

1.3

0.67

6.20

nmol/l

0.77

503

COPD, hospital admissions

411

2451

1.42

10.14

1.3

2.75

2.51

nmol/l

0.04

389

2350

Dentofacial anomalies [including malocclusion]

718

4328

1.30

10.08

1.3

0.57

1.65

nmol/l

1.31

687

4194

Caries of dentine, including avohilmo

736

2881

1.31

10.06

1.3

0.62

1.91

nmol/l

1.07

708

2783

Heart failure and bmi 25plus

353

1614

1.47

10.00

1.3

0.68

2.60

nmol/l

0.92

338

1554

Disorders of sclera, cornea, iris and ciliary body

541

4039

1.35

9.87

1.3

4.19

1.51

nmol/l

0.51

529

3884

Chronic laryngitis and laryngotracheitis

146

827

1.78

9.82

1.3

0.60

4.66

nmol/l

0.93

146

796

Menorrhagia

318

1187

1.50

9.80

1.3

0.59

2.45

nmol/l

0.65

301

1142

Peripheral arterial reconstruction

148

842

1.77

9.79

1.3

7.73

2.80

nmol/l

0.30

143

801

Procreative management

342

1941

1.46

9.77

2.0

1.3

0.50

2.41

nmol/l

1.07

337

1878

Metatarsalgia

110

572

1.95

9.72

1.2

1.3

0.58

5.70

nmol/l

0.79

110

552

Exposure to other specified factors

798

5386

1.28

9.69

1.3

0.56

1.49

nmol/l

1.45

767

5210

Glomerulonephritis

103

525

1.99

9.66

1.2

1.3

0.61

3.99

nmol/l

0.50

505

KRA_PSY_EATING, excluding more controls

310

2.29

9.63

1.5

1.3

0.47

6.09

nmol/l

0.50

303

Unspecific neurodegenerative disorder

177

1980

0.61

9.62

1.3

11.00

1.94

nmol/l

0.42

164

1892

Coxarthrosis [arthrosis of hip](FG)

514

2610

1.36

9.59

1.3

0.66

1.56

nmol/l

0.89

496

2518

Symptoms and signs involving speech and voice

337

2339

1.45

9.57

1.4

1.3

0.60

2.49

nmol/l

1.20

317

2258

COPD, hospital admission 2, with asthma infections

280

1606

1.51

9.54

1.3

3.77

3.49

nmol/l

0.03

259

1540

Social phobias

405

2.12

9.54

1.1

1.4

0.49

0.54

nmol/l

0.80

392

Senile cataract

593

2714

1.33

9.50

1.3

5.38

0.86

nmol/l

0.72

570

2622

Immunodeficiency with predominantly antibody defects

135

3.04

9.39

1.2

1.4

0.50

0.62

nmol/l

2.04

128

Paracetamol or NSAID medication

120

312

1.95

9.35

1.3

1.2

0.56

1.29

nmol/l

0.57

113

303

Other postsurgical states

344

2.21

9.32

1.8

1.3

0.54

5.80

nmol/l

0.51

329

Other menopausal disorders

277

1016

1.53

9.30

1.3

4.73

2.78

nmol/l

0.18

266

978

Other bacterial intestinal infections

173

1043

1.67

9.30

1.3

0.62

3.81

nmol/l

0.92

165

1007

N06DA Anticholinesterases

126

1710

0.57

9.27

1.4

1.3

15.01

1.66

nmol/l

0.45

118

1630

Use of anticholinesterases

126

1710

0.57

9.27

1.4

1.3

15.01

1.66

nmol/l

0.45

118

1630

Familial hypercholesterolemia

127

703

1.82

9.24

1.4

1.3

0.64

3.76

nmol/l

0.64

122

676

Diseases of external ear

346

2431

1.43

9.20

1.3

0.58

2.56

nmol/l

1.36

334

2348

Disorders of lens

635

3010

1.31

9.19

1.3

6.86

0.83

nmol/l

0.99

610

2914

Dental caries, including avohilmo

676

2655

1.31

9.18

1.3

0.63

2.03

nmol/l

1.07

651

2559

Bipolar affective disorders

179

1093

1.65

9.16

1.2

1.3

2.95

3.19

nmol/l

0.03

172

1066

Type 1 diabetes, wide definition, subgroup 1

184

1130

1.64

9.15

1.3

6.21

1.57

nmol/l

0.38

178

1088

Pulmonary heart disease, diseases of pulmonary circulation

299

2046

1.47

9.15

1.4

1.3

2.05

2.58

nmol/l

0.11

288

1969

Other bacterial intestinal infections, including avohilmo

225

1452

1.56

9.13

1.3

0.61

3.63

nmol/l

1.18

216

1398

Disturbance of activity and attention

124

668

1.83

9.07

1.2

1.3

0.46

nmol/l

0.04

119

648

Malignant neoplasm of small intestine

117

3.16

9.03

1.5

1.4

0.64

16.14

nmol/l

0.50

110

Autonomic disorders

112

3.20

8.99

1.5

1.3

0.51

0.62

nmol/l

1.32

106

Spondylolisthesis/Spondylolysis

179

1099

1.64

8.98

1.2

1.3

0.65

4.59

nmol/l

1.17

172

1064

Gestational [pregnancy-induced] hypertension

248

1638

1.52

8.97

1.3

0.54

2.57

nmol/l

0.93

242

1591

Other abnormal uterine and vaginal bleeding

221

1016

1.57

8.85

1.2

1.3

0.66

2.78

nmol/l

0.63

210

976

COPD-related respiratory insufficiency

108

578

1.89

8.79

1.5

1.3

0.74

3.71

nmol/l

0.48

101

554

Hyperkinetic disorders

128

703

1.79

8.77

1.2

1.3

0.45

0.46

nmol/l

0.17

123

684

Oter anti-inflammatory and antirheumatic agents, non-steroids

172

561

1.69

8.76

1.2

1.3

0.64

1.84

nmol/l

0.83

161

537

Mental and behavioural disorders due to alcohol, excluding acute intoxication

395

2842

1.38

8.68

1.2

1.3

0.63

2.26

nmol/l

1.29

377

2755

Pulmonary heart disease

275

1873

1.48

8.65

1.4

1.3

2.14

2.76

nmol/l

0.13

268

1800

Pulmonary embolism

275

1875

1.48

8.61

1.4

1.3

2.14

2.76

nmol/l

0.12

268

1804

Benign neoplasm: Colon, unspecified

243

1619

1.51

8.56

1.3

0.64

3.35

nmol/l

1.18

228

1560

Neuroendocrine tumor and carcinoma of small intestine

3.80

8.55

1.2

0.64

0.65

nmol/l

0.07

Voice disturbances

273

1863

1.48

8.54

1.4

1.3

0.61

2.40

nmol/l

0.93

257

1805

Unspecified fall

487

3594

1.33

8.51

1.3

4.63

1.63

nmol/l

0.51

468

3455

Type 1 diabetes, wide definition

188

1183

1.60

8.50

1.3

6.09

1.53

nmol/l

0.38

182

1138

Diabetic nephropathy

178

1098

1.62

8.38

1.4

0.73

3.91

nmol/l

1.02

171

1064

Diabetic nephropathy, excluding more controls

175

883

1.63

8.28

1.4

0.73

3.54

nmol/l

0.76

168

855

Other female pelvic inflammatory diseases

177

1108

1.61

8.28

1.3

0.59

3.60

nmol/l

0.93

171

1075

Appendectomy

629

4677

1.28

8.26

1.3

0.57

1.58

nmol/l

1.31

607

4513

Degeneration of macula and posterior pole

451

2589

1.35

8.23

1.3

4.61

1.21

nmol/l

0.41

431

2483

Other and unspecified tonsillitis

297

1716

1.44

8.19

1.5

1.4

0.52

1.69

nmol/l

0.60

290

1665

Other peripheral vertigo

102

550

1.88

8.17

1.3

0.63

3.86

nmol/l

0.50

529

Benign neoplasm: Caecum

115

644

1.81

8.15

1.3

0.64

3.40

nmol/l

0.50

107

618

Dislocation, sprain and strain of joints and ligaments of knee

595

4179

1.29

8.12

1.3

0.54

0.99

nmol/l

1.03

584

4031

Alcohol use disorder, Swedish definition

483

3317

1.33

8.10

1.2

1.4

0.64

2.03

nmol/l

1.27

462

3217

Injuries to the thorax

421

3126

1.35

8.03

1.3

0.60

2.15

nmol/l

1.36

404

3010

Diseases of the myoneural junction and muscle

122

698

1.76

8.03

1.5

1.3

0.65

3.19

nmol/l

0.49

117

666

Malignant neoplasm of digestive organs, including Hilmo

386

2068

1.38

7.99

1.4

1.3

0.74

2.34

nmol/l

0.90

369

1992

Family history of other specific disorders

4.05

7.95

3.6

1.3

0.46

0.50

nmol/l

0.32

Abnormal serum enzyme levels

250

1641

1.48

7.92

1.4

1.3

0.65

2.58

nmol/l

0.90

242

1577

Aneurysms, operations, SAH

159

981

1.63

7.90

1.6

1.3

0.66

4.02

nmol/l

0.91

151

945

Diseases of male genital organs

386

1403

1.39

7.89

1.3

1.4

0.56

1.62

nmol/l

0.79

369

1363

Cystic kidney disease

149

2.74

7.89

1.5

1.3

0.69

0.60

nmol/l

0.62

141

Cellulitis

211

1390

1.53

7.88

1.3

0.56

3.87

nmol/l

1.27

201

1344

Atopic dermatitis

570

3516

1.29

7.84

1.3

0.56

1.87

nmol/l

1.28

542

3408

Impingement syndrome of shoulder

219

1456

1.51

7.83

1.3

1.4

0.57

2.79

nmol/l

0.90

207

1398

378

2492

1.37

7.80

1.3

2.93

2.50

nmol/l

0.07

354

2391

Superficial injury of lower leg

256

1758

1.46

7.79

1.3

0.60

1.43

nmol/l

0.72

246

1697

Zoster [herpes zoster], including avohilmo

505

3732

1.31

7.79

1.3

2.27

1.90

nmol/l

0.08

483

3600

Diseases of appendix

707

5040

1.26

7.79

1.2

1.3

0.58

1.55

nmol/l

1.38

683

4870

Emotionally unstable personality disorder

113

638

1.79

7.78

1.2

1.3

0.54

3.28

nmol/l

0.50

106

619

Other medical care

450

2841

1.33

7.73

1.4

1.3

1.06

2.17

nmol/l

0.65

430

2736

Arthropathies in other diseases classified elsewhere

168

2.61

7.72

1.3

1.4

23.80

0.62

nmol/l

0.49

160

Hyperfunction of pituitary gland

216

2.39

7.71

1.7

1.2

0.57

8.79

nmol/l

0.50

207

Presence of cardiac and vascular implants and grafts

386

2084

1.37

7.66

1.3

3.40

2.45

nmol/l

0.13

371

1993

Sequelae of cerebrovascular disease

312

1896

1.41

7.65

1.4

1.3

3.35

3.07

nmol/l

0.03

295

1817

Gonarthrosis, primary, with knee surgery

542

3258

1.30

7.63

1.2

1.3

1.71

1.65

nmol/l

0.02

522

3133

Appendicitis, broad definition

699

5007

1.26

7.63

1.2

1.3

0.58

1.55

nmol/l

1.38

675

4840

Viral and other specified intestinal infections, including avohilmo

244

1602

1.47

7.63

1.4

1.3

0.55

2.50

nmol/l

0.87

238

1550

Malignant neoplasm of skin, including Hilmo

479

2433

1.32

7.54

1.3

1.2

0.68

2.07

nmol/l

0.94

453

2350

Chronic diseases of tonsils and adenoids

742

3746

1.25

7.54

1.3

0.58

1.81

nmol/l

1.28

719

3623

Early lumbar disc prolapse, operated

473

1.90

7.46

1.3

0.47

0.98

nmol/l

0.62

460

Alzheimer disease

119

1431

0.59

7.44

1.4

1.3

0.66

2.07

nmol/l

0.58

111

1365

Other blood glucose lowering drugs, excl. Insulins

142

866

1.65

7.42

1.3

0.78

3.18

nmol/l

0.74

136

828

Excessive attrition of teeth

591

4603

1.27

7.42

1.3

2.32

1.36

nmol/l

0.23

576

4441

Other viral diseases, including avohilmo

346

2507

1.37

7.33

1.3

0.54

2.37

nmol/l

1.27

336

2429

Other diseases of pleura

391

2527

1.35

7.33

1.4

1.3

0.66

2.45

nmol/l

1.23

373

2428

Iron deficiency anaemia secondary to blood loss (chronic)

150

931

1.62

7.31

1.3

0.72

3.77

nmol/l

0.75

140

896

Persistent mood disorders

183

1191

1.55

7.27

1.3

0.62

3.02

nmol/l

0.77

175

1155

Otitis externa

218

1473

1.49

7.25

1.3

0.55

3.55

nmol/l

1.20

208

1422

Vitamin D deficiency

3.13

7.23

1.4

1.2

0.65

0.59

nmol/l

0.39

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

326

2.07

7.21

1.3

0.58

6.11

nmol/l

0.51

312

Alzheimer disease, including avohilmo

150

1641

0.63

7.21

1.4

1.3

0.66

2.78

nmol/l

1.00

140

1567

Rosacea

134

813

1.66

7.17

1.4

1.3

0.61

4.14

nmol/l

0.78

123

791

Disorders of psychological development

102

531

1.79

7.10

1.3

0.48

3.81

nmol/l

0.50

512

Acute appendicitis

654

4855

1.25

7.09

1.2

1.3

0.58

1.58

nmol/l

1.38

630

4694

Mental and behavioural disorders due to alcohol

440

3193

1.32

7.07

1.2

1.4

0.62

2.08

nmol/l

1.29

422

3097

Vasomotor and allergic rhinitis

345

2484

1.36

7.01

1.2

1.3

0.55

2.42

nmol/l

1.30

335

2406

Necrosis of pulp, including avohilmo

556

4324

1.27

7.00

1.2

1.3

0.57

1.69

nmol/l

1.37

540

4181

Non-allergic asthma (mode), excluding more controls

158

996

1.58

6.94

1.3

0.57

3.01

nmol/l

0.74

150

961

Skin changes due to chronic exposure to nonionizing radiation

352

2357

1.36

6.92

1.3

3.11

2.61

nmol/l

0.07

329

2261

Other diseases of the respiratory system

174

1133

1.55

6.92

1.5

1.3

0.62

3.12

nmol/l

0.78

166

1092

Other respiratory disorders and diseases

174

1133

1.55

6.92

1.5

1.3

0.62

3.12

nmol/l

0.78

166

1092

Calcific aortic valvular stenosis

235

1564

1.45

6.91

1.3

5.07

1.93

nmol/l

0.31

228

1491

Calcific aortic valvular stenosis, operated

235

1564

1.45

6.91

1.3

5.07

1.93

nmol/l

0.31

228

1491

COPD, hospital admissions 3, with asthma pneumonia sepsis

219

1277

1.48

6.89

1.4

1.3

4.74

4.22

nmol/l

0.04

198

1225

Dermatographic urticaria

374

1.98

6.88

1.3

0.50

5.30

nmol/l

0.51

361

Any dementia

173

1814

0.66

6.88

1.4

1.3

0.66

2.58

nmol/l

1.00

159

1734

Viral infections of the central nervous system, including avohilmo

416

1.92

6.87

1.5

1.3

15.53

4.84

nmol/l

0.31

401

Acute appendicitis, no complications

513

3988

1.28

6.82

1.3

0.57

1.74

nmol/l

1.31

500

3864

Fracture of rib(s), sternum and thoracic spine

273

1947

1.41

6.82

1.3

0.61

2.98

nmol/l

1.28

261

1877

Superficial injury of abdomen, lower back and pelvis

147

925

1.60

6.80

1.3

0.55

3.75

nmol/l

0.79

140

887

Postmenopausal atrophic vaginitis

252

949

1.46

6.79

1.2

1.3

0.64

2.95

nmol/l

0.64

244

915

Alzheimer’s disease, strict definition

1205

0.55

6.78

1.4

1.3

0.64

2.19

nmol/l

0.53

1147

Calcific aortic valvular stenosis, diagnosis (helper)

234

1562

1.45

6.78

1.3

5.09

1.94

nmol/l

0.31

227

1489

Operations 2 for CAVS

234

1562

1.45

6.78

1.3

5.09

1.94

nmol/l

0.31

227

1489

Monoamine oxidase A inhibitors

117

696

1.70

6.78

1.4

1.3

0.64

4.75

nmol/l

0.77

112

676

Noninflammatory disorders of female genital tract

351

1287

1.37

6.76

1.3

0.58

2.30

nmol/l

0.65

338

1237

Problems related to lifestyle

548

1.78

6.74

1.4

1.3

0.62

3.80

nmol/l

0.49

528

Contact with and exposure to communicable diseases

267

1892

1.41

6.73

1.4

1.3

0.53

2.06

nmol/l

0.79

256

1842

Sequelae of injuries, of poisoning and of other consequences of external causes

220

1514

1.46

6.71

1.4

1.3

0.67

3.59

nmol/l

1.20

213

1469

Atopic dermatitis, strict definition with reimbursement

273

1874

1.41

6.71

1.3

0.54

2.42

nmol/l

1.00

262

1822

Deviated nasal septum

283

2036

1.39

6.67

1.4

0.58

2.93

nmol/l

1.35

277

1972

Malignant neoplasm of skin

449

2327

1.31

6.67

1.3

1.2

0.68

2.05

nmol/l

0.87

425

2247

Mycoses

266

1897

1.41

6.67

1.4

1.3

0.60

3.01

nmol/l

1.27

258

1838

505

3525

1.28

6.66

1.3

0.63

1.94

nmol/l

1.29

485

3418

Bacterial intestinal infections, IBD co-morbidities

167

1088

1.54

6.65

1.3

0.62

3.31

nmol/l

0.78

159

1048

Ulcer of lower limb, not elsewhere classified

131

807

1.64

6.63

1.2

1.3

0.76

2.84

nmol/l

0.46

122

775

Periapical abscess

437

3364

1.30

6.62

1.2

1.3

0.65

1.96

nmol/l

1.19

425

3250

Injuries to the shoulder and upper arm

814

5172

1.22

6.58

1.3

2.16

1.44

nmol/l

0.25

786

4997

Calcific aortic valvular stenosis, including rheumatic fever

234

1570

1.44

6.57

1.3

5.09

1.93

nmol/l

0.31

227

1496

L04AA Selective immunosuppressants

214

1473

1.46

6.54

1.3

0.60

2.84

nmol/l

0.92

206

1431

Alcohol use disorder, ICD-based

354

2651

1.34

6.53

1.2

1.3

0.62

2.38

nmol/l

1.30

340

2566

Actinic keratosis

339

2290

1.35

6.53

1.3

3.21

2.66

nmol/l

0.07

316

2195

Delirium, not induced by alcohol and other psychoactive substances

110

649

1.70

6.51

1.4

1.3

0.65

0.69

nmol/l

0.41

103

619

Myocardial infarction, unclassifiable

162

938

1.55

6.49

1.5

1.3

7.07

2.59

nmol/l

0.30

156

898

Cystic kidney disease, including avohilmo

165

2.47

6.48

1.5

1.3

0.69

0.60

nmol/l

0.57

157

Early onset COPD

197

1337

1.48

6.47

1.2

1.3

0.62

3.87

nmol/l

1.18

186

1293

Liquid cancers, including Hilmo

309

1997

1.37

6.44

1.4

1.3

0.65

2.29

nmol/l

0.90

303

1927

Other skin changes

181

1212

1.50

6.36

1.2

1.3

5.28

3.36

nmol/l

0.16

172

1172

Benign lipomatous neoplasm

278

2016

1.39

6.34

1.4

1.3

4.28

2.38

nmol/l

0.21

273

1944

Propionic acid derivatives

207

699

1.49

6.34

1.3

0.59

1.57

nmol/l

0.85

199

672

L04AD Calcineurin inhibitors

106

626

1.71

6.34

1.3

0.63

3.41

nmol/l

0.49

101

606

Disorders of breast

496

3437

1.27

6.22

1.3

2.26

1.57

nmol/l

0.16

483

3315

DVT of lower extremities and pulmonary embolism

369

2791

1.32

6.19

1.4

1.3

1.75

2.21

nmol/l

0.13

360

2677

Complications of internal orthopaedic prosthetic devices, implants and grafts

207

1433

1.45

6.16

1.4

1.3

0.66

3.42

nmol/l

1.04

199

1377

524

3621

1.26

6.07

1.3

0.63

1.90

nmol/l

1.27

503

3511

Use of pramipexole

207

1438

1.45

6.06

1.2

1.3

0.60

2.94

nmol/l

0.94

197

1388

Later onset COPD

218

1221

1.44

6.03

1.4

1.3

4.62

3.48

nmol/l

0.10

207

1169

Alzheimer’s disease (Late onset)

1099

0.56

5.98

1.3

0.65

2.35

nmol/l

0.53

1046

Disorders of ocular muscles, binocular movement, accommodation and refraction

442

3427

1.28

5.95

1.4

1.3

2.45

1.92

nmol/l

0.10

432

3306

Sub-endpoint used in defining T1D endpoints

239

1681

1.40

5.93

1.4

1.3

4.92

2.32

nmol/l

0.25

232

1621

Cauda equina syndrome

3.49

5.92

1.7

1.4

0.66

0.58

nmol/l

0.30

Fibroblastic disorders

191

1314

1.46

5.89

1.3

6.00

2.89

nmol/l

0.24

185

1258

Uterine polyps

257

1074

1.40

5.88

1.3

0.61

2.66

nmol/l

0.65

247

1036

Achilles tendinitis

579

1.71

5.88

1.2

1.3

0.56

6.31

nmol/l

0.93

563

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

210

1427

1.43

5.84

1.8

1.3

1.63

2.98

nmol/l

0.37

203

1369

Other and unspecified diseases of blood and blood-forming organs

125

2.61

5.83

1.5

1.3

0.84

0.64

nmol/l

0.85

119

Left ventricular outflow tract obstruction (LVOTO), broad definition

567

1.71

5.78

1.4

1.3

0.60

0.62

nmol/l

0.22

551

Non-allergic asthma (mode)

158

1042

1.51

5.74

1.3

0.57

2.91

nmol/l

0.74

150

1005

Polycystic kidney disease

115

2.66

5.68

1.6

1.3

0.72

0.59

nmol/l

0.79

109

Misadventures to patients during surgical and medical care

132

848

1.57

5.68

1.5

1.3

6.88

4.04

nmol/l

0.17

127

819

Poisoning by drugs, medicaments and biological substances

211

1490

1.42

5.67

1.4

1.3

0.63

2.49

nmol/l

0.74

201

1450

Fracture of lower leg, including ankle

512

4025

1.25

5.67

1.2

1.3

4.00

1.28

nmol/l

0.37

502

3877

Use of memantine

1299

0.61

5.63

1.3

19.53

0.71

nmol/l

0.49

1236

Use of other anti-dementia drugs

1299

0.61

5.63

1.3

19.53

0.71

nmol/l

0.49

1236

Aortic valve malfunction, age under 60 years

534

1.72

5.63

1.4

0.61

0.62

nmol/l

0.11

518

Polyp of the female genital tract

266

1093

1.38

5.58

1.3

0.59

2.62

nmol/l

0.66

255

1055

All influenza

226

1622

1.40

5.53

1.6

1.3

4.22

3.29

nmol/l

0.09

220

1573

Benign leiomyoma with endometriosis

167

1136

1.48

5.52

1.3

0.57

3.56

nmol/l

0.95

162

1099

Other disorders of the musculoskeletal system and connective tissue

141

926

1.53

5.51

1.2

1.3

0.57

3.77

nmol/l

0.80

131

893

Papulosquamous disorders

367

2836

1.30

5.50

1.3

2.91

2.23

nmol/l

0.11

348

2739

Blepharochalasis

274

2036

1.35

5.44

1.2

1.3

0.61

2.82

nmol/l

1.22

264

1954

Amiodarone users

502

1.73

5.43

1.5

1.3

0.72

4.20

nmol/l

0.49

481

Other disorders of conjunctiva

130

842

1.56

5.42

1.2

1.3

0.60

4.09

nmol/l

0.79

125

812

Pre-eclampsia or poor fetal growth

271

2003

1.35

5.40

1.2

1.3

0.53

2.21

nmol/l

0.94

261

1943

Degenerative diseases of the nervous system

155

1639

0.68

5.39

1.3

0.67

2.78

nmol/l

0.99

144

1564

Other disorders of central nervous system

3.37

5.36

1.4

0.55

0.56

nmol/l

0.07

Superficial injury of head

215

1538

1.40

5.36

1.3

4.43

2.78

nmol/l

0.16

209

1484

Other benign neoplasms of skin

341

2620

1.31

5.36

1.4

1.3

0.62

2.30

nmol/l

1.19

334

2525

Ganglion

185

1293

1.44

5.30

1.3

0.61

3.02

nmol/l

0.86

179

1248

Colonic or urogenital fistula

241

1764

1.37

5.28

1.2

1.3

0.58

3.19

nmol/l

1.28

229

1710

249

1569

1.37

5.26

1.3

7.97

1.79

nmol/l

0.40

234

1497

Haemorrhage in early pregnancy

259

1862

1.36

5.26

1.2

1.3

0.57

2.37

nmol/l

0.93

251

1804

Allergic rhinitis

270

1986

1.35

5.26

1.2

1.3

0.52

2.33

nmol/l

1.04

263

1927

Malignant neoplasm of pancreas, including Hilmo

433

1.77

5.24

1.6

1.3

0.94

4.73

nmol/l

0.45

419

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

173

1198

1.45

5.22

1.3

0.55

3.33

nmol/l

0.93

167

1159

Dementia

224

2101

0.73

5.21

1.3

8.75

2.41

nmol/l

0.36

210

2006

Fracture of skull and facial bones

192

1357

1.42

5.18

1.3

0.57

3.49

nmol/l

1.05

182

1311

Rheumatoid arthritis

273

1804

1.34

5.18

1.2

1.3

0.64

1.40

nmol/l

0.62

261

1735

Gastrointestinal stromal tumor and sarcoma

3.10

5.17

2.7

1.3

0.60

26.80

nmol/l

0.49

Hyperplasia of prostate

245

1001

1.38

5.17

1.5

1.4

0.65

2.06

nmol/l

0.73

231

968

Respiratory insufficiency

369

1.82

5.12

1.6

1.3

0.72

5.42

nmol/l

0.49

358

Nontraumatic intracranial haemmorrhage

162

1112

1.46

5.11

1.5

1.3

0.64

3.66

nmol/l

0.93

157

1067

Fall on same level involving ice and snow

544

4440

1.23

5.10

1.3

3.26

1.54

nmol/l

0.46

524

4286

Eating disorder

399

1.79

5.09

1.5

1.3

0.47

4.88

nmol/l

0.50

386

Eating disorders

503

1.70

5.09

1.4

1.3

0.52

4.02

nmol/l

0.50

485

Dementia, including avohilmo

248

2275

0.74

5.08

1.3

7.94

2.28

nmol/l

0.36

233

2170

COPD, hospital admissions 1, only main diagnosis

273

1756

1.34

5.07

1.3

0.66

3.26

nmol/l

1.25

255

1684

Excessive earwax

583

4342

1.22

5.06

1.3

0.63

1.91

nmol/l

1.54

571

4180

Viral infections characterized by skin and mucous membrane lesions

382

3000

1.28

5.05

1.3

2.74

2.13

nmol/l

0.10

372

2889

Acute pancreatitis

165

1141

1.45

5.03

1.2

1.3

0.61

4.43

nmol/l

1.18

160

1105

Conductive and sensorineural hearing loss

714

3958

1.20

5.03

1.3

0.62

2.04

nmol/l

1.58

690

3820

Pre-eclampsia or eclampsia

200

1435

1.40

4.98

1.2

1.3

0.54

2.87

nmol/l

0.94

193

1397

Glaucoma

502

3455

1.24

4.97

1.3

0.63

2.27

nmol/l

1.59

485

3324

Anti-inflammatory and antirheumatic products, non-steroids

198

699

1.43

4.95

1.3

9.50

1.57

nmol/l

0.43

191

672

Basal cell carcinoma

384

2051

1.28

4.95

1.3

1.2

0.68

2.25

nmol/l

0.88

362

1980

Leisure time condition

159

1096

1.46

4.94

1.3

0.59

2.22

nmol/l

0.50

154

1056

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

252

1878

1.35

4.94

1.3

0.58

2.21

nmol/l

0.84

242

1820

Sensorineural hearing loss

675

3745

1.20

4.94

1.3

0.62

2.12

nmol/l

1.58

653

3613

Idiopathic urticaria

118

2.51

4.92

1.3

0.60

15.59

nmol/l

0.49

113

Malignant neoplasm of digestive organs

328

1934

1.30

4.87

1.4

1.3

0.66

2.36

nmol/l

0.90

312

1865

Pericarditis

156

2.27

4.84

1.8

1.3

0.61

12.09

nmol/l

0.50

148

Poisoning by medicine

188

1342

1.41

4.83

1.4

1.3

0.62

2.71

nmol/l

0.75

178

1307

Basal cell carcinoma, including Hilmo

396

2120

1.27

4.75

1.3

1.2

0.68

2.20

nmol/l

0.88

374

2049

Other and unspecified immunodeficiencies with predominantly antibody defects

3.10

4.72

1.1

1.3

0.51

0.53

nmol/l

0.10

Postmenopausal bleeding

240

922

1.37

4.71

1.2

1.3

0.64

3.03

nmol/l

0.65

235

887

Liquid cancers

237

1668

1.35

4.69

1.4

1.3

0.67

2.63

nmol/l

0.90

232

1604

Supplementary factors related to causes of morbidity and mortality classified elsewhere

275

2093

1.32

4.69

1.3

0.57

2.78

nmol/l

1.28

266

2021

Inflammatory bowel disease

275

2093

1.32

4.69

1.3

0.69

2.75

nmol/l

1.15

268

2027

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

407

2183

1.26

4.67

1.4

1.2

0.68

2.15

nmol/l

0.87

387

2110

Hyperprolactinaemia

146

2.29

4.66

1.3

1.2

0.55

12.87

nmol/l

0.50

138

Retinal haemorrhage

109

2.52

4.66

1.1

1.3

0.56

0.66

nmol/l

1.29

103

Unspecified privation

603

1.60

4.64

1.2

1.3

5.01

3.55

nmol/l

0.11

581

Umbilical hernia

222

1641

1.36

4.63

1.2

1.3

0.62

3.47

nmol/l

1.31

213

1592

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

264

2003

1.32

4.61

1.4

1.3

2.23

2.66

nmol/l

0.08

256

1938

Other malignant neoplasms of skin (=non-melanoma skin cancer)

392

2110

1.26

4.60

1.3

1.2

0.69

2.21

nmol/l

0.88

372

2039

Medical abortion

599

2681

1.21

4.60

1.4

1.3

0.61

1.85

nmol/l

0.92

585

2570

Striking against or struck by other objects

283

2166

1.31

4.59

1.3

0.53

2.68

nmol/l

1.30

268

2099

Perforation of tympanic membrane

546

1.62

4.48

1.3

0.58

3.85

nmol/l

0.51

526

Other and unspecified mononeuropathies of lower limb

136

2.32

4.48

1.2

1.3

0.63

13.73

nmol/l

0.50

130

178

1190

1.40

4.47

1.3

10.93

0.69

nmol/l

0.50

166

1136

Atopic dermatitis, strict definition

251

1857

1.33

4.47

1.2

1.3

0.54

2.43

nmol/l

1.00

240

1804

Other and unspecified mononeuropathies, also in other diseases

124

2.37

4.44

1.4

0.68

15.16

nmol/l

0.49

117

Speech therapy

231

1731

1.34

4.43

1.3

4.19

3.15

nmol/l

0.10

223

1672

Benign neoplasm: Brain, supratentorial

2.94

4.37

2.1

1.3

0.67

0.53

nmol/l

0.52

Sulfonylureas

247

1484

1.33

4.31

1.4

1.3

0.68

2.15

nmol/l

0.79

236

1417

Arterial embolism and thrombosis

232

1.96

4.30

1.4

1.3

0.70

8.38

nmol/l

0.49

220

Malignant neoplasm of bladder, including Hilmo

491

1.64

4.29

1.3

0.69

4.25

nmol/l

0.49

472

Follicular cysts of skin and subcutaneous tissue

164

1170

1.41

4.29

1.2

1.3

0.56

3.08

nmol/l

0.80

155

1136

Benign neoplasm: Ascending colon

130

889

1.47

4.29

1.6

1.3

7.14

3.92

nmol/l

0.19

123

855

Erosion of teeth , including avohilmo

237

1793

1.33

4.27

1.3

0.57

2.52

nmol/l

0.99

227

1739

Methotrexate

124

841

1.48

4.26

1.2

1.3

0.61

4.54

nmol/l

0.92

118

814

Keratitis

316

2485

1.28

4.25

1.3

3.21

1.99

nmol/l

0.18

308

2397

Diagnoses used for exclusion with ILD

208

1547

1.35

4.21

1.3

0.60

3.44

nmol/l

1.19

198

1496

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

258

1983

1.31

4.15

1.3

0.55

2.35

nmol/l

1.01

253

1916

Any event in hilmo or specialist outpatient

+∞

4.12

2.6

0.0

0.38

—

nmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

240

1142

1.33

4.08

1.3

0.48

0.51

nmol/l

0.54

234

1105

Acute pancreatitis (for exclusion)

165

1190

1.39

4.07

1.2

1.3

0.61

3.94

nmol/l

1.04

160

1147

Disorders of tooth development and eruption

139

787

1.44

4.07

1.3

0.55

4.53

nmol/l

0.86

133

758

Nonhereditary hypogammaglobulinemia

3.01

4.06

1.2

1.4

0.48

0.53

nmol/l

0.40

Early lumbar disc prolapse operation

569

1.57

4.04

1.3

0.47

0.89

nmol/l

0.62

561

Trigger finger

129

895

1.45

3.97

1.2

1.3

0.59

3.87

nmol/l

0.79

124

864

Tuberous sclerosis 1

7.98

3.97

2.3

1.6

0.56

0.46

nmol/l

—

Reimbursement for rheumatic diseases

515

4274

1.20

3.95

1.3

0.60

1.88

nmol/l

1.51

494

4123

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

350

1.73

3.92

1.5

1.3

0.55

5.69

nmol/l

0.51

336

Injuries to the wrist and hand

936

5416

1.15

3.90

1.3

1.69

1.44

nmol/l

0.08

912

5225

Pre-eclampsia

177

1302

1.37

3.89

1.2

1.3

0.53

3.10

nmol/l

0.94

172

1267

Other obstetric conditions, not elsewhere classified

244

1175

1.31

3.89

1.3

0.49

0.51

nmol/l

0.47

238

1138

Covid-19 suspected case

183

1354

1.36

3.87

1.2

1.3

7.84

1.88

nmol/l

0.45

178

1309

Malignant melanoma

126

875

1.45

3.87

1.2

1.3

0.65

4.45

nmol/l

0.92

119

842

Other and unspecified rosacea

552

1.57

3.87

1.5

1.3

0.60

3.80

nmol/l

0.50

534

Type of accident

251

1944

1.30

3.85

1.3

0.57

2.95

nmol/l

1.28

243

1878

Bronchitis, not specified as acute or chronic

443

1.64

3.85

1.5

1.4

0.60

4.56

nmol/l

0.50

430

Psoriasis

250

1936

1.30

3.85

1.2

1.3

3.96

2.95

nmol/l

0.11

238

1881

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

133

934

1.43

3.84

1.3

0.57

2.50

nmol/l

0.52

124

903

Any death

422

3583

0.82

3.82

1.3

0.68

2.14

nmol/l

1.42

396

3462

Hallux rigidus

123

853

1.45

3.82

1.2

1.3

0.64

2.00

nmol/l

0.50

117

815

Other cataract

376

2264

1.24

3.79

1.3

8.89

0.91

nmol/l

0.80

360

2185

Any dementia, excluding more controls

166

1550

0.73

3.79

1.4

1.3

0.67

3.34

nmol/l

1.10

153

1488

Malignant melanoma, including Hilmo

141

1004

1.41

3.78

1.3

0.66

3.95

nmol/l

0.91

132

967

Follow-up examination after treatment for malignant neoplasms

477

1.60

3.75

1.8

1.3

0.64

7.72

nmol/l

0.92

453

Superficial injury of ankle and foot

105

709

1.49

3.74

1.3

0.55

3.05

nmol/l

0.50

684

Polycythaemia vera

168

2.05

3.72

1.1

1.3

0.76

11.31

nmol/l

0.49

160

Perioral dermatitis

109

2.33

3.71

1.3

1.2

0.67

16.91

nmol/l

0.49

104

Benign neoplasm of meninges

646

1.51

3.71

1.5

1.3

0.62

3.38

nmol/l

0.51

622

Ulcerative colitis

203

1537

1.33

3.70

1.3

0.73

2.60

nmol/l

0.76

196

1491

Colorectal neuroendocrine tumor and carcinoma

2.74

3.69

1.3

1.4

0.59

0.66

nmol/l

0.38

Polyglandular dysfunction, other/unspecified

11.59

3.63

3.3

1.2

0.53

0.45

nmol/l

—

Graves disease, strict definition

626

1.51

3.60

1.3

0.59

3.40

nmol/l

0.50

606

Parkinson's disease, excluding more controls

567

1.52

3.58

1.5

1.3

0.69

nmol/l

0.01

542

In situ neoplasms

346

2811

1.23

3.58

1.3

0.63

2.26

nmol/l

1.25

327

2705

Hypothyroidism due to medicaments and other exogenous substances

2.87

3.56

1.4

0.57

33.94

nmol/l

0.49

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

137

983

1.40

3.54

1.4

1.3

0.60

3.50

nmol/l

0.77

128

954

Malignant neoplasm of pancreas

346

1.69

3.52

1.7

1.3

0.59

5.77

nmol/l

0.51

333

Salpingitis and oophoritis

166

1235

1.35

3.45

1.2

1.3

0.56

3.29

nmol/l

0.95

159

1204

Benign neoplasm: Cerebral meninges

592

1.51

3.45

1.4

1.3

0.58

3.64

nmol/l

0.51

569

Neurofibromatosis, type 2

7.64

3.45

2.6

1.4

0.59

0.54

nmol/l

—

Injuries to the elbow and forearm

650

4797

1.16

3.44

1.3

0.65

1.75

nmol/l

1.44

610

4646

Atrophic disorders of skin

153

1126

1.37

3.42

1.2

1.3

0.58

3.56

nmol/l

0.94

147

1094

Preterm labour and delivery

233

1823

1.28

3.37

1.3

4.10

2.40

nmol/l

0.19

227

1767

Other factor of the environment

2.77

3.35

1.8

1.2

0.51

0.55

nmol/l

0.14

Unspecified threat to breathing

2.99

3.33

1.1

1.4

0.41

0.54

nmol/l

0.74

Hidradenitis suppurativa

176

1.95

3.30

1.2

1.4

0.60

0.56

nmol/l

0.30

169

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

145

1064

1.37

3.29

1.2

1.3

0.57

3.53

nmol/l

0.87

136

1029

Other and unspecified disorders of autonomic nervous system

4.95

3.29

1.4

1.5

0.36

0.46

nmol/l

—

L04AC Interleukin inhibitors

369

1.64

3.28

1.2

1.4

0.53

5.32

nmol/l

0.51

359

Other disorders of pigmentation

242

1.79

3.24

1.4

0.60

7.97

nmol/l

0.50

233

Other hearing loss

222

1681

1.28

3.22

1.2

1.3

0.61

3.40

nmol/l

1.29

212

1604

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

199

1.88

3.22

1.3

0.65

9.61

nmol/l

0.50

190

Deficiency of other B group vitamins

2.30

3.22

1.2

0.55

19.26

nmol/l

0.50

Congenital malformations of the circulatory system

116

800

1.41

3.21

1.5

1.3

0.58

2.79

nmol/l

0.50

110

772

Arterial embolism and thrombosis of lower extremity artery

130

2.10

3.18

1.6

1.2

0.72

14.24

nmol/l

0.49

125

Other disorders of thyroid

2.59

3.15

1.4

0.41

28.50

nmol/l

0.50

Bitten or struck by other mammals

654

1.46

3.14

1.4

1.3

0.59

3.27

nmol/l

0.49

633

Open wound of head

456

3620

1.19

3.13

1.3

1.08

1.88

nmol/l

0.49

437

3493

Parkinson's disease, strict definition, excluding more controls

533

1.49

3.12

1.4

1.3

0.67

0.69

nmol/l

0.18

509

Diseases of middle ear and mastoid

487

3378

1.18

3.10

1.4

1.3

2.25

1.93

nmol/l

0.06

469

3263

Other viral diseases

233

1837

1.27

3.10

1.2

1.3

0.52

2.25

nmol/l

0.88

225

1780

Seborrhoeic dermatitis

566

1.49

3.10

1.3

0.66

3.74

nmol/l

0.49

545

Benign neoplasm: Aortic body and other paraganglia

11.67

3.09

5.6

1.8

0.36

0.78

nmol/l

—

Idiopathic gout

462

1.55

3.08

1.2

1.3

0.62

4.50

nmol/l

0.50

441

Malignant neoplasm of colon, including Hilmo

141

1039

1.36

3.07

1.3

0.62

3.86

nmol/l

0.93

133

997

Hallux valgus (acquired)

277

1593

1.25

3.06

1.2

1.3

2.17

1.35

nmol/l

0.20

265

1534

Astigmatism

314

1.67

3.05

1.2

1.3

0.59

6.18

nmol/l

0.50

304

Drug-induced Cushing's syndrome

10.94

3.04

1.0

1.2

1.00

0.50

nmol/l

—

Stomatitis and related lesions

171

1304

1.32

3.04

1.3

0.60

3.14

nmol/l

0.92

166

1259

Renal cell carcinoma of kidney

140

2.02

3.02

2.6

1.4

0.70

13.50

nmol/l

0.50

133

Malignant melanoma of skin, including Hilmo

113

810

1.40

3.01

1.3

0.65

4.75

nmol/l

0.92

106

780

Unspecified mental disorder

335

2767

1.21

3.00

1.3

0.66

2.24

nmol/l

1.18

318

2674

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

218

1698

1.27

3.00

1.5

1.3

0.54

2.25

nmol/l

0.78

212

1641

Diseases of spleen

2.27

2.99

1.4

1.3

0.61

19.69

nmol/l

0.49

Autoimmune hepatitis, wide definition

235

1.76

2.93

1.2

1.3

0.63

8.14

nmol/l

0.50

227

Sequelae of injuries of head

250

1.73

2.93

1.1

1.4

0.56

0.61

nmol/l

0.82

241

Biological medicines for asthma

108

2.16

2.92

1.3

0.47

0.55

nmol/l

0.95

100

Crohn disease (strict definition, require KELA, min 2 HDR)

334

1.63

2.92

1.4

0.63

5.86

nmol/l

0.49

323

Prolonged pregnancy

760

0.64

2.92

1.2

1.3

0.44

0.52

nmol/l

3.17

737

Other diseases of spinal cord

135

2.02

2.92

1.3

0.54

0.63

nmol/l

0.69

128

Benign neoplasm: Peripheral nerves and autonomic nervous system

2.41

2.92

2.3

1.3

0.46

25.20

nmol/l

0.50

Superficial injury of forearm

566

1.47

2.90

1.3

0.58

3.67

nmol/l

0.50

548

Recurrent aphthous stomatitis , including avohilmo

122

892

1.37

2.90

1.3

0.60

3.87

nmol/l

0.78

117

859

Second line medication for Crohn's disease

512

4403

1.16

2.86

1.3

0.61

1.68

nmol/l

1.31

494

4251

Malignant melanoma of skin

659

1.43

2.85

1.2

1.3

0.64

3.33

nmol/l

0.50

636

Nonsuppurative otitis media, including avohilmo

258

1802

1.24

2.84

1.4

1.3

0.54

2.39

nmol/l

0.93

250

1744

Crohn's disease of small intestine

376

1.58

2.83

1.3

1.4

0.61

5.24

nmol/l

0.49

365

Suicide or other Intentional self-harm

198

1556

1.28

2.83

1.3

0.61

2.56

nmol/l

0.83

188

1510

Coeliac disease

702

1.42

2.83

1.3

0.59

4.73

nmol/l

0.78

679

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

152

1154

1.32

2.83

1.5

1.3

1.80

3.53

nmol/l

0.37

146

1110

Malignant neoplasm of oropharynx

2.50

2.81

1.9

1.3

0.58

29.01

nmol/l

0.50

Urethritis and urethral syndrome

110

2.12

2.80

1.6

1.3

0.52

16.97

nmol/l

0.50

104

Family history of malignant neoplasm

100

712

1.41

2.80

2.4

1.3

0.54

5.21

nmol/l

0.93

100

693

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

354

1.59

2.79

1.7

1.4

0.54

5.53

nmol/l

0.50

343

Other congenital malformations of skin

202

1.80

2.78

1.2

1.3

0.54

9.37

nmol/l

0.50

194

Speech disturbances, not elsewhere classified

490

1.50

2.78

1.3

0.58

4.30

nmol/l

0.51

467

Pregnancy with abortive outcome

597

2697

1.16

2.78

1.3

0.61

1.84

nmol/l

0.91

582

2586

Nontoxic diffuse goitre

166

1.89

2.78

1.3

1.2

0.53

11.52

nmol/l

0.50

156

Mononeuritis multiplex

8.67

2.78

1.4

1.3

0.60

0.40

nmol/l

—

Bronchiectasis

426

1.54

2.77

1.4

1.3

0.66

4.83

nmol/l

0.50

407

Suppurative and unspecified otitis media

286

2077

1.22

2.76

1.4

1.3

3.41

2.05

nmol/l

0.18

277

2012

D07AA Corticosteroids, weak (group I)

119

873

1.37

2.75

1.3

0.53

2.58

nmol/l

0.51

113

844

Diabetes mellitus in pregnancy

244

1244

1.25

2.75

1.3

0.48

1.45

nmol/l

0.54

239

1208

Crohn disease (strict definition, require KELA)

340

1.60

2.74

1.4

0.63

5.76

nmol/l

0.49

329

Cardiomyopathy, Hypertrophic obstructive

2.39

2.74

1.2

1.3

0.70

25.98

nmol/l

0.49

Colorectal cancer, including Hilmo

202

1489

1.27

2.73

1.3

0.62

2.89

nmol/l

0.93

193

1426

Congenital iodine-deficiency syndrome/hypothyroidism

139

1.96

2.71

1.4

1.2

0.64

13.71

nmol/l

0.50

130

Allergic purpura

132

1.99

2.71

1.3

0.52

14.28

nmol/l

0.50

124

Viral warts

550

1.46

2.71

1.2

1.3

0.60

3.78

nmol/l

0.50

533

Sequelae of injuries of lower limb

534

1.47

2.71

1.4

1.3

0.56

3.88

nmol/l

0.51

518

Monoplegia

2.32

2.70

1.2

1.4

0.53

23.91

nmol/l

0.50

L04AX Other immunosuppressants

495

4271

1.16

2.69

1.3

0.61

1.68

nmol/l

1.25

477

4122

Melanocytic naevi

264

2159

1.23

2.68

1.4

1.3

0.60

2.60

nmol/l

1.17

257

2090

Benign neoplasm: Nasopharynx

2.86

2.67

1.1

1.5

0.43

46.49

nmol/l

0.49

Other other unspecified disorders of the circulatory system

176

1.84

2.65

1.3

0.53

10.75

nmol/l

0.50

168

Vestibular neuronitis

512

1.47

2.65

1.2

1.3

0.57

4.09

nmol/l

0.51

493

Female infertility

226

1082

1.26

2.65

1.2

1.3

0.53

2.59

nmol/l

0.67

221

1048

Injury of muscle and tendon at shoulder and upper arm level

295

2444

1.21

2.63

1.2

1.3

0.63

2.41

nmol/l

1.19

285

2358

Orchitis and epididymitis

399

1.54

2.63

1.2

1.3

0.51

3.20

nmol/l

0.53

387

Other maltreatment syndromes

148

1.91

2.62

1.3

1.4

0.60

0.54

nmol/l

0.46

142

Infections with a predominantly sexual mode of transmission, including avohilmo

324

2476

1.20

2.61

1.3

0.53

1.98

nmol/l

1.02

314

2395

Infections with a predominantly sexual mode of transmission

246

1999

1.23

2.60

1.3

0.52

2.31

nmol/l

1.02

239

1938

Postprocedural musculoskeletal disorders, not elsewhere classified

417

1.52

2.59

1.3

1.4

0.62

4.91

nmol/l

0.50

400

Subacute thyroiditis

207

1.76

2.59

1.3

1.2

0.51

9.29

nmol/l

0.51

196

Other misadventures during surgical and medical care

107

2.08

2.59

1.2

1.4

0.57

0.60

nmol/l

0.23

Entropion and trichiasis of eyelid

409

1.52

2.58

1.2

1.3

0.70

5.02

nmol/l

0.49

391

Phlebitis and thrombophlebitis (not including DVT)

192

1523

1.27

2.58

1.3

0.58

3.47

nmol/l

1.20

186

1478

Benign neoplasm: Scapula and long bones of upper limb

2.78

2.57

1.1

1.4

0.59

0.51

nmol/l

0.47

Coxarthrosis, primary

509

3665

1.15

2.56

1.3

2.30

1.94

nmol/l

0.08

488

3531

Retinal vascular occlusion

633

1.41

2.54

1.2

1.3

0.59

0.67

nmol/l

2.38

605

Glaucoma suspect

309

2581

1.20

2.53

1.2

1.3

0.62

2.44

nmol/l

1.29

302

2479

Retinal vascular disorders

642

1.41

2.52

1.2

1.3

0.58

0.67

nmol/l

2.50

614

Tonsillectomy and adenotomy

464

2780

1.16

2.52

1.3

0.58

1.81

nmol/l

0.97

446

2700

Other inflammatory liver diseases

348

1.56

2.51

1.2

1.4

0.64

5.75

nmol/l

0.50

333

Disorder of thyroid, unspecified

2.36

2.50

1.4

1.3

0.41

27.64

nmol/l

0.50

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

357

1.55

2.48

1.4

0.61

5.58

nmol/l

0.50

344

5-aminosalicylic acid

165

1294

1.28

2.45

1.3

0.73

4.07

nmol/l

1.16

156

1256

Macular pucker

131

997

1.32

2.45

1.3

0.66

1.08

nmol/l

0.51

126

959

Female infertility, associated with anovulation

342

1.56

2.45

1.6

1.3

0.43

0.51

nmol/l

1.68

335

Cerebral atherosclerosis

2.58

2.44

1.2

1.4

0.73

37.52

nmol/l

0.49

Viral warts, including avohilmo

179

1421

1.26

2.42

1.2

1.3

0.57

2.62

nmol/l

0.79

173

1376

Medicines for HER+ breast cancer

246

2776

0.82

2.41

1.4

1.3

3.99

1.83

nmol/l

0.28

239

2676

Use of antiglaucoma preparations and miotics

400

1.51

2.41

1.3

0.57

5.17

nmol/l

0.51

379

Paraplegia, diplegia of upper limbs

2.14

2.40

1.3

0.58

0.60

nmol/l

0.05

Endometriosis of intestine

2.37

2.40

1.1

0.49

0.50

nmol/l

0.03

Maltreatment syndromes

235

1.67

2.39

1.2

1.5

0.56

0.54

nmol/l

0.22

226

Sulfasalazine

229

1873

1.23

2.37

1.3

0.66

3.04

nmol/l

1.21

218

1810

Other and unspecified paralytic syndromes

2.29

2.36

1.4

1.3

0.46

26.32

nmol/l

0.50

Laparoscopic left hemicolectomy

2.21

2.33

1.4

0.72

24.21

nmol/l

0.49

Crowding of teeth, including avohilmo

332

1.50

2.32

1.2

1.3

0.49

nmol/l

0.01

321

Specific development disorders of speech and language

243

1.64

2.32

1.2

0.51

7.90

nmol/l

0.50

230

Idiopathic thrombocytopenic purpura

126

1.92

2.32

1.5

1.4

0.57

14.76

nmol/l

0.50

120

Somnolence

2.41

2.31

1.6

1.3

57.71

0.51

nmol/l

0.48

Benign neoplasm of other and unspecified sites

155

1.82

2.31

1.9

1.3

0.52

12.27

nmol/l

0.50

146

Asthma and opportunity respiratory infection

238

1.65

2.30

1.4

1.3

0.53

8.13

nmol/l

0.51

228

Other fall from one level to another

167

1325

1.26

2.28

1.2

1.3

5.48

3.71

nmol/l

0.13

162

1281

Scar conditions and fibrosis of skin

231

1.66

2.27

1.2

1.4

0.60

8.27

nmol/l

0.50

222

Burns and corrosions confined to eye and internal organs

120

1.94

2.26

1.2

1.4

0.57

0.54

nmol/l

0.12

114

Alkalosis

5.79

2.24

1.0

1.2

0.30

0.49

nmol/l

—

L02BG Aromatase inhibitors

200

2420

0.81

2.24

1.3

4.75

2.02

nmol/l

0.29

195

2331

Acute suppurative otitis media

200

1512

1.24

2.23

1.5

1.3

0.52

1.71

nmol/l

0.51

195

1465

Wet age-related macular degeneration

125

924

1.31

2.23

1.2

1.3

0.73

2.61

nmol/l

0.48

116

887

Systemic sclerosis (FG)

128

1.90

2.23

1.3

0.75

0.62

nmol/l

0.75

120

Other specified/unspecified hearing loss

490

1.44

2.22

1.2

1.3

0.55

4.29

nmol/l

0.52

470

Benign neoplasm: Other parts of oropharynx

2.74

2.22

1.8

1.4

100.57

0.52

nmol/l

0.47

Loose body in joint

100

2.02

2.22

1.1

1.6

0.53

0.60

nmol/l

0.42

Seropositive rheumatoid arthritis

198

1602

1.23

2.18

1.3

0.64

2.00

nmol/l

0.80

188

1539

Benign neoplasm of thyroid gland

188

1.72

2.18

1.5

1.3

0.65

10.13

nmol/l

0.50

179

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

111

842

1.32

2.17

1.4

1.3

0.64

4.05

nmol/l

0.77

111

812

Malignant neoplasm of colon

111

842

1.32

2.16

1.4

1.3

0.61

4.61

nmol/l

0.93

105

810

Malignant neoplasm of tonsil

2.33

2.16

2.1

1.3

0.55

31.04

nmol/l

0.50

malignant neoplasm of male genital organs

168

803

1.26

2.15

1.5

1.3

0.62

0.61

nmol/l

0.19

161

777

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

840

4798

1.11

2.14

1.3

0.63

1.77

nmol/l

1.50

806

4643

Sequelae of injuries of upper limb

587

1.39

2.13

1.6

1.3

0.91

3.62

nmol/l

0.43

568

Malignant neoplasm of prostate

161

753

1.27

2.13

1.5

1.3

0.63

0.61

nmol/l

0.37

154

729

Crohn disease (strict definition, all UC cases excluded)

259

1.59

2.12

1.5

0.63

7.44

nmol/l

0.49

248

Lung cancer and mesothelioma

137

907

1.28

2.12

1.2

1.3

8.41

3.07

nmol/l

0.30

129

868

Benign neoplasm of other and unspecified intrathoracic organs

2.49

2.12

2.0

1.4

0.60

0.55

nmol/l

0.23

Maternal care for other conditions predominantly related to pregnancy

157

1218

1.26

2.11

1.3

0.49

1.47

nmol/l

0.54

151

1186

Ulcerative ileocolitis

198

1.68

2.09

1.2

1.5

0.53

0.60

nmol/l

0.67

191

Endometriosis in cutaneous scar

5.14

2.09

2.0

1.1

0.40

0.54

nmol/l

—

Nonsuppurative otitis media

171

1193

1.25

2.07

1.4

1.3

0.56

2.02

nmol/l

0.49

163

1148

Benign neoplasm: Liver/bile ducts

132

1.84

2.05

1.2

1.3

0.50

0.59

nmol/l

1.32

125

6-mercaptopurine

154

1.77

2.04

1.4

0.55

0.56

nmol/l

0.11

149

Benign neoplasm: Vulva

118

1.89

2.03

1.4

1.3

0.61

15.82

nmol/l

0.50

112

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

367

1.48

2.03

1.4

0.63

5.36

nmol/l

0.49

356

Right bundle-branch block

162

1.74

2.02

1.3

0.63

11.59

nmol/l

0.50

155

Female infertility, cervical, vaginal, other or unspecified origin

205

1074

1.22

2.02

1.2

1.3

0.53

2.61

nmol/l

0.66

200

1040

Burn and corrosion confined to eye and adnexa

111

1.91

2.02

1.2

1.4

0.58

0.54

nmol/l

0.25

106

Other disorders of veins

359

3055

1.16

2.02

1.4

1.3

0.63

2.32

nmol/l

1.40

347

2956

Malignant neoplasm of tonsil and base of tongue

2.02

2.01

1.9

1.4

0.56

20.70

nmol/l

0.50

Lichen planus, including avohilmo

166

1341

1.24

2.00

1.3

0.66

3.10

nmol/l

0.90

159

1297

Colorectal cancer

174

1357

1.23

1.96

1.3

0.61

3.10

nmol/l

0.94

166

1301

Hypertrophy of breast in women and men

166

1345

1.24

1.95

1.2

1.3

0.60

3.04

nmol/l

0.91

159

1303

Systemic sclerosis

135

1.80

1.92

1.3

1.2

0.75

13.70

nmol/l

0.49

130

Congenital malformations of the nervous system

1.94

1.91

1.5

1.3

0.49

0.52

nmol/l

0.18

Malignant neoplasm of oropharynx, including Hilmo

1.98

1.91

1.8

1.3

0.57

20.20

nmol/l

0.50

Malignant neoplasm of prostate, including Hilmo

163

773

1.25

1.91

1.5

1.3

0.63

0.62

nmol/l

0.15

157

748

Symptoms and signs involving emotional state

128

1.81

1.90

1.2

1.5

0.55

0.60

nmol/l

0.22

122

Vascular syndromes of brain in cerebrovascular disorders

204

1.63

1.89

1.4

1.3

0.66

0.68

nmol/l

0.15

192

malignant neoplasm of male genital organs, including Hilmo

170

827

1.24

1.87

1.5

1.3

0.61

nmol/l

0.03

164

800

Inguinal hernia

444

2598

1.14

1.85

1.4

1.3

0.59

2.43

nmol/l

1.35

427

2517

Purpura and other haemorrhagic conditions

100

767

1.31

1.85

1.4

1.3

0.62

2.93

nmol/l

0.50

100

737

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

350

1.46

1.85

1.1

1.4

0.63

0.53

nmol/l

1.02

337

Tracheo-bronchomalasia

3.61

1.85

1.5

1.3

0.40

0.49

nmol/l

—

Vasculitis limited to skin, not elsewhere classified

122

1.82

1.85

1.4

1.3

0.55

15.15

nmol/l

0.50

117

Alcohol dependence

191

1580

1.21

1.85

1.2

1.3

0.63

3.23

nmol/l

1.10

181

1523

Other respiratory diseases principally affecting the interstitium

126

997

1.27

1.84

1.4

1.3

7.51

3.89

nmol/l

0.21

117

959

Benign neoplasm: Skin of scalp and neck

115

1.84

1.83

1.2

1.3

0.55

16.16

nmol/l

0.50

109

Family history of other conditions

2.15

1.83

2.6

1.2

0.43

0.51

nmol/l

0.66

Superficial injury of thorax

115

901

1.28

1.82

1.3

0.60

2.57

nmol/l

0.50

109

872

Other arterial embolism and thrombosis

101

1.90

1.81

1.2

1.3

0.64

18.32

nmol/l

0.49

Malnutrition

1.97

1.80

2.8

1.4

0.66

21.58

nmol/l

0.49

Other diseases of biliary tract

486

1.39

1.80

1.3

0.70

4.30

nmol/l

0.49

465

Schizophrenia or delusion, excluding more controls

212

1754

1.20

1.79

1.3

0.66

2.94

nmol/l

1.06

199

1702

Allergic contact dermatitis due to drugs in contact with skin

109

1.85

1.78

1.2

1.3

0.51

17.27

nmol/l

0.50

102

Endometriosis of rectovaginal septum and vagina

445

1.40

1.78

1.1

1.2

0.57

5.49

nmol/l

0.65

431

Dislocation, sprain and strain of joints and ligaments of thorax

169

1.67

1.78

1.3

1.4

0.64

11.10

nmol/l

0.49

162

Psoriasis vulgaris

144

1163

1.24

1.77

1.3

6.41

4.15

nmol/l

0.15

138

1130

Other facial nerve disorders

139

1.74

1.76

1.2

1.4

0.48

13.52

nmol/l

0.50

132

Other specified disorders of external ear

162

1.68

1.75

1.4

0.61

11.68

nmol/l

0.50

154

Benign neoplasm: Liver

117

1.81

1.75

1.2

1.3

0.50

0.58

nmol/l

0.86

110

Premenstrual syndrome

2.25

1.74

1.3

1.2

0.46

0.51

nmol/l

0.38

Lichen planus

109

855

1.28

1.73

1.3

1.4

0.66

4.50

nmol/l

0.91

103

828

Ectopic pregnancy

144

1167

1.24

1.73

1.3

0.57

3.43

nmol/l

0.93

137

1128

Other protozoal intestinal diseases, including avohilmo

103

1.86

1.72

1.3

0.79

0.54

nmol/l

0.51

Malignant neoplasm of brain, including Hilmo

250

1.53

1.71

1.4

1.3

0.62

7.74

nmol/l

0.50

240

Other and unspecified vasculitis limited to skin

111

1.82

1.69

1.5

1.3

0.52

16.66

nmol/l

0.50

106

Systemic sclerosis, icd10

141

1.72

1.69

1.3

0.75

13.22

nmol/l

0.49

135

Golimumab

195

1.60

1.69

1.5

1.4

0.63

0.57

nmol/l

0.44

186

Benign neoplasm: Choroid

383

1.42

1.68

1.3

0.61

5.28

nmol/l

0.50

367

Retinal detachments and breaks

276

2384

1.16

1.65

1.3

4.74

0.99

nmol/l

0.43

263

2293

Malignant neoplasm of tonsil, including Hilmo

2.05

1.65

2.1

1.3

0.55

27.26

nmol/l

0.50

Unspecified abortion

291

0.55

1.65

1.1

1.4

0.58

4.43

nmol/l

0.50

285

Otitis media, unspecified

542

1.33

1.64

1.3

11.44

3.79

nmol/l

0.30

524

Disorders of speech understanding and production

178

1.61

1.2

1.3

0.53

10.64

nmol/l

0.50

168

Pedal cyclist injured in transport accident

173

1441

1.20

1.61

1.3

5.42

3.03

nmol/l

0.20

166

1392

Osteonecrosis due to drugs

2.03

1.60

1.3

1.4

0.57

27.18

nmol/l

0.49

Dermatophytosis, including avohilmo

555

4917

1.11

1.59

1.4

1.3

0.60

1.57

nmol/l

1.35

531

4752

Burn and corrosion of trunk

129

1.72

1.57

1.1

1.3

0.58

0.59

nmol/l

0.06

122

ILD, hospital admission 2, with pulmonary infections

499

1.35

1.57

1.4

1.3

14.04

4.19

nmol/l

0.32

482

Tuberculosis of other organs, strict

1.86

1.56

2.3

1.2

0.67

20.40

nmol/l

0.49

Morphin

1.86

1.56

1.6

1.4

0.80

20.21

nmol/l

0.49

Lifestyle-related condition

2.14

1.56

2.0

1.2

0.48

0.54

nmol/l

0.18

Other protozoal intestinal diseases

1.91

1.56

1.3

1.4

0.83

0.56

nmol/l

0.46

Bicuspidal aortic valve syndrome

176

1.60

1.55

1.1

1.5

0.55

0.60

nmol/l

0.30

169

Non-small cell lung cancer, including Hilmo

103

765

1.27

1.54

1.2

1.3

0.63

5.00

nmol/l

0.92

735

Anogenital herpesviral [herpes simplex] infection

323

1.43

1.53

1.3

0.51

5.97

nmol/l

0.50

313

Other secondary coxarthrosis

177

1.59

1.52

1.5

1.4

0.76

10.70

nmol/l

0.49

169

Tuberculosis of other organs, strict, including avohilmo

1.84

1.52

2.3

1.2

0.67

20.17

nmol/l

0.49

Diabetic retinopathy, excluding more controls

247

1186

1.17

1.52

1.3

1.4

4.75

2.80

nmol/l

0.18

240

1148

Other congenital malformations of intestine, including avohilmo

2.19

1.52

2.7

1.3

0.55

37.46

nmol/l

0.49

Bacterial, viral and other infectious agents

451

1.36

1.51

1.8

1.4

0.52

4.50

nmol/l

0.51

438

Contraceptive management

265

2133

0.87

1.51

1.3

0.54

1.43

nmol/l

0.91

257

2071

Other appendicitis

460

1.35

1.50

1.2

1.4

0.61

4.46

nmol/l

0.50

443

Convalescence

308

1.44

1.50

1.2

1.3

0.54

6.34

nmol/l

0.51

299

Hypertrophy of breast

147

1216

1.21

1.50

1.2

1.3

0.59

3.30

nmol/l

0.91

141

1178

Herpesviral keratitis and keratoconjunctivitis

210

1.53

1.49

1.4

0.66

9.02

nmol/l

0.50

203

Cervical polyps

609

1.30

1.48

1.1

1.3

0.57

4.19

nmol/l

0.66

591

Fitting and adjustment of other devices

275

2111

1.15

1.46

1.2

1.3

0.65

2.73

nmol/l

1.18

270

2026

Ulcerative enterocolitis

132

1.68

1.46

1.6

1.3

0.64

0.56

nmol/l

0.43

126

Seborrhoeic keratosis

205

1752

1.17

1.45

1.3

4.82

3.13

nmol/l

0.16

193

1691

Other congenital malformations of skin, including avohilmo

455

1.35

1.44

1.3

0.52

4.47

nmol/l

0.51

440

Exposure to other and unspecified animate mechanical forces

164

1.60

1.44

1.1

1.4

0.43

0.57

nmol/l

2.02

156

Strabismus

199

1695

1.17

1.42

1.4

1.3

4.74

2.54

nmol/l

0.21

193

1640

Superficial injury of neck

1.83

1.42

1.1

1.4

0.66

0.54

nmol/l

0.72

Primary open-angle glaucoma, strict

198

1687

1.17

1.42

1.3

0.63

3.29

nmol/l

1.21

188

1612

Multiple delivery

542

0.70

1.42

1.3

0.65

1.37

nmol/l

0.46

522

Fracture at wrist and hand level

274

2391

1.14

1.41

1.3

4.36

2.06

nmol/l

0.26

266

2311

Other injuries of spine and trunk, level unspecified

2.21

1.41

1.3

1.4

0.76

0.55

nmol/l

—

Benign neoplasm: Short bones of lower limb

2.21

1.41

1.1

1.4

0.66

0.52

nmol/l

—

Acute appendicitis, with complications

141

1170

1.21

1.41

1.1

1.3

0.61

3.26

nmol/l

0.85

130

1134

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

493

3465

1.11

1.40

1.3

0.61

1.85

nmol/l

1.14

477

3349

Lymphoid leukaemia

255

1.46

1.38

1.5

1.3

0.63

7.66

nmol/l

0.50

243

Malignant neoplasm of floor of mouth, including Hilmo

2.23

1.38

1.1

1.4

0.60

0.61

nmol/l

—

Kela-code for severe mental illness

280

2461

1.14

1.37

1.3

0.69

2.44

nmol/l

1.16

265

2385

Separation of retinal layers (serosa)

215

1.50

1.36

1.3

1.5

0.61

0.64

nmol/l

0.23

208

Fall on and from stairs and steps

208

1792

1.16

1.35

1.4

1.3

4.67

3.04

nmol/l

0.15

197

1734

Microscopic polyangiitis

0.00

1.35

0.0

1.2

—

0.54

—

Contact with lifting and transmission devices, not elsewhere classified

1.88

1.35

1.2

1.4

0.71

0.58

nmol/l

0.49

Failed attempted abortion

2.15

1.34

1.0

1.2

0.64

0.44

nmol/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

105

1.73

1.34

1.9

1.4

0.56

17.87

nmol/l

0.50

Use of cabergoline

1.99

1.33

1.3

0.57

0.53

nmol/l

0.27

Benign neoplasm of ovary

149

1251

1.19

1.33

1.4

1.3

0.65

3.29

nmol/l

0.91

141

1211

Lichen ruber planus, wide definition including periferal and oral lichen planus

189

1619

1.17

1.33

1.4

1.3

0.65

2.68

nmol/l

0.91

182

1567

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

136

1.63

1.33

1.5

1.3

0.68

13.86

nmol/l

0.50

129

Chronic lymphocytic leukaemia, helper endpoint

136

1.63

1.33

1.5

1.3

0.68

13.86

nmol/l

0.50

129

Chronic lymphocytic leukaemia

136

1.63

1.33

1.5

1.3

0.68

13.86

nmol/l

0.50

129

Enteropathic arthropathies

113

1.70

1.32

1.4

0.53

0.59

nmol/l

0.37

106

Benign neoplasm: other/unspecified salivary gland

121

1.67

1.31

1.4

1.2

0.71

15.68

nmol/l

0.49

113

Other superficial mycoses

106

1.71

1.30

1.8

1.4

0.52

0.61

nmol/l

0.66

101

Disorders of eyelid in diseases classified elsewhere

153

1.58

1.29

1.8

1.3

33.90

12.09

nmol/l

0.27

148

Osteitis due to dental implant

2.12

1.29

1.0

1.4

0.53

nmol/l

—

Use of galantamine

354

0.65

1.28

1.7

1.3

0.53

5.88

nmol/l

0.52

329

Tubulo-interstitial nephritis, not specified as acute or chronic

327

1.38

1.28

1.1

1.3

0.62

6.03

nmol/l

0.50

314

ILD, hospital admissions

102

829

1.23

1.28

1.4

1.3

9.10

2.79

nmol/l

0.33

796

Other interstitial pulmonary diseases

103

838

1.23

1.28

1.4

1.3

9.01

2.77

nmol/l

0.33

805

Hepatocellular carcinoma, including Hilmo

122

1.65

1.28

1.2

1.4

1.55

15.31

nmol/l

0.46

116

Interstitial lung disease

103

839

1.23

1.26

1.4

1.3

9.01

2.77

nmol/l

0.33

805

Interstitial lung disease endpoints

103

839

1.23

1.26

1.4

1.3

9.01

2.77

nmol/l

0.33

805

Labour and delivery complicated by umbilical cord complications

252

1.44

1.26

1.1

1.3

0.59

0.57

nmol/l

0.19

243

Maternal care for cervical incompetence

236

1.45

1.25

1.2

1.3

0.57

0.66

nmol/l

0.99

227

Lower leg

2.26

1.25

1.0

1.5

0.58

0.49

nmol/l

—

Neuroendocrine tumor and carcinoma of lung

2.03

1.24

1.6

1.3

0.68

0.66

nmol/l

—

malignant neoplasm of female genital organs, including Hilmo

147

1183

1.19

1.24

1.4

1.2

0.66

3.47

nmol/l

0.91

140

1135

Blepharospasm

2.03

1.24

1.0

1.3

0.49

44.20

nmol/l

—

Congenital malformations of aortic and mitral valves

196

1.49

1.22

1.2

1.4

0.56

0.59

nmol/l

0.20

189

Spontaneous abortion

384

2316

1.11

1.22

1.3

2.73

2.03

nmol/l

0.12

375

2225

Lung diseases due to external agents

699

1.25

1.22

1.5

1.3

0.65

3.18

nmol/l

0.50

672

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.81

1.22

1.2

1.3

0.55

24.17

nmol/l

0.49

MS-disease / Multiple Sclerosis

391

1.34

1.21

1.4

1.3

0.67

5.06

nmol/l

0.48

379

Primary open-angle glaucoma

237

2002

1.14

1.21

1.3

0.64

2.97

nmol/l

1.27

225

1905

False labour

220

1188

1.15

1.20

1.2

1.3

0.49

1.52

nmol/l

0.54

215

1146

Noise effects on inner ear

164

1.53

1.20

1.2

1.5

0.54

0.60

nmol/l

0.35

158

Bacterial, viral and other infectious agents, including avohilmo

488

1.30

1.19

1.7

1.4

0.52

4.19

nmol/l

0.52

475

Traumatic ischaemia of muscle

1.90

1.19

2.2

1.3

0.68

0.52

nmol/l

0.61

Other and unspecified haemorrhagic conditions

1.89

1.18

1.2

1.3

0.83

29.85

nmol/l

0.49

Rheumatoid arthritis, including avohilmo

309

2764

1.12

1.18

1.3

0.63

2.21

nmol/l

1.18

294

2663

Complications associated with artificial fertilization

1.89

1.18

2.6

1.1

0.48

0.50

nmol/l

0.13

Foreign body in alimentary tract

256

1.41

1.18

1.4

1.3

0.57

7.54

nmol/l

0.50

246

Other and unspecified aplastic anaemias

2.02

1.17

1.0

1.3

0.57

0.53

nmol/l

—

Fracture of forearm

477

3918

1.09

1.16

1.3

0.61

1.98

nmol/l

1.47

449

3796

Injuries involving multiple body regions

190

1.48

1.16

1.0

1.3

0.59

9.89

nmol/l

0.50

183

Organic, including symptomatic, mental disorders

343

2677

0.90

1.15

1.3

5.90

2.02

nmol/l

0.33

324

2565

Other maternal disorders predominantly related to pregnancy

480

2744

1.10

1.15

1.2

1.3

0.54

1.80

nmol/l

0.98

464

2656

Palmar fascial fibromatosis [Dupuytren]

750

1.23

1.15

1.2

1.4

12.11

4.56

nmol/l

0.28

722

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.70

1.14

2.1

1.2

0.94

20.03

nmol/l

0.49

Other degenerative diseases of the nervous system

183

1153

1.16

1.14

1.4

1.3

0.68

2.20

nmol/l

0.49

176

1106

Hereditary retinal dystrophy

1.86

1.14

1.0

1.4

0.53

0.61

nmol/l

0.54

Embedded teeth, including avohilmo

439

1.30

1.13

1.3

0.48

0.52

nmol/l

0.37

423

Other secondary gonarthrosis

301

1.37

1.13

1.2

1.4

0.58

0.67

nmol/l

1.32

288

Disorders of brain, other and unspecified

2.02

1.12

1.1

1.3

0.79

0.53

nmol/l

—

Injury of muscle and tendon at lower leg level

106

879

1.21

1.12

1.2

1.3

16.62

2.03

nmol/l

0.44

106

848

Alopecia areata

143

1.55

1.12

1.3

0.59

nmol/l

0.01

135

Infections specific to the perinatal period

2.28

1.10

1.1

1.3

0.39

0.40

nmol/l

—

LSIL lesion of the vulva

168

1.50

1.10

1.1

1.3

0.51

11.12

nmol/l

0.50

162

Benign neoplasm: Connective and other soft tissue, unspecified

1.84

1.10

1.3

0.58

0.57

nmol/l

0.06

Asymmetry of jaw

1.84

1.09

1.7

1.3

0.51

0.50

nmol/l

0.05

Perichondritis of external ear

1.74

1.09

1.2

1.3

0.53

22.97

nmol/l

0.50

Other renal tubulo-interstitial diseases

112

1.62

1.09

1.1

1.3

0.61

16.48

nmol/l

0.49

107

Endometriosis of fallopian tube

2.22

1.09

1.4

1.2

0.56

53.73

nmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

210

1.43

1.08

1.2

1.4

1.23

9.09

nmol/l

0.45

202

Other disorders of binocular vision

1.88

1.08

1.5

1.3

0.43

0.47

nmol/l

0.32

Obstructed labour due to maternal pelvic abnormality

1080

0.82

1.07

1.3

0.64

3.67

nmol/l

0.91

1049

Nasal polyp

132

1123

1.18

1.07

1.3

1.4

0.62

4.69

nmol/l

1.26

125

1084

Abrasion of teeth

300

2699

1.11

1.07

1.3

0.59

2.30

nmol/l

1.28

287

2612

Contact with venomous snakes and lizards

1.95

1.07

1.1

1.5

0.40

0.53

nmol/l

—

Deep endometriosis

604

1.25

1.07

1.1

1.2

0.55

3.50

nmol/l

0.51

585

therapeutic use

153

1.51

1.06

1.0

1.3

0.63

12.56

nmol/l

0.50

143

Lesion of sciatic nerve

178

1.47

1.05

1.2

1.3

0.62

10.78

nmol/l

0.50

168

Sixth [abducent] nerve palsy

154

1.50

1.04

1.1

1.3

0.67

12.29

nmol/l

0.50

146

Exposure to other and unspecified forces of nature

2.09

1.03

1.1

1.4

0.50

59.12

nmol/l

—

Other prurigo

1.85

1.03

1.0

1.4

0.45

0.61

nmol/l

1.81

Otorrhagia

2.09

1.03

1.0

1.4

0.69

50.59

nmol/l

—

Other specified/unspecified necrotizing vasculopathies

1.85

1.03

1.3

0.84

0.60

nmol/l

0.71

Certolizumab pegol

1.70

1.02

1.1

1.3

0.51

nmol/l

0.04

Benign neoplasm: Skin of lower limb, including hip

147

1.51

1.01

1.3

1.4

0.64

12.78

nmol/l

0.50

140

Injury of urinary and pelvic organs

1.66

1.01

1.7

1.4

0.56

0.60

nmol/l

0.31

Increased muscle tone

2.03

1.00

1.0

1.5

0.37

0.49

nmol/l

—

Unspecified event, undetermined intent

115

1.58

1.00

1.4

0.48

16.16

nmol/l

0.50

109

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.72

0.99

1.2

1.3

0.68

24.55

nmol/l

0.49

Benign neoplasm: Orbit, unspecified

0.00

0.98

0.0

1.5

—

0.48

—

Non-Hodgkin lymphoma, all

190

1.43

0.97

1.1

1.3

0.72

10.09

nmol/l

0.49

180

Dependence on enabling machines and devices, not elsewhere classified

1.81

0.96

1.1

1.3

0.52

0.55

nmol/l

—

Left ventricular outflow tract obstruction, narrow definition

224

1.39

0.96

1.2

1.4

0.54

0.59

nmol/l

0.34

215

Lesion of lateral popliteal nerve

233

1.38

0.95

1.5

0.56

8.26

nmol/l

0.50

223

malignant neoplasm of female genital organs

127

1066

1.17

0.95

1.3

1.2

0.64

3.79

nmol/l

0.92

121

1020

Maternal care for known or suspected fetal abnormality and damage

773

0.82

0.94

1.7

1.3

0.46

0.52

nmol/l

1.69

749

Injury of nerves and spinal cord at neck level

1.62

0.94

1.3

1.4

0.59

0.62

nmol/l

0.18

Benign neoplasm of other and unspecified female genital organs

277

1.34

0.94

1.5

1.3

0.62

7.07

nmol/l

0.50

265

Other noninflammatory disorders of cervix uteri

303

1.33

0.94

1.2

1.3

0.60

7.77

nmol/l

0.65

295

Gestational diabetes (for exclusion)

261

1613

1.11

0.94

1.3

0.46

1.25

nmol/l

0.58

254

1567

Right side

2.18

0.92

1.2

1.5

0.72

74.46

nmol/l

—

Chondromalacia

134

1.50

0.92

1.2

1.4

0.77

0.60

nmol/l

0.31

126

Other osteochondropathies

348

1.30

0.92

1.1

1.4

0.61

0.60

nmol/l

0.06

336

Early complications of trauma

218

1.38

0.91

1.6

1.4

0.61

8.79

nmol/l

0.50

208

!Aliquae complicationes praecoces traumatis

218

1.38

0.91

1.6

1.4

0.61

8.79

nmol/l

0.50

208

Benign neoplasm: Skin of upper limb, including shoulder

102

1.58

0.91

1.6

1.3

0.66

18.31

nmol/l

0.49

Other mental disorders due to brain damage and dysfunction and to physical disease

682

1.21

0.90

1.5

1.3

0.67

0.68

nmol/l

0.08

649

Acute myeloid leukaemia and myelodysplastic syndromes

104

0.48

0.89

1.6

1.3

0.48

18.39

nmol/l

—

Superficial injuries involving multiple body regions

127

1.50

0.89

1.1

1.4

0.58

14.73

nmol/l

0.50

120

Primary coxarthrosis, bilateral

219

1963

1.12

0.88

1.3

0.66

2.98

nmol/l

1.25

211

1883

Anomalies of dental arch relationship, including avohilmo

143

1127

1.15

0.88

1.4

1.3

0.54

3.13

nmol/l

0.79

138

1091

Presence of other devices

163

1412

1.14

0.88

1.2

1.3

0.66

3.16

nmol/l

0.98

158

1346

Carcinoma in situ of skin of scalp and neck

111

1.54

0.88

1.5

1.2

0.68

16.84

nmol/l

0.49

105

Lichen sclerosus et atrophicus

831

1.18

0.88

1.2

1.3

0.57

4.61

nmol/l

0.94

804

Type 1 diabetes, definitions combined

465

1.25

0.87

1.7

1.3

0.49

0.51

nmol/l

0.20

453

Erythema nodosum

161

1.44

0.87

1.7

1.4

0.54

11.66

nmol/l

0.50

154

Reactive arthropathies, FINNGEN

369

1.28

0.87

1.2

1.4

0.62

0.59

nmol/l

0.32

355

Fracture of shoulder and upper arm

280

2542

1.10

0.86

1.4

1.3

2.13

2.27

nmol/l

0.03

267

2442

Postzoster neuralgia

1.73

0.86

1.2

1.3

0.58

29.44

nmol/l

0.49

Nystagmus and other irregular eye movements

1.73

0.86

1.2

1.4

0.60

0.52

nmol/l

0.48

Lesion of radial nerve

170

1.42

0.85

1.3

1.5

0.65

11.19

nmol/l

0.50

161

Other degenerative diseases of the basal ganglia

1.64

0.85

1.2

1.3

0.65

0.61

nmol/l

0.17

Personal history of medical treatment

1.79

0.84

1.3

1.2

0.60

0.55

nmol/l

—

Generalized epilepsy

188

1.39

0.83

1.2

1.3

0.57

9.96

nmol/l

0.50

181

Benign neoplasm: Tonsil

1.71

0.83

1.5

1.3

0.60

29.37

nmol/l

0.49

Complications following abortion and ectopic and molar pregnancy

214

1.36

0.83

1.1

1.4

0.65

8.97

nmol/l

0.50

204

Type 1 diabetes, strict (exclude DM2)

460

1.24

0.82

1.6

1.3

0.50

0.51

nmol/l

0.12

448

Open wound of wrist and hand

340

3021

1.09

0.82

1.3

0.61

1.81

nmol/l

1.02

332

2921

Optic atrophy

1.66

0.82

1.7

1.4

0.54

0.60

nmol/l

0.21

Other strabismus

156

1374

1.13

0.81

1.3

5.88

2.98

nmol/l

0.22

151

1330

Malignant neoplasm of respiratory system and intrathoracic organs

136

988

1.14

0.80

1.3

0.66

4.02

nmol/l

0.91

130

948

ILD, hospital admissions 3, with pneumonia sepsis

437

1.24

0.79

1.5

1.4

17.37

4.72

nmol/l

0.33

420

Chronic myeloproliferative disease

1.68

0.79

1.2

1.3

0.95

29.39

nmol/l

0.48

Blindness, monocular

1.68

0.79

1.3

1.4

0.56

42.01

nmol/l

—

Psoriasis (vulgaris), strict definition

173

1.39

0.79

1.1

1.4

0.61

nmol/l

0.06

167

Other specific arthropathies, wide

1.54

0.78

1.2

1.4

0.46

0.59

nmol/l

1.07

Colon adenocarcinoma

666

1.19

0.78

1.4

1.3

0.64

5.02

nmol/l

0.79

644

Manic episode

140

1.44

0.77

1.3

1.4

0.63

0.59

nmol/l

0.14

134

Sequelae of poliomyelitis

1.78

0.76

1.0

1.4

1.08

0.61

nmol/l

—

Corneal scars and opacities

132

1.45

0.76

1.3

0.63

14.14

nmol/l

0.50

126

Horner syndrome

1.71

0.76

1.9

1.4

0.61

0.54

nmol/l

—

Iridocyclitis in diseases classified elsewhere

1.58

0.75

1.5

1.3

0.53

0.62

nmol/l

0.63

Impetigo

218

1.33

0.75

1.3

1.4

0.58

0.59

nmol/l

0.14

210

L01XE Protein kinase inhibitors

277

0.72

0.73

1.3

0.66

7.16

nmol/l

0.50

262

Benign neoplasm: Lip

100

1.51

0.73

1.1

1.3

0.68

0.62

nmol/l

0.27

Malignant immunoproliferative diseases

1.81

0.73

1.1

1.4

0.56

0.53

nmol/l

—

Personal history of allergy to drugs, medicaments and biological substances

1.68

0.72

1.1

1.2

0.45

0.55

nmol/l

—

Optic atrophy, wide definition

1.59

0.72

1.7

1.3

0.54

24.52

nmol/l

0.50

Other congenital malformations of intestine

1.77

0.71

2.4

1.3

0.50

0.48

nmol/l

—

Other and unspecified mononeuropathies of upper limb

151

1.40

0.71

1.4

0.58

0.66

nmol/l

0.50

142

Benign neoplasm: Lower jaw bone

1.95

0.71

1.0

1.6

0.68

0.52

nmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

157

0.63

0.69

1.1

1.3

0.57

11.99

nmol/l

—

150

Injuries to the hip and thigh

368

3075

1.07

0.67

1.3

2.91

2.18

nmol/l

0.12

352

2954

Abnormal findings on diagnostic imaging of breast

1.50

0.67

1.3

0.66

19.94

nmol/l

0.49

severe traumatic brain injury, does not include concussion

143

1278

1.12

0.66

1.2

1.3

0.62

2.85

nmol/l

0.78

137

1230

Coxarthrosis, primary, with hip surgery

357

3087

1.07

0.66

1.3

3.00

2.20

nmol/l

0.13

342

2965

Non-small cell lung cancer

498

1.19

0.65

1.1

1.3

0.63

4.20

nmol/l

0.50

480

Other melanin hyperpigmentation

120

1.42

0.65

1.5

1.3

0.67

15.44

nmol/l

0.50

115

Open wound of shoulder and upper arm

1.48

0.64

2.4

1.4

0.59

19.67

nmol/l

0.49

Varicose veins

488

3473

1.06

0.64

1.2

1.3

0.68

2.23

nmol/l

1.47

462

3353

Amputation of thigh

1.48

0.64

1.1

1.2

0.71

19.52

nmol/l

0.49

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

153

1131

1.11

0.64

1.2

1.3

7.55

3.60

nmol/l

0.24

145

1082

Colorectal adenocarcinoma

130

1145

1.12

0.63

1.3

0.62

3.56

nmol/l

0.93

122

1099

Status post-ami

145

986

1.12

0.63

1.3

8.33

2.65

nmol/l

0.33

133

942

Respiratory and cardiovascular disorders specific to the perinatal period

1.57

0.63

1.1

1.2

0.47

0.42

nmol/l

0.29

Other intracranial haemorrhages

121

1.41

0.62

1.6

1.3

0.74

15.43

nmol/l

0.49

115

Prolapse and hernia of ovary and fallopian tube

186

0.69

0.62

1.3

1.2

0.74

10.60

nmol/l

0.50

172

Habitual aborter

1.56

0.62

1.3

1.1

0.66

0.48

nmol/l

0.92

Persons encountering health services in circumstances related to reproduction

469

2962

1.06

0.62

1.6

1.3

0.53

2.14

nmol/l

1.34

458

2870

Whooping cough

1.68

0.61

1.0

1.3

0.50

0.46

nmol/l

—

Use of levodopa decarboxylase inhibitor

758

1.15

0.61

1.4

1.3

0.64

3.01

nmol/l

0.51

725

Sequelae of infectious and parasitic diseases

379

1.22

0.61

1.1

1.4

0.65

5.25

nmol/l

0.49

366

Type 1 diabetes, strict definition, subgroup 1

333

1.23

0.61

1.1

1.3

0.46

0.48

nmol/l

0.24

327

Benign neoplasm of major salivary glands

554

1.18

0.61

1.2

1.3

0.68

3.84

nmol/l

0.49

531

Traumatic amputation of wrist and hand

191

1.31

0.61

1.5

0.50

0.63

nmol/l

2.25

183

Other cestode infections, including avohilmo

0.00

0.61

0.0

1.6

—

0.53

—

Congenital malformations of gallbladder, bile ducts and liver

1.58

0.61

1.6

1.4

0.41

0.57

nmol/l

—

Septal defects

301

1.24

0.60

2.2

1.3

0.61

6.45

nmol/l

0.49

290

Erythema intertrigo

131

1.38

0.59

1.2

1.4

0.63

14.35

nmol/l

0.50

124

Left hemicolectomy

1.45

0.59

1.7

1.3

0.57

19.53

nmol/l

0.50

Malignant neoplasm of bronchus and lung, including Hilmo

134

1003

1.12

0.59

1.2

1.3

8.59

3.97

nmol/l

0.24

126

965

Polyarteritis nodosa and related conditions

1.57

0.59

1.7

1.3

0.50

0.56

nmol/l

—

Caries of enamel

835

5232

1.04

0.59

1.3

0.56

1.67

nmol/l

1.67

808

5056

Crystalline deposits in vitreous body

1.73

0.58

1.0

1.4

0.52

0.57

nmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.49

0.57

2.0

1.3

0.69

35.33

nmol/l

—

Open wound of lower leg

105

933

1.13

0.57

1.4

1.3

11.59

0.63

nmol/l

0.49

100

897

Leukaemia of unspecified cell type

1.68

0.57

1.0

1.4

0.45

0.52

nmol/l

—

Other and unspecified corneal deformities and disorders

167

1.32

0.57

1.1

1.4

0.55

11.21

nmol/l

0.50

161

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

292

1.24

0.56

1.2

1.4

1.11

6.68

nmol/l

0.45

283

Guillain-Barre syndrome

1.52

0.56

1.4

1.5

0.56

25.58

nmol/l

0.49

Mental retardation

157

1.33

0.56

1.2

1.4

0.52

0.57

nmol/l

0.24

151

Other diseases of appendix

1.46

0.56

1.0

1.3

0.51

34.61

nmol/l

—

Fracture of femur

181

1493

1.09

0.56

1.3

5.35

2.91

nmol/l

0.21

174

1427

Retinoschisis and retinal cysts

107

1.41

0.55

1.2

1.3

0.64

0.66

nmol/l

0.05

100

Congenital malformations of spine and bony thorax, including avohilmo

1.59

0.54

1.2

1.5

0.45

0.51

nmol/l

—

Melanoma in situ of upper limb, including shoulder

1.59

0.54

1.2

0.80

0.52

nmol/l

—

Carcinoma in situ of rectum

1.51

0.54

1.4

1.3

0.62

32.05

nmol/l

—

Other deformities of toe(s)

204

1.28

0.54

1.2

1.4

0.65

0.64

nmol/l

0.04

195

Other and unspecified types of non-Hodgkin lymphoma, hilmo

193

0.72

0.53

1.4

1.3

0.54

9.90

nmol/l

0.51

184

Malignant neoplasm of bronchus and lung

117

878

1.12

0.53

1.2

1.3

0.65

4.44

nmol/l

0.91

111

843

Disorders of globe

108

1.39

0.53

1.5

1.4

0.57

17.67

nmol/l

0.50

100

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.55

0.53

1.0

1.3

0.58

0.64

nmol/l

—

Obstructive hydrocephalus

1.46

0.53

1.6

1.3

0.54

31.41

nmol/l

—

Melanocytic naevi of lower limb, including hip

250

1.24

0.52

1.7

1.4

0.61

7.78

nmol/l

0.50

238

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

136

0.66

0.51

1.6

1.2

0.84

13.85

nmol/l

—

129

Multiple myeloma

136

0.66

0.51

1.6

1.2

0.84

13.85

nmol/l

—

129

Seropositive rheumatoid arthritis, wide

198

1830

1.08

0.51

1.3

0.64

2.46

nmol/l

0.91

188

1757

Malignant neoplasm of brain

170

1.30

0.51

1.3

0.66

11.20

nmol/l

0.50

161

Malignant neoplasm of eye and adnexa, including Hilmo

1.48

0.51

1.3

1.5

0.59

25.31

nmol/l

0.50

Malignant neoplasm of eye, brain and central nervous system

224

1.25

0.51

1.3

0.64

8.57

nmol/l

0.50

215

Dyshidrosis [pompholyx]

1.47

0.51

1.3

1.5

0.52

0.55

nmol/l

0.10

Varicella [chickenpox], including avohilmo

242

1.24

0.50

1.4

0.48

0.61

nmol/l

1.47

231

Embolic stroke with flimmer

1.42

0.50

1.3

1.2

0.72

20.63

nmol/l

0.49

Disorder of external ear, unspecified

180

1.28

0.49

1.2

1.3

0.64

10.57

nmol/l

0.50

171

Malignant neoplasm of breast, HER-positive

232

1854

0.93

0.49

1.4

1.2

4.21

2.41

nmol/l

0.20

225

1790

Overjet

106

0.65

0.49

1.1

1.3

0.46

0.45

nmol/l

—

101

Acute nephritic syndrome

1.40

0.48

1.3

1.4

0.63

0.65

nmol/l

0.06

Open bite

253

1.23

0.48

2.0

1.4

0.53

0.52

nmol/l

0.10

245

Femoral hernia

208

1.25

0.48

1.2

1.3

0.57

9.28

nmol/l

0.50

197

Complications of labour and delivery

486

2832

0.95

0.48

1.2

1.3

2.26

1.77

nmol/l

0.10

478

2729

ILD, hospital admissions 1, main diag only

757

1.12

0.47

1.5

1.3

10.70

3.00

nmol/l

0.34

725

Other spirochaetal diseases, including avohilmo

270

2535

1.07

0.47

1.3

0.58

2.42

nmol/l

1.30

256

2447

Other/unspecified reactive arthropathies

346

1.19

0.46

1.2

1.4

0.65

5.73

nmol/l

0.49

332

Pregnancy, childbirth and the puerperium

213

1033

1.08

0.46

1.3

0.63

2.79

nmol/l

0.64

206

975

Embolic stroke

191

1.26

0.46

1.4

1.3

0.67

10.11

nmol/l

0.50

180

Inguinal hernia, unilateral

138

1.31

0.45

1.3

0.61

13.64

nmol/l

0.50

131

Inguinal of femoral hernia, unilateral

138

1.31

0.45

1.3

0.61

13.64

nmol/l

0.50

131

Femoral hernia, unilateral

138

1.31

0.45

1.3

0.61

13.64

nmol/l

0.50

131

1.41

0.45

1.3

1.4

0.46

0.53

nmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

234

1857

0.94

0.44

1.4

1.2

4.18

2.41

nmol/l

0.20

227

1792

Prurigo nodularis

139

1.30

0.44

1.3

0.51

13.64

nmol/l

0.50

131

Open wound of abdomen, lower back and pelvis

139

1.30

0.43

1.2

1.4

0.53

13.54

nmol/l

0.50

131

Malignant neoplasm of larynx, including Hilmo

1.42

0.43

1.2

0.72

0.69

nmol/l

0.10

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

1.42

0.43

1.5

1.3

0.60

23.94

nmol/l

0.50

Congenital malformations of cardiac septa

320

1.18

0.43

2.2

1.3

0.60

6.08

nmol/l

0.49

309

Other/unspecified seropositive rheumatoid arthritis

195

1819

1.07

0.43

1.3

0.64

2.47

nmol/l

0.92

185

1746

Oesophageal varices

196

0.76

0.43

1.2

1.3

0.80

9.59

nmol/l

0.49

190

Mental retardation, wide definition

174

1.26

0.42

1.2

1.4

0.50

0.58

nmol/l

0.42

167

Injury of nerves at ankle and foot level

1.57

0.42

1.8

1.5

0.38

0.51

nmol/l

—

Burn and corrosion of head and neck

0.64

0.42

1.2

1.4

0.50

0.57

nmol/l

—

All dysplastic lesions of the cervix uteri

160

1697

0.93

0.42

1.2

1.3

0.51

2.50

nmol/l

0.94

154

1644

Benign neoplasm: Other and unspecified parts of mouth

167

1.26

0.42

2.1

1.4

0.70

11.46

nmol/l

0.49

157

Parkinson's disease, including avohilmo

879

1.10

0.42

1.4

1.3

0.70

2.68

nmol/l

0.49

843

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.41

0.0

1.3

—

0.57

—

Stenosis and insufficiency of lacrimal passages

548

1.13

0.41

1.3

0.61

3.87

nmol/l

0.51

528

Other injuries of upper limb, level unspecified

1.32

0.39

1.1

1.4

0.71

0.52

nmol/l

—

Toxic liver disease

1.42

0.39

1.3

0.59

0.60

nmol/l

—

Hypersensitivity pneumonitis due to organic dust

1.42

0.39

1.2

1.3

0.61

27.13

nmol/l

—

Type 1 diabetes, strict definition

361

1.16

0.39

1.1

1.3

0.45

0.48

nmol/l

0.41

355

Melanocytic naevi of scalp and neck

115

1.31

0.39

1.1

1.4

0.56

0.57

nmol/l

0.05

108

Other spirochaetal diseases

264

2499

1.06

0.39

1.3

0.58

2.45

nmol/l

1.30

250

2412

Benign neoplasm: Bronchus and lung

1.37

0.38

1.1

1.3

0.54

0.56

nmol/l

—

Benign neoplasm: Skin of lip

1.37

0.38

1.6

1.3

0.53

28.45

nmol/l

—

Acute alcohol intoxication

158

1471

1.07

0.38

1.3

0.61

3.42

nmol/l

1.11

151

1418

Other meningitis

1.38

0.38

1.4

1.3

0.49

0.57

nmol/l

0.43

Placental disorders

1.39

0.38

1.0

1.3

0.50

0.56

nmol/l

—

Parkinson's disease, strict definition

770

1.11

0.38

1.4

1.3

0.67

2.98

nmol/l

0.50

737

Foreign body in respiratory tract

261

1.19

0.38

1.2

1.3

0.65

7.35

nmol/l

0.50

253

Hereditary corneal dystrophies

203

0.79

0.38

1.1

1.2

0.56

9.42

nmol/l

0.50

194

Acute nasopharyngitis (common cold)

679

1.11

0.38

1.3

0.62

3.47

nmol/l

0.57

660

Parkinson's disease

847

1.10

0.38

1.5

1.3

0.69

2.76

nmol/l

0.49

811

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

111

0.72

0.37

1.4

0.55

17.04

nmol/l

—

104

Keratoconus

116

0.69

0.37

1.0

1.5

0.51

0.60

nmol/l

—

111

Benign neoplasm: Skin of trunk

216

1.21

0.37

1.5

1.3

0.65

8.89

nmol/l

0.50

206

Colon adenocarcinoma, helper endpoint

715

1.11

0.36

1.4

1.3

0.64

3.15

nmol/l

0.51

684

Schizophrenia

965

0.91

0.36

1.3

0.78

3.59

nmol/l

0.71

934

Prophylactic surgery

1.47

0.36

1.0

1.4

0.57

0.52

nmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

192

1806

1.06

0.36

1.3

0.64

2.48

nmol/l

0.91

182

1734

Diabetic retinopathy, strict definition

138

1139

1.08

0.35

1.3

1.4

8.14

2.75

nmol/l

0.32

133

1104

Syphilis

122

0.74

0.35

1.2

1.4

0.40

0.61

nmol/l

—

114

Syphilis, including avohilmo

122

0.74

0.35

1.2

1.4

0.40

0.61

nmol/l

—

114

Generalized epilepsy, mode (most common among epilepsy diagnosis)

135

1.26

0.35

1.2

1.3

0.61

0.59

nmol/l

0.09

129

Myelodysplastic syndrome, including Hilmo

126

1.27

0.35

1.3

1.2

0.92

14.96

nmol/l

0.48

119

Post-traumatic wound infection, not elsewhere classified

127

1.26

0.33

1.3

0.52

14.80

nmol/l

0.50

120

Burns and corrosions of multiple and unspecified body regions

0.67

0.33

1.2

1.4

0.50

0.58

nmol/l

—

Melanoma of uvea

1.28

0.32

1.3

1.4

0.78

0.55

nmol/l

—

Superficial injury of shoulder and upper arm

712

1.10

0.32

1.2

1.3

10.77

3.09

nmol/l

0.33

686

Spirochaetal infections, other/unspecified, including avohilmo

262

2498

1.05

0.32

1.3

0.58

2.45

nmol/l

1.30

248

2411

Toxic effect of carbon monoxide

1.33

0.32

1.5

1.3

0.55

0.56

nmol/l

0.02

Bacterial pneumoniae

285

2389

1.05

0.32

1.3

3.59

2.60

nmol/l

0.12

271

2305

Exposure to other specified electric current

101

1.29

0.32

1.2

1.4

0.62

0.55

nmol/l

0.16

Delayed milestone in childhood

1.37

0.31

1.1

1.2

0.66

0.45

nmol/l

—

Bacterial pneumonia (organism specified)

304

2634

1.05

0.31

1.3

3.41

2.43

nmol/l

0.13

289

2537

LSIL lesion of the cervix uteri, vagina or vulva

897

1.08

0.30

1.2

1.3

0.49

3.77

nmol/l

0.80

873

HSIL lesion of the cervix uteri

107

1151

0.93

0.30

1.2

1.3

0.51

3.05

nmol/l

0.79

101

1118

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.34

0.30

1.6

1.2

2.26

25.69

nmol/l

—

Mature T/NK-cell lymphomas, hilmo

1.28

0.30

1.1

1.3

0.66

0.60

nmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

505

1.11

0.30

1.1

1.3

0.68

4.15

nmol/l

0.49

484

Occupational exposure to risk-factors

141

0.78

0.29

2.4

1.4

0.61

0.62

nmol/l

0.03

136

Other autoimmune haemolytic anaemias

1.23

0.29

1.3

1.4

0.51

33.28

nmol/l

—

Chronic suppurative otitis media, including avohilmo

392

1.12

0.29

1.2

1.3

0.58

5.14

nmol/l

0.50

376

Benign neoplasm: Skin of ear and external auricular canal

176

1.20

0.29

1.2

0.82

10.75

nmol/l

0.48

168

Other specified/unspecified disorders of bone/cartilage

121

1.24

0.28

1.3

0.90

15.66

nmol/l

0.48

113

Other and unspecified acne

1.29

0.28

1.0

1.5

0.29

0.48

nmol/l

—

Bacterial pneumonia, not elsewhere classified

265

2228

1.04

0.28

1.3

3.80

2.75

nmol/l

0.12

252

2150

Other congenital malformations of the digestive system

203

1.18

0.28

1.7

1.3

0.44

9.30

nmol/l

0.51

195

Chronic hepatitis NAS

1.25

0.27

1.1

1.3

0.60

0.59

nmol/l

—

L02BX Other hormone antagonists and related agents

226

0.84

0.27

2.4

1.3

0.77

0.65

nmol/l

0.79

217

Malignant neoplasm of liver and intrahepatic bile ducts

131

1.22

0.27

1.3

1.4

1.64

14.26

nmol/l

0.45

125

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

224

1.16

0.27

1.3

1.4

1.22

8.58

nmol/l

0.45

215

Right hemicolectomy

290

1.14

0.27

1.3

0.68

6.88

nmol/l

0.50

274

Glucosamine medication

355

2733

1.04

0.27

1.3

0.66

2.63

nmol/l

1.47

337

2629

Mild mental retardation

104

1.25

0.26

1.2

1.4

0.59

0.57

nmol/l

0.06

Thrombocytopenia, unspecified

376

1.12

0.26

1.6

1.4

0.65

5.38

nmol/l

0.50

359

Hypothermia

0.66

0.26

1.0

1.4

0.36

0.64

nmol/l

—

Deep bite

558

1.09

0.25

1.2

1.3

0.57

3.74

nmol/l

0.50

537

Spinal enthesopathy

1.22

0.25

1.3

1.2

0.73

25.26

nmol/l

—

Benign neoplasm: Short bones of upper limb

1.20

0.25

1.0

1.3

0.53

0.58

nmol/l

—

Anorexia

1.19

0.24

1.1

1.4

0.56

0.52

nmol/l

—

Mental and behavioural disorders due to cannabinoids

142

1.20

0.24

1.0

1.5

0.69

0.48

nmol/l

0.70

136

Other/unspecified cytomegaloviral diseases

1.27

0.24

1.5

1.3

0.45

0.61

nmol/l

1.39

Adhesive middle ear disease

1.17

0.24

1.4

0.70

24.19

nmol/l

—

Carcinoma in situ of breast, other/unspecified

0.73

0.24

1.3

0.47

22.75

nmol/l

—

Alcohol abuse counselling and surveillance

0.74

0.24

1.0

1.4

0.83

0.57

nmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs

0.70

0.24

1.2

1.3

0.52

21.93

nmol/l

—

Dysplasia of cervi uteri

154

1030

1.05

0.23

1.2

1.3

0.51

2.71

nmol/l

0.68

148

992

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.29

0.23

1.8

1.3

0.68

0.59

nmol/l

—

Encephalopathy

1.29

0.23

1.4

1.3

0.78

0.57

nmol/l

—

Acquired absence of limb

1.29

0.23

1.0

1.2

0.46

0.55

nmol/l

—

Memory loss

505

1.09

0.23

1.3

0.69

0.68

nmol/l

0.06

483

Hyphaema and other vascular disorders of iris and ciliary body

0.77

0.22

1.3

0.60

20.37

nmol/l

—

Moderate visual impairment, binocular

125

1.20

0.22

1.2

1.3

0.70

15.28

nmol/l

0.49

116

Peripheral retinal degeneration

153

1.18

0.22

1.3

1.4

0.57

0.64

nmol/l

0.37

146

Cholesteatoma of middle ear

238

1.14

0.22

1.3

0.70

8.10

nmol/l

0.49

228

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

0.00

0.21

0.0

1.6

—

0.59

—

Lyme disease

257

2481

1.04

0.21

1.3

0.58

2.46

nmol/l

1.30

243

2394

Lyme disease, including avohilmo

257

2481

1.04

0.21

1.3

0.58

2.46

nmol/l

1.30

243

2394

Acrodermatitis chronica atrophicans

0.00

0.21

0.0

1.3

—

0.59

—

Congenital mitral valve regurgitation

0.00

0.21

0.0

2.2

—

0.54

—

Glycosuria

0.00

0.21

0.0

1.4

—

0.61

—

Need for immunization against certain single viral diseases

0.00

0.21

0.0

1.4

—

0.47

—

Lipoprotein deficiency

0.00

0.21

0.0

1.9

—

0.41

—

Benign neoplasm: Pineal gland

0.00

0.21

0.0

1.5

—

0.41

—

Onychogryphosis

0.00

0.21

0.0

1.5

—

0.61

—

Central nervous system disorder causing precocious puberty

0.00

0.21

0.0

1.2

—

0.42

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

0.21

0.0

1.4

—

0.57

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

3.2

—

0.73

—

Disorders of puberty, other/unspecified

0.00

0.21

0.0

1.3

—

0.51

—

Feeding problems of newborn

0.00

0.21

0.0

1.3

—

0.69

—

Viral pneumonia (known virus, not influenza)

126

1.19

0.21

1.3

0.52

14.80

nmol/l

0.50

120

Oral lichen planus

166

0.84

0.20

1.1

1.3

0.54

11.46

nmol/l

0.50

157

Acute alcohol intoxication, ICD10

126

1199

1.05

0.20

1.3

0.60

4.05

nmol/l

1.11

121

1158

Multiple myeloma, including Hilmo

219

0.87

0.20

2.2

1.3

0.90

8.82

nmol/l

0.48

209

Ventricular septal defect, a heart condition

1.24

0.20

1.2

0.51

nmol/l

0.02

Seropositive rheumatoid arthritis, strict definition

104

985

1.06

0.20

1.3

0.64

4.00

nmol/l

0.91

949

Intentional self-harm by sharp object

111

0.81

0.20

1.3

1.4

0.81

0.52

nmol/l

—

106

Multiple myeloma and malignant plasma cell neoplasms

229

0.87

0.20

2.1

1.3

0.88

8.54

nmol/l

0.48

216

Exposure to smoke, fire and flames

115

0.78

0.20

1.0

1.4

0.49

0.56

nmol/l

—

107

Otosclerosis

442

1.09

0.19

1.7

1.3

0.76

4.64

nmol/l

0.48

425

Severe visual impairment, monocular

1.18

0.19

1.2

1.3

0.73

38.36

nmol/l

—

Other embolism and thrombosis

782

1.06

0.19

1.3

0.56

2.87

nmol/l

0.52

758

Hepatocellular carcinoma

1.22

0.19

1.3

1.2

2.11

20.87

nmol/l

0.45

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.16

0.19

2.5

1.3

0.48

0.59

nmol/l

—

Injury of nerves at shoulder and upper arm level

1.16

0.19

1.2

1.6

0.60

0.61

nmol/l

—

Other papulosquamous disorders

1.16

0.19

1.2

1.4

0.53

0.57

nmol/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

289

1.11

0.19

1.1

1.4

0.62

6.63

nmol/l

0.49

281

Medical treatment for female infertility

131

1241

1.05

0.18

1.4

1.3

0.48

1.44

nmol/l

0.53

131

1207

Other and unspecified mental retardation

1.22

0.18

1.1

1.4

0.49

0.57

nmol/l

—

Hodgkin lymphoma, hilmo

132

0.83

0.18

1.2

1.4

0.55

0.60

nmol/l

0.21

125

Atypical mycobacterium lung infection

1.21

0.18

1.4

0.50

0.65

nmol/l

—

Other chondrocalcinosis

1.19

0.18

1.0

1.3

0.64

32.09

nmol/l

—

Other acute viral hepatitis

1.19

0.18

1.6

1.3

0.63

0.56

nmol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.17

0.18

1.3

0.70

0.57

nmol/l

—

Type1 diabetes, definitions combined, early onset

299

1.10

0.17

1.7

1.3

0.41

0.49

nmol/l

1.41

291

Brain glioblastoma, helper endpoint

1.13

0.17

1.4

1.5

1.04

30.44

nmol/l

—

Antepartum haemorrhage, not elsewhere classified

465

0.92

0.17

1.1

1.3

0.44

0.54

nmol/l

2.01

454

Cirrhosis of liver, NAS

272

1.10

0.17

1.3

0.78

7.14

nmol/l

0.48

262

Malignant neoplasm of breast, including Hilmo

337

2104

1.03

0.16

1.4

1.2

0.66

2.19

nmol/l

0.88

329

2031

Maternal care for other known or suspected fetal problems

148

892

1.04

0.16

1.3

0.49

0.54

nmol/l

1.12

143

861

Malignant neoplasm of breast, HER2-negative, including Hilmo

337

2105

1.03

0.16

1.4

1.2

0.66

2.19

nmol/l

0.88

329

2032

Cerebral palsy

1.13

0.16

1.3

1.4

0.48

0.56

nmol/l

—

Follow-up care involving plastic surgery

235

0.89

0.16

1.1

1.3

0.60

8.13

nmol/l

0.50

227

Carcinoma in situ of skin of trunk

149

1.14

0.15

2.5

1.2

0.79

12.78

nmol/l

0.49

140

Other/unspecified rheumatoid arthritis

741

1.05

0.15

1.2

1.3

0.62

4.61

nmol/l

0.79

709

Serous carcinoma of ovary, including Hilmo

234

0.90

0.15

1.7

1.3

0.71

8.22

nmol/l

0.49

225

Other diseases caused by chlamydiae, including avohilmo

1.10

0.15

1.2

1.3

0.51

0.52

nmol/l

—

Other and unspecified epidermal thickening

129

0.85

0.14

1.1

1.3

0.53

0.61

nmol/l

0.60

124

Acute otitis externa, noninfective

1.09

0.14

1.1

1.3

0.49

22.38

nmol/l

—

Other infestations, including avohilmo

1.19

0.14

1.2

1.3

0.61

20.38

nmol/l

0.50

Varicella [chickenpox]

217

1.11

0.14

1.3

1.4

0.51

0.59

nmol/l

0.62

207

Malignant neoplasm of breast, HER2-negative

330

2080

1.02

0.14

1.3

1.2

0.66

2.21

nmol/l

0.88

322

2007

Bacterial meningitis

181

0.88

0.14

1.3

1.4

0.51

10.38

nmol/l

0.50

174

All dysplastic lesions of the cervix uteri, vagina or vulva

206

1954

1.03

0.14

1.2

1.3

0.52

2.26

nmol/l

0.95

199

1892

Communicating hydrocephalus

0.81

0.13

1.3

1.2

0.50

19.07

nmol/l

—

Malignant neoplasm of ovary

325

0.92

0.13

1.5

1.3

0.70

6.07

nmol/l

0.49

314

Small cell lung cancer, including Hilmo

106

0.85

0.13

1.4

1.2

0.51

17.68

nmol/l

—

100

Small cell lung cancer

106

0.85

0.13

1.4

1.2

0.51

17.68

nmol/l

—

100

Normal-pressure hydrocephalus

221

0.90

0.12

2.1

1.2

0.79

8.88

nmol/l

0.49

207

Sequelae of other and unspecified infectious and parasitic diseases

287

1.08

0.12

1.1

1.4

0.61

6.68

nmol/l

0.49

279

Beningn neoplasm: Meninges, unspecified

1.18

0.12

1.1

1.3

0.52

22.42

nmol/l

—

Patent foramen ovale

104

1.16

0.12

4.2

1.4

0.58

0.54

nmol/l

0.25

Granulomatous disorders of skin and subcutaneous tissue

137

0.87

0.12

1.3

0.59

13.51

nmol/l

0.50

132

Malignant neoplasm of breast

329

2082

1.02

0.11

1.3

1.2

0.66

2.21

nmol/l

0.88

321

2009

Single spontaneous delivery

300

1613

0.98

0.10

1.3

0.61

2.52

nmol/l

0.90

292

1540

Delivery, wide proxy

246

1279

1.02

0.10

1.3

0.63

2.37

nmol/l

0.64

239

1214

Thyrotoxicosis with toxic single thyroid nodule

1.14

0.10

1.0

1.4

0.76

0.60

nmol/l

—

Delivery

313

1621

1.02

0.09

1.2

1.3

0.61

2.51

nmol/l

0.90

305

1548

Exposure to unspecified smoke, fire and flames

1.09

0.09

1.0

1.4

0.46

0.52

nmol/l

—

Impacted teeth

109

963

0.97

0.09

1.8

1.3

0.48

0.49

nmol/l

0.17

104

932

Oral leukoplakia, including avohilmo

145

1.11

0.09

1.3

1.4

0.53

13.25

nmol/l

0.50

135

Frostbite

1.04

0.09

1.0

1.4

0.30

0.49

nmol/l

—

Embedded and impacted teeth

156

1295

0.98

0.09

1.6

1.3

0.48

1.86

nmol/l

0.51

151

1255

Other and specified injuries of hip and thigh

1.14

0.09

1.2

1.3

0.61

19.47

nmol/l

0.49

Benign neoplasm: Appendix

1.11

0.09

1.2

0.55

0.59

nmol/l

—

Diabetic retinopathy

297

1813

1.02

0.09

1.3

1.4

4.13

2.07

nmol/l

0.24

287

1750

Pedestrian injured in other and unspecified transport accidents

1.07

0.08

1.8

1.4

1.03

0.59

nmol/l

—

Contusion of toe(s) with damage to nail

1.05

0.08

1.2

1.3

0.67

0.52

nmol/l

—

Coronary artery bypass grafting

127

918

1.03

0.08

1.3

0.72

2.79

nmol/l

0.54

122

879

Tularaemia

0.83

0.08

1.2

1.3

0.52

0.54

nmol/l

—

Carcinoma in situ of cervix uteri

552

0.96

0.08

1.2

1.3

0.53

3.71

nmol/l

0.50

534

Other osteochondrodysplasias, including avohilmo

0.79

0.08

1.0

1.4

0.68

0.57

nmol/l

—

Personal history of malignant neoplasm

558

1.04

0.08

1.1

1.3

0.58

6.61

nmol/l

0.93

535

Evidence of alcohol involvement determined by blood alcohol level

0.77

0.08

1.2

1.4

0.68

0.58

nmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

117

1.11

0.08

1.2

1.3

0.64

16.04

nmol/l

0.49

110

Late syphilis

1.09

0.08

1.3

1.2

0.34

0.57

nmol/l

—

Myeloid leukaemia

117

1.11

0.08

1.4

1.3

0.48

0.63

nmol/l

1.62

110

Problems related to social environment

117

1.11

0.08

1.4

1.3

0.59

16.05

nmol/l

0.50

110

Thyroiditis, unspecified

1.08

0.08

2.1

1.3

0.73

29.38

nmol/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

391

2840

1.01

0.08

1.3

0.60

1.75

nmol/l

0.89

377

2747

Drug-induced cataract

123

0.89

0.08

1.6

1.3

73.28

0.62

nmol/l

0.47

117

Malignant neoplasm of other and unspecified parts of biliary tract

0.80

0.07

1.3

1.5

0.55

25.36

nmol/l

—

Third [oculomotor] nerve palsy

1.05

0.07

3.5

1.5

0.79

24.91

nmol/l

—

Portal vein thrombosis

1.04

0.07

1.1

1.3

0.84

24.54

nmol/l

—

Late syphilis, including avohilmo

1.03

0.07

1.3

1.2

0.39

0.57

nmol/l

—

Aggressive periodontitis

112

0.89

0.07

1.3

0.80

16.95

nmol/l

—

104

Congenital deformities of hip

0.85

0.07

1.0

1.4

0.60

22.60

nmol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

163

0.92

0.07

1.0

1.3

0.42

0.50

nmol/l

1.06

156

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.83

0.07

1.0

1.4

0.54

0.55

nmol/l

—

Diffuse large B-cell lymphoma, helper endpoint

255

0.94

0.07

1.5

1.4

0.79

7.64

nmol/l

0.49

244

Diffuse large B-cell lymphoma, including Hilmo

255

0.94

0.07

1.5

1.4

0.79

7.64

nmol/l

0.49

244

Diffuse large B-cell lymphoma

255

0.94

0.07

1.5

1.4

0.79

7.64

nmol/l

0.49

244

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

118

1.10

0.07

1.1

1.3

0.72

15.85

nmol/l

0.49

112

Drug-induced osteoporosis with pathological fracture

1.13

0.07

1.1

1.3

0.60

21.39

nmol/l

—

Mixed connective tissue disease

0.85

0.06

1.3

0.48

19.67

nmol/l

—

Contact with sharp object, undetermined intent

128

1.10

0.06

1.2

1.4

0.53

0.57

nmol/l

0.46

121

UC patients in KELA-register (code 208), prior to 1994

226

1.06

0.06

1.1

1.4

0.68

8.50

nmol/l

0.50

217

Malignant neoplasm of bone and articular cartilage, including Hilmo

1.11

0.06

1.1

1.4

0.51

18.97

nmol/l

0.50

Disorders of oesophagus in diseases classified elsewhere

1.11

0.06

1.7

1.3

0.82

18.77

nmol/l

0.49

Other and unspecified nonorganic psychotic disorders

122

1196

1.02

0.06

1.2

1.3

0.67

2.02

nmol/l

0.45

112

1162

Non-follicular lymphoma

517

0.97

0.06

1.4

1.3

0.69

4.11

nmol/l

0.49

493

Melanocytic naevi of upper limb, including shoulder

119

1.09

0.06

1.5

1.3

0.85

15.73

nmol/l

0.48

112

Other lesions of median nerve

121

0.91

0.06

1.3

0.68

15.73

nmol/l

0.50

113

Meningitis

267

1.05

0.05

1.3

0.52

7.25

nmol/l

0.51

256

Assault by unspecified means

100

1.10

0.05

1.0

1.4

0.55

nmol/l

0.04

Pedestrian injured in collision with car, pick-up truck or van

110

0.91

0.05

1.1

1.3

0.52

17.27

nmol/l

—

102

Erosion and ectropion of cervix uteri

169

1.07

0.05

1.3

1.2

0.67

13.44

nmol/l

0.64

164

Chronic suppurative otitis media

327

1.04

0.04

1.3

1.4

0.57

6.04

nmol/l

0.50

314

Other disorders of iris and ciliary body

130

0.92

0.04

1.2

0.63

14.21

nmol/l

0.50

125

Hepatic failure, not elsewhere classified

170

1.06

0.04

1.4

1.3

0.67

11.14

nmol/l

0.50

162

Burn and corrosion of wrist and hand

170

1.06

0.04

1.7

1.4

0.58

nmol/l

0.02

164

HSIL lesion of the cervix uteri, vagina or vulva

130

1285

1.01

0.03

1.2

1.3

0.53

2.79

nmol/l

0.79

123

1251

Non-allergic asthma

459

1.02

0.03

1.6

1.3

0.64

4.43

nmol/l

0.49

446

Diffuse brain injury

112

1.07

0.03

1.1

1.5

0.58

16.64

nmol/l

0.50

106

Malignant neoplasm of ovary, including Hilmo

430

0.98

0.02

1.5

1.3

0.66

7.40

nmol/l

0.78

415

Failed induction of labour

279

0.97

0.02

1.3

0.42

0.47

nmol/l

0.66

270

Systemic atrophies primarily affecting the central nervous system

198

0.96

0.02

1.2

1.4

0.67

9.69

nmol/l

0.50

188

Chronic iridocyclitis

262

1.03

0.02

1.0

1.4

0.66

7.38

nmol/l

0.49

252

Oral lichen planus and hypothyroidism or thyroxine medication

123

1.06

0.01

1.2

0.72

15.17

nmol/l

0.49

117

LSIL lesion of the cervix uteri

681

1.01

0.01

1.3

0.50

3.11

nmol/l

0.51

663

conjunctival degenerations and deposits

106

0.94

0.01

1.6

1.5

0.73

17.50

nmol/l

—

101

Mumps, including avohilmo

136

0.96

0.00

1.2

1.5

0.59

13.88

nmol/l

0.50

128

Fall involving bed

154

1.04

0.00

1.3

1.2

0.75

12.20

nmol/l

0.49

147

Schizophrenia or delusion

212

2113

1.00

0.00

1.3

0.66

2.74

nmol/l

1.19

199

2046

Atrial septal defect

173

1.03

0.00

1.3

1.4

0.68

0.58

nmol/l

0.59

165

Respiratory tuberculosis, not confirmed, including avohilmo

169

1.01

0.00

1.1

1.2

0.66

11.28

nmol/l

0.50

160

Respiratory tuberculosis, not confirmed

169

1.01

0.00

1.1

1.2

0.66

11.28

nmol/l

0.50

160

Schizophrenia, schizotypal and delusional disorders

212

2122

1.00

0.00

1.3

0.66

2.73

nmol/l

1.20

199

2056

Benign neoplasm: Parotid gland

451

1.00

0.00

1.1

1.3

0.66

4.57

nmol/l

0.49

433

Burn and corrosion of hip and lower limb, except ankle and foot

104

0.96

0.00

1.5

1.4

0.63

0.58

nmol/l

—

Oesophageal obstruction

156

1.03

0.00

1.4

1.2

0.69

12.09

nmol/l

0.50

149

Secondary parkinsonism

128

1.02

0.00

1.3

0.76

14.57

nmol/l

0.49

122

Anisometropia and aniseikonia

166

1.02

0.00

1.8

1.3

47.73

11.23

nmol/l

0.34

160

Orthopaedic devices associated with adverse incidents

109

1.01

0.00

1.1

1.2

0.65

17.14

nmol/l

0.49

103

Secondary parkinsonism+Parkinsonism in other disease

129

1.01

0.00

1.3

0.76

14.46

nmol/l

0.49

123

Short Achilles tendon (acquired)

141

0.99

0.00

1.1

1.4

0.61

13.25

nmol/l

0.50

135

Mumps

133

0.98

0.00

1.2

1.5

0.59

14.20

nmol/l

0.50

125

Rare circulating lymphoid malignancy, including Hilmo

128

1.02

0.00

1.7

1.3

0.50

14.70

nmol/l

0.50

121

Hypospadias with an incomplete glans penis

0.00

0.0

2.3

—

0.45

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

2.3

—

0.47

—

Noonan syndrome

0.00

0.0

2.0

—

0.45

—

Defect, injury or illness of face

0.00

0.0

1.4

—

0.40

—

Marginal zone B-cell lymphoma, including Hilmo

0.93

0.00

1.1

1.3

0.58

22.18

nmol/l

—

Defect, injury or illness of skull

0.00

0.0

1.6

—

0.66

—

Other and unspecified disorders of sclera

0.00

0.0

2.1

—

0.42

—

Mucinosis of skin

0.00

0.0

1.2

—

0.38

—

Dextrocardia

0.00

0.0

2.8

—

0.38

—

Hypoplasia of dental enamel, prenatal

0.00

0.0

1.6

—

0.55

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

2.5

—

0.45

—

Other nonthrombocytopenic purpura

0.92

0.00

1.0

1.4

0.42

0.57

nmol/l

—

Pectus carinatum

0.00

0.0

1.1

—

0.49

—

Coccidioidomycosis, including avohilmo

0.00

0.0

1.4

—

0.56

—

Other disorders of kidney and ureter in diseases classified elsewhere

0.00

0.0

1.4

—

0.52

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.0

1.4

—

0.59

—

Disorders of glycoprotein metabolism

0.00

0.0

1.3

—

0.37

—

Certain zoonotic bacterial diseases

1.00

-0.00

1.1

1.4

0.56

0.57

nmol/l

—

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

-0.00

0.0

1.6

—

0.46

—

Syndactyly

0.00

-0.00

0.0

1.1

—

0.43

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

0.32

—

Congenital malformations of nose, including avohilmo

0.00

-0.00

0.0

2.8

—

0.48

—

Leprosy [Hansen's disease]

0.00

-0.00

0.0

2.8

—

0.50

—

Congenital malformations of nose

0.00

-0.00

0.0

3.0

—

0.49

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.8

—

0.51

—

Retinoblastoma, including Hilmo

0.00

-0.00

0.0

2.8

—

0.64

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.2

—

0.38

—

Secondary thrombocytopenia

0.85

-0.00

1.2

1.3

0.62

0.58

nmol/l

—

Endometroid carcinoma of ovary, including Hilmo

0.85

-0.00

1.4

1.3

0.84

32.16

nmol/l

—

Pectus carinatum, including avohilmo

0.00

-0.00

0.0

1.8

—

0.49

—

Huntington disease

0.00

-0.00

0.0

1.4

—

0.54

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.3

—

0.59

—

Hereditary ataxia

0.89

-0.00

1.2

1.3

0.40

0.55

nmol/l

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

3.4

—

0.94

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

0.48

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.2

—

0.46

—

Linear scleroderma

0.00

-0.00

0.0

2.0

—

0.57

—

Acute poliomyelitis, including avohilmo

0.95

-0.00

2.2

1.3

1.02

30.44

nmol/l

—

Disorders of glycine metabolism

0.00

-0.00

0.0

1.0

—

0.50

—

0.00

-0.00

0.0

1.6

—

0.48

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.3

—

0.53

—

Nephropathy induced by unspecified drug, medicament or biological substance

0.00

-0.00

0.0

1.4

—

0.76

—

Congenital deformities of hip, including avohilmo

0.92

-0.00

1.0

1.3

0.63

21.26

nmol/l

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

2.7

—

0.35

—

Freckles

0.00

-0.00

0.0

1.4

—

0.62

—

conjunctival scars

0.00

-0.00

0.0

2.4

—

0.50

—

Malignant neoplasm of base of tongue, including Hilmo

1.00

-0.00

1.2

1.3

0.56

38.41

nmol/l

—

Degenerative and vascular disorders of ear

0.00

-0.00

0.0

1.4

—

0.80

—

Atypical virus infections of central nervous system, including avohilmo

1.00

-0.00

1.0

1.3

0.50

0.56

nmol/l

—

Operations for atrial fibrillation

0.97

-0.00

1.3

0.55

0.54

nmol/l

—

Other drug-induced osteomalacia in adults

0.00

-0.00

0.0

1.4

—

0.54

—

Small cell lung cancer, helper endpoint

0.93

-0.00

1.4

1.3

0.51

0.68

nmol/l

—

Other specified air transport accidents

0.00

-0.00

0.0

1.2

—

0.60

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

0.42

—

Atypical virus infections of central nervous system

1.02

-0.00

1.0

1.3

0.50

0.57

nmol/l

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

2.0

—

0.44

—

Erythema elevatum diutinum

0.00

-0.00

0.0

1.4

—

0.62

—

Juvenile dermatomyositis

0.00

-0.00

0.0

2.2

—

0.50

—

Genetic anomalies of leukocytes

0.00

-0.00

0.0

1.4

—

0.62

—

Other disorders of choroid

0.95

-0.00

2.3

1.5

0.67

0.63

nmol/l

—

Other and unspecified injuries of thorax

0.94

-0.00

1.0

1.3

0.59

0.56

nmol/l

—

Other early complications of trauma

0.00

-0.00

0.0

1.4

—

0.58

—

Melanoma in situ of trunk

0.87

-0.00

1.7

1.4

0.68

0.58

nmol/l

—

Complicated migraine, drug-induced

0.00

-0.00

0.0

1.5

—

0.63

—

Chronic drug-induced interstitial lung disorders

0.00

-0.00

0.0

2.6

—

0.59

—

Exposure to excessive cold of man-made origin

0.00

-0.00

0.0

1.8

—

0.60

—

Exposure to electric transmission lines

0.00

-0.00

0.0

1.0

—

0.60

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.4

—

0.62

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

0.44

—

Foreign body in ear

0.95

-0.00

1.6

1.2

0.70

0.51

nmol/l

—

Explosion and rupture of other specified pressurized devices

0.00

-0.00

0.0

2.1

—

0.44

—

Crohn's disease (strict) with PSC

0.00

-0.00

0.0

2.0

—

0.52

—

Other histiocytosis syndromes

0.00

-0.00

0.0

1.4

—

0.57

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.6

—

0.74

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

-0.00

0.0

1.0

—

0.74

—

Retinoblastoma

0.00

-0.00

0.0

2.8

—

0.64

—

Thalassaemia trait

0.00

-0.00

0.0

1.2

—

0.44

—

Pinta [carate], including avohilmo

0.00

-0.00

0.0

1.6

—

0.78

—

Convulsions of newborn

0.00

-0.00

0.0

1.0

—

0.50

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.3

—

0.44

—

Mantle cell lymphoma, including Hilmo

0.92

-0.00

1.2

1.3

0.62

28.98

nmol/l

—

Acute poliomyelitis

0.95

-0.00

2.2

1.3

1.02

30.44

nmol/l

—

Disorders of copper metabolism

0.00

-0.00

0.0

2.2

—

0.37

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

2.2

—

0.51

—

Victim of lightning

0.00

-0.00

0.0

1.3

—

0.59

—

Marginal zone B-cell lymphoma

0.86

-0.00

1.2

1.3

0.60

33.33

nmol/l

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.2

—

0.47

—

Diphyllobothriasis and sparganosis, including avohilmo

0.00

-0.00

0.0

1.3

—

0.46

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

-0.00

0.0

2.3

—

0.53

—

Lichen nitidus

0.00

-0.00

0.0

1.6

—

0.42

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Normetanephrine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS